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ABSTRACT
Synthesis, RNA Binding and Antibacterial Studies of 2-DOS Mimetics
AND
Development of Polymer Supported Nanoparticle Catalysts for Nitroarene and Azide Reduction
Venkata Reddy Udumula
Department of Chemistry & Biochemistry, BYU
Doctor of Philosophy
Project I 2-Deoxystreptamine (2-DOS), the most conserved central scaffold of
aminoglycosides, is known to specifically recognize the 5’-GU-‘3 sequence step through highly
conserved hydrogen bonds and electrostatic interactions within and without the context of
aminoglycosides. We proposed that a novel monomeric unnatural amino acid building block
using 2-DOS as a template would allow us to develop RNA binding molecules with higher
affinity and selectivity than those currently available. Conjugating two or more of the monomeric
building blocks by an amide bond would introduce extra hydrogen bonding donors and acceptors
that are absent in natural aminoglycosides and increase specificity of binding to a target RNA
through a network of hydrogen bonds. In addition, the amide conjugation between the
monomeric building blocks places two GU-base recognizing amines at 5 Å distance, which is
equal to the distance of neighboring base stacks in dsRNAs We hypothesized that targeting
dsRNAs containing multiple consecutive 5’-GU-‘3 sequence steps would become possible by
connecting two or more of the monomeric building blocks by amide bonds. According to the
proposed hypothesis, we designed three dimeric 2-DOS compounds connected by an amide
bond. These three targets include the dimeric 2-DOS substrate connected by an amide bond, the
dimeric 2-DOS containing the sugar moiety from Neamine, and a dimeric 2-DOS connected by a
urea linker. These compounds were then tested for sequence specific binding against 8 different
RNA strands, and for antibacterial activity against E. coli, actinobacter baumannii and klebsiella.

Key Words: aminoglycosides, RNA binding studies, 2-DOS, antibiotics

Project II A dual optimization approach was used for to enhance the catalytic activity
and chemoselectivity for nitro reduction. In this approach the composition of the nanoparticles
and electronics effects of the polymer were studied towards nitro reduction. Bimetallic
Ruthenium−Cobalt nanoparticles showed exceptional catalytic activity and chemoselectivity
compared to monometallic Ruthenium nanoparticles. The electronic effects of the polymer
also had a significant effect on the catalytic activity of the bimetallic nanoparticles. The
electron-deficient poly(4-trifluoromethylstyrene) supported bimetallic nanoparticles undergo
nitro reduction in 20 minutes at room temperature, whereas electron-rich poly(4methylstyrene) and poly(4-methoxystyrene) supported bimetallic nanoparticles to longer
reaction times to go to completion. Electronics of the polymers also effects the change in
mechanism of nitroreduction. Polystyrene bimetallic Ruthenium−Cobalt nanoparticles showed
excellent yields and chemoselectivity towards nitro functional group in the presence of easily
reducible functional groups like alkenes, alkynes, allyl ethers, propargyl ethers.

Monometallic ruthenium nanoparticles also showed excellent reactivity and chemoselectivity
towards azide reduction in the presence of easily reducible functional groups. Interestingly
monometallic ruthenium nanoparticles showed regioselective reduction of primary azides in the
presence of secondary and benzylic azides, also aromatic azides can be selectively reduced in the
presence of secondary azides. These polystyrene supported nanoparticles are heterogeneous and
are easily separated from the reaction mixture and reused multiple times without significant of
catalytic activity.

Key words: bimetallic nanoparticle, nitroarene reduction, polymer support, metal-support
interaction
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Chapter-1
Aminoglycoside Antibiotics and Selective RNA Binding Molecules
1.1 Introduction
1.1.1 RNA as Drug Target
Ribonucleic acid or RNA, along with DNA and proteins, is one of the important biological
macromolecules used by all forms of life. The genetic information in a cell flows from DNA to
RNA, and then from RNA to proteins. “DNA makes RNA makes protein”. Proteins are the
workhorses of the cell and play important roles as enzymes and structural components. DNA
carries all of the genetic information required for the cell to grow, to take in nutrients, and to
propagate. When a cell requires a protein, the portion of DNA that codes for that protein gets
activated and produces multiple copies of mRNA. These copies of mRNA, with the help of
ribosomes, are then used to build proteins. Until recently, RNA was believed to be important
only in protein synthesis as mRNA, tRNA and rRNA. However, scientists begun to realize that
the functions of RNA are much broader. Ribozymes are catalytic RNAs that help to speed
chemical reactions. In several clinically important viruses, RNA has also been shown to carry
genetic information rather than DNA.
Until recently pharmaceutical companies focus on targeting proteins for drug discovery, but
with the discovery of several other functions of RNA, researchers started designing of RNA
binding small molecules as a part of drug discovery efforts. Targeting RNA has several
advantages compared to protein targeted drugs due to several reasons First, RNA provides
unprecedented access to targets that have not been susceptible to conventional drug discovery
efforts. Traditional drug discovery has focused targeting on only a few hundred endogenous
1

proteins such as receptors, enzymes and ion channels, which accounts for about 17 % of the
human genome.1 Second, targeting mRNAs is a much more economical approach compared to
targeting proteins because the cellular pathways may be controlled one step ahead of protein
translation with relatively fewer numbers of targets and structural diversities. In addition, Human
mRNA molecules are frequently tissue or disease specific, and mRNAs encoding oncogenic
proteins often contain unique sequences that are not found in normal cells.4 Thus, RNA has
received increasing attention as a proven drug target over the past few years. Ribosomal RNAs
(rRNAs) are targets of numerous antibiotics.2 Naturally occurring antibiotics also bind to viral
mRNA such as HIV-I RRE (Rev Response Element) and TAR3 (Trans Activation Response),
and reduce HIV-1 replication rates.
Antisense and RNAi (RNA interference) technology are also commonly used strategies to
target RNA for preventing and controlling disease 5. In this approach, nucleic acid strand or
antisense strand is synthesized complementary to mRNA produced by that gene that causes a
disease. The synthesized antisense strand is delivered into cytoplasm which binds to the mRNA
and forms double helix, thus preventing them from synthesizing the proteins responsible for that
disease. However these strategies have several disadvantages like the toxicity, instability and
also lack of efficient delivery mechanism of the RNAi and antisense molecules. Due to these
disadvantages these strategies are limited in practical therapeutic application6 so, due to several
disadvantages of these strategies it is necessary to design and develop small molecules that bind
selectively to RNA and prevent the proteinsynthesis responsible for that disease.

2

1.1.2 RNA Structure
The binding of several ligands to RNA is due to the ability of the RNA to have several
different tertiary conformations7. The structure of the RNA has been elucidated by variety of
spectroscopic and chemical probing experiments

8

which made little easier to find the binding

sites of the RNA. RNA has structural characters that are similar to both DNA and proteins. DNA
exists as a double helix, while RNA exists largely as a single stranded nucleotide chains.
However RNA can fold on itself by base pairing, forming small self-complementary stands,
which results in tertiary structures. The folded RNA is stabilized by a variety of interactions, the
most important of which are hydrogen bonding and base stacking. RNA can assume several
different secondary and tertiary conformations similar to proteins 9 via hydrogen bonding and
base stacking between base pairs. Naturally occurring RNAs largely exists in A-form
conformations or exists as spherical double helix connected by single stranded regions (Figure
1.1). RNA A- helix has major and minor groove similar to DNA, the major groove largely
contributes to the binding of the proteins and small molecules. The mismatched bases of major
groove of A-helix RNA widen the major groove allowing the binding of small molecules.

Figure 1.1 Possible secondary structures of RNA
3

The secondary and tertiary interactions of the RNA form complex three-dimensional
structures containing bulges, hairpins, loops and peudoknots (Figure 1.1). Rational design of
RNA binding small molecules is a challenge due to the complex three-dimensional structure of
RNA. There are few reports on how small molecules bind to RNA with high affinity and
specificity 10 However there are no specific rules or model for the structure-based rational design
of small molecules to target specific RNA sequences and structures.
1.2 Aminoglycosides
The aminoglycosides are a class of antibiotics whose mode of action involves specific
binding to RNA. The important structural features of the aminoglycoside antibiotics is a 1, 3diaminocyclohexanetriol core structure termed known as 2-deoxystreptamine or 2-DOS (Figure
1.2). 2-Deoxystreptamine is important for the biological activity of the aminoglycosides, which
form a large class of clinically important antibiotics with a broad antibacterial spectrum,
particularly against Gram-negative bacteria.10b Naturally occurring aminoglycosides can be
readily isolated from actinomycetes of either genus Streptomyces or Micromonospora.11 Most of
the aminoglycosides contain amino sugars, which are either mono 6-amino or 2,6-diamino
substituted.
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Figure 1.2 Chemical structures of the three aminoglycoside subclasses and their substitution
sites. The central scaffold 2-DOS is shown in the red color and is present in all types of
aminoglycoside antibiotics.
The streptamine core structure of the aminoglycosides contains a highly conserved 1,3diamino functional groups. Apart from this conserved structure, streptamine also contains
hydroxyl groups at various positions. Streptamine itself contains hydroxyl groups at each of the 4
carbons not containing amine functionality. If streptamine contains only 3-hydroxyl groups,
which is most common among the aminoglycoside antibiotics, then the core structure is called 2deoxystreptamine. The hydroxyl groups of the streptamine core act as anchoring points for the
attachment of various aminosugars. Based on the substitution pattern of the streptamine ring, the
aminoglycosides can be categorized as 4-monosubstituted 4,5-disubstituted or 4, 6-disubstituted
(Figure 1.3). The presence of various amino group in the aminoglycosides, which are protonated
and charged under physiological conditions, explains their strong affinity towards negatively
charged nucleotides.
5

Figure 1.3 Structures of aminoglycosides based on connectivity around central scaffold 2-DOS
Aminoglycoside antibiotics bind to the aminoacyl site or A-site decoding region of the
bacterial 16S ribosomal RNA within the 30S subunit and prevent the translocation of peptidyl tRNA from A-site to P-site thereby inhibiting the synthesis of proteins necessary for bacteria to
grow, leading to cell death

12

. Aminoglycosides are shown to have high promiscuous binding

towards A-site RNA which means they bind to different to several different structural elements
of RNA such as Bulges, internal loops, hairpin loops and stem junctions without any specificity
3

. Many nucleic acid intercalating molecules such as 2, 6-diaminopurine-linked acridine,

ethidium-arginine, acrine-4-carboxamide derivatives, and tetracationic diphenylfuran derivatives
are also shown to have high promiscuous binding towards RNA

13.

Aminoglycosides are also

shown to have strong binding affinity towards RRE (Rev Response Element) of HIV-1 thereby
preventing the growth of the virus. Neomycin is shown to bind to HIV TAR and HIV RRE

6

prevents the growth of HIV virus 3. The strong binding affinity of the aminoglycosides to A-site
RNA is due to the noncovalent interaction or hydrogen bonding between the amino groups of
aminoglycosides and the hydroxyl groups of the RNA bases and also due to the electrostatic
interactions between the negatively charged phosphate backbone of RNA and positively charged
ammonium groups of the aminoglycosides.
All these studies showed that aminoglycosides serve as potential antibiotics.
Aminoglycosides are also shown to have binding towards viral RNA and inhibits viral
replication which opens the door for further drug development of antiviral drugs.
1.3 Toxicity and Resistance in Aminoglycoside Antibiotics
Aminoglycosides are highly potent, broad spectrum antibiotics. Despite their broad
application, the high levels of ototoxicity (hearing loss) and nephrotoxicity (kidney damage)
caused by treatment with these aminoglycosides often limits their use.14 Nephrotoxicity is
usually reversible, while ototoxicity is permanent and not reversible. Nephrotoxicity is caused by
the accumulation of aminoglycosides in the renal cortex. Ototoxicity results from a combination
of different mechanisms, one mechanism resulting from the structural similarity between
bacterial rRNA and mitochondrial rRNA. Aminoglycosides also bind to mitochondrial 12S
rRNA and cause misreading in mitochondrial protein synthesis. Thus, tissues rich in
mitochondria are predominantly effected.16 Aminoglycosides also decrease mitochondrial ATP
synthesis, which in turn decreases ion pump activity. Reduced ion pump activity in strial
intermediate cells could ultimately lead to a progressive decrease of the endocochlear potential17.
The main cause of the toxicity of the aminoglycosides is due to the basicity of the amine groups.
It has been shown that a decrease in the number of amine groups in aminoglycosides results in
lower toxicity. In addition, a decrease in the number of hydroxyl group’s results in higher
7

toxicity.18 For example, it was shown that neomycin is more toxic than paromycin because of the
presence of the greater number of amine groups in neomycin. Also removing hydroxyl groups,
which are electron-withdrawing groups significantly increases the toxicity of aminoglycosides.
Displacement of 5-OH in 2-DOS with a fluorine group results in a decrease in toxicity in
amikacin. This decrease is due to a lowering of the basicity of the amine groups by the electron
withdrawing fluorine group.19 N-acetylated aminoglycosides also possess considerably lower
toxicity than their free amine compounds, further substantiating this hypothesis.20
The increasing resistance of bacteria to the major classes of antibiotics alarms the
development of novel antibiotics. Bacteria develops resistance to aminoglycoside antibiotics via
three different mechanisms. 1) Mutation of the ribosomal target, 2) Reduced permeability for the
antibiotics, 3) enzymatic modification of drugs leading to inactivation

22

. Among these three

resistance pathways, enzymatic modification is the most significant source of resistance
development.23 Based on their mode of action of the enzymes that modify aminoglycosides, they
are classified in to different types.
transferases

(ANTs)

and

They include N-acetyltransferases (AACs), O-adenyl

O-phosphotransferases

(APHs).

These

enzymes

modify

aminoglycosides through N-acetylation of amino groups, or by adenylation and phosphorylation
of hydroxyl groups.
Information on the structure-activity profile of aminoglycoside antibiotics has also been
reported. Recent studies on tobramycin, kanamycin A and B, amikacin and gentamicin showed
that differences in ring III did not alter the interaction of aminoglycosides with target rRNA, but
variations in ring I and II significantly affected the binding of aminoglycosides to RNA (Figure
1.4).24 It is the I and II rings that make the highly conserved interactions with the target RNA.
Acetylation of amines, adenylation and phosphorylation of hydroxyl groups results in loss of
8

ability to form hydrogen bonding and electrostatic interactions between aminoglycosides and
target RNAs, ultimately causing the aminoglycosides to lose binding affinity completely for
RNA targets.25 Therefore, while it is necessary to discover new aminoglycosides that are less
prone to enzymatic modification and that have low toxicity, modification of the 2deoxystreptamine core of the aminoglycosides (rings I and II) may be a good starting point for
these pursuits.

Figure 1.4 Ring structure of aminoglycosides.
1.4 Molecular Mechanism of Action of Aminoglycosides
Aminoglycosides are traditionally gram-negative antibacterial therapeutic agents and act
by inhibiting protein synthesis. This is mainly due to their promiscuous structural properties,
which allow them to bind to different types of RNA targets such as prokaryotic ribosomal A-site,
HIV TAR, HIV RRE, Group 1 intron, RNase P, and tmRNA. Aminoglycosides are known to
induce miscoding during protein synthesis. The binding site of aminoglycosides was found to be
located at the aminoacyl-tRNA decoding site (A-site) on the 16S ribosomal RNA of the bacterial
30S ribosomal sub unit.26 This binding prevents the translocation of peptidyl-tRNA from the Asite to the P-site. This inhibits synthesis of vital bacterial proteins or leads to the synthesis of
nonfunctional misfolded proteins, eventually killing the bacteria. Puglisi et al. prepared a small
model oligonucleotide that mimics A-site RNA to study the important nucleotides of A-site RNA
that effect the binding of aminoglycosides27-28. This finding initiated the characterization of
9

aminoglycoside molecules that bind to A-site RNA at molecular level. This section will
summarize the molecular mechanism of aminoglycoside antibiotic recognition by the ribosomal
RNA from the available crystal structures of the various aminoglycoside/A-site complexes
Ramakrishnan et al. reported the high-resolution structure of the 30S ribosomal subunit
from Thermus thermophilus in both free form29 and 30S subunit complexed with
paromomycin30. These crystal structures help in understanding the mechanism of action of
antibiotics. Paromomycin has one specific binding site called the A-site in the 30S particle. The
A-site of the bacterial ribosome has certain features that help in binding of the aminoglycosides.
The strong binding affinity of aminoglycosides is attributed to the hydrogen bonding and
electrostatic interactions that they form in the narrow drug pocket of the A-site. It is believed that
the wobble base pair U1495-U1406; bases A1408, A1492 and A1493; as well as the base pair
C1409-G1491 are responsible for hydrogen bonding ability in the A-site31 (Figure 1.5).

Figure 1.531 Crystal structure of the 30S particle. (a) View of the 50S-facing side, with the
16SrRNA and the proteins shown in grey and red, respectively.8 The A site (green box) is located
at the foot of helix 44 (bold). The conserved A-site sequence and its corresponding numbering in
E. coli are speciﬁed. (b) Superimposition (based on the sugar–phosphate backbone atoms) of the
A site free (grey) 8and bound to paromomycin (gold) 31 inside the 30S particle
The currently accepted mechanism for the primary mode of action of most of 4, 5- and 4,
6-disubstituted 2-DOS aminoglycosides suggests that these aminoglycosides bind to the
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ribosomal A-site and lock the A-site conformation in active (open) state in the absence of
cognate the tRNA-mRNA complex.32 This increases the affinity of A-site to non-cognate tRNAmRNA complexes which unable the ribosome to distinguish between non-cognate and cognate
complexes. This results in the synthesis of mistranslated proteins and eventually the death of the
bacterial cell.31
The A-site RNA is made up of three Watson-Crick G= C pairs, one U=U wobble base
pair, and an internal loop made of three adenines (A1408, A1492 and A1493) in which A1492
and A1493 fold back within the helix (Figure 1.5). When aminoglycoside paromomycin binds to
the ribosomal A-site RNA, the puckered sugar I (figure 1.4) is inserted into the A-site helix by
stacking against the G1491 residue by forming two hydrogen bonds to the Watson-Crick sites of
the universally conserved A1408. This causes A1492 and A1493 to fully bulge out from the
helix31.
The first step of translation is the formation of a helix between the codon of the mRNA
and the anticodon of the cognate aminoacyl-tRNA, which helps in selection of the aminoacyltRNA, this happens at the A-site near A1492 and A1493

41

. When the complex is formed

between the tRNA-mRNA, the two adenines (A1492 and A1493) flip out from the A-site helix.
This molecular switch decides the continuation of translation42. The stability of the
conformations of A-site is increased only when cognate tRNA-mRNA complex is formed, but
when aminoglycosides like paromomycin binds to mRNA the stability of the non-cognate
aminoacyl-tRNA binding to A-site is also increased and this disturbs the translation as the
ribosome is unable to discriminate between cognate and noncognate tRNA-mRNA complexes.
This results in the synthesis of mistranslated proteins and eventually the death of bacteria.31
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1.5 2-Deoxystreptamine Mimetics
This section describes some of the most recent research on 2-deoxystreptamine (2-DOS)
aminoglycoside mimetics, as well as provides the background that led to the design of our
research. Aminoglycosides provide very important insights through their binding to RNA at a
molecular level through X-ray crystal structures of aminoglycosides complexed with the 30S
ribosomal particle or the A-site 16S rRNA29. Aminoglycosides have been shown to bind to
RNAs, such as A-site rRNA, ribozymes, and HIV-1, RRE and TAR3. These RNAs contain 5’GU-‘3 or 5’-GG-‘3 base steps in common next to bulge nucleotides. A similar binding pattern
was observed without exception for 2-DOS, the central scaffold of aminoglycodides, regardless
of its substitution positions. For instance, the crystal structure of six aminoglycoside antibiotics
(neamine, gentamycin, C1A, kanamycin A, ribostamycin, lividomcin A and neomycin B) and
oligonucleotides containing the decoding A-site of bacterial ribosome revealed that the rings I
and II (2-DOS) are essential for sequence-specific recognition (Figure 1.6). Up to eight direct
hydrogen bonds are conserved in rings I and II (2-DOS) of the six aminoglycosides. The
puckered sugar ring I is inserted into the A-site helix by stacking against G1491 and forms of
pseudo base pair with two hydrogen bonds to the Watson-Crick sites of the universally
conserved A1408 33 (figure 1.6).
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Figure 1.6 Sequence specific recognition of A-site RNA by rings I and II (2-DOS) in six different
aminoglycosides. Hydrogen bonding (
) and electrostatic interactions (-------) that are
conservative throughout the aminoglycosides are indicated with dashed lines. Ring I shows
highly conserved binding pattern with A1408. The 2-DOS (ring II) unanimously recognizes the
5’-GU-‘3 base step (bold) in A-site regardless of aminosugar substitution among different
aminoglycosides. The contact made by 2-DOS to the RNA is independent of their structural
context of aminosugar subunits and more dependent on helical sequence.33

This central interaction helps to maintain A1492 and A1493 in a bilged-out
conformation. The ring II (2-DOS) unanimously recognizes the same 5’-GU-‘3 step in A-site in
spite of the different aminosugar substitution at various locations of 2-DOS (Figure 1.6). 2-DOS
specifically recognizes 5’-GU-‘3 base step in A-site through hydrogen bonding with N7 of
G1494 and O4 of U1495 and electrostatic interactions with negatively charged phosphate
13

backbone (Figure 1.6)33. Recently it was reported that the replacement of G1494A in the target
A-site RNA with other base pairs results in weaker binding of paromomycin to the A-site RNA
(Figure 1.7).34 This shows that the 2-DOS ring of paromomycin strictly recognizes the 5’-G(N7)U(O4)-‘3 sequence step.

Ring II
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Figure 1.7 Loss of binding affinity of paromomycin when G 1494 is mutated to A. This indicates
that the 2-DOS ring of paromomycin strictly recognizes the 5-G(N7)-U(O4)-3 sequence step
(highlighted in bold) but not 5’-A(N7)-U(O4)-‘3.

Puglisi et al. isolated 2-DOS, without the aminosugar subunit and treated with the wild
type A-site of 16S rRNA (Figure 1.8).35 The binding activity between the 2-DOS and A-site
RNA was monitored by high resolution NMR techniques. It was reported that 2-DOS
specifically recognizes the two 5’-GU-‘3 base steps (G1494-U1495 and G1405-U1406) with a
binding affinity of 1mM.
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Figure 1.8 Sequence specific recognition of 5-GU-3 base steps by a 2-DOS monomer that does
not have any aminosugar substitution
2-Deoxystreptamine with no aminosugar subunit attached is increasingly recognized as a
platform for the design of novel RNA-binding molecules because it has demonstrated RNAbinding capability within and without the context of aminoglycosides. Wang et al. recently
reported two examples of novel aminoglycoside antibiotics by removing one or both
aminosugars from the original aminoglycoside structures. This modification leaves the core 2DOS as the sole or main component of the compounds (Figure 1.9).36 Both compounds
demonstrated strong affinity to the target RNA A-site and inhibited bacterial translation. It is
important to note that the deoxystreptamine compound with no aminosugar subunits still binds to
the RNA target with Kd value of 88 µM. This suggests the likely success of generating libraries
of mimics that maintain the conformation/function of aminoglycosides yet lack the aminosugars.
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Figure 1.9 RNA binding molecules with one or no aminosugar subunit
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Herman et al.37 synthesized a small library of monomeric 2-DOS analogs conjugated with
a small number of heterocycles via an amide bond (Figure 1.10). Although some compounds
have shown slightly improved binding affinity to the target RNA A-site, most did not
demonstrate enhanced binding activity. It is somewhat contrary to the above observation that one
unit of the 2-DOS amide showed a dramatic increase in binding affinity with the addition of an
alkyl tertiary amine, even though the amide functionality was present in a different. The
heterocycles employed in this experiment may not be able to make electrostatic or hydrogen
bonding interaction, possibly because of the inappropriate positions of amino groups in the rigid
structures. The more flexible alkylamino arm in the Wang example participated in the
electrostatic interactions with a phosphate backbone and increased the binding affinity. This
signifies the importance of the subunits connected to the 2-DOS in the interactions with the
target RNA, which becomes apparent in the following example.
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Figure 1.10 Amide conjugated 2-deoxystreptamine analogs
Ding et al.38 also prepared heterocyclic 2-DOS derivatives as neamine mimics (Figure
1.11). Most of the compounds demonstrated a modest increase in binding affinity with a
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conjugation of a variety of heterocycles, while the binding affinity of the compound containing
an electron-withdrawing (CF3) did not show any increase. This implies that the subunit
conjugated to the deoxystrptamine analog plays an important role in RNA-binding; therefore
careful selection of the subunit may be essential element in improving binding affinity in the
design of 2-DOS- based RNA-binding molecules.
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Figure 1.11 2-DOS analogs conjugated with heterocyclic compounds
Recently, two molecules of 2-DOS were utilized in the design of RNA-binding molecules
by Hergenrother et al.39 This example provides convincing evidence of the strong binding
affinity between 2-DOS and RNA (Figure 1.12). The presence of the bivalent structure of 2-DOS
shows low micromolar binding to RNA hairpin loops. These dimers demonstrated strong binding
affinity to RNA hairpin loops of a variety of sizes containing two 5-GU-3 steps for recognition.
Standard RNA-binding molecules such as aminoglycosides do not generally recognize those
hairpin loops. Considering that the library was constructed by connecting two 2-DOS
compounds with simple alkyl or aryl linkers of various lengths, the enhanced binding affinity is
believed to result from the existence of one extra 2-DOS molecule. This is because the simple
alkyl chain will not affect the binding affinity because of the lack of an adequate binding motif.
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This example clearly demonstrates that novel RNA-binding molecules may be designed based
solely on the 2-DOS structure.
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Figure 1.12 Binding 2-DOS dimers to RNA stem loops
According to the studies discussed so far, RNA-binding molecules containing two or
more 2-DOS analogs may be able to bind to target RNAs with strong binding affinity, while
those molecules containing one deoxystreptamine analog bind with only moderate affinity.
However, the studies mentioned did not address sequence specificity, despite the promising
observation of 2-DOS in sequence-specific recognition of RNAs. Therefore, building dimeric
and trimeric compounds using the monomeric building block may result in small RNA-binding
ligands with both strong binding affinity and sequence-specific recognition capability.
Tor et al.40 synthesized conformationally restricted neomycin and paromomycin by
covalently connecting aminosugar ring I with aminosugar ring III to reduce the number of
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available conformations caused by the flexible glycosidic linkages (Figure 1.13). These two
conformationally restricted aminoglycosides were tested for specific binding against two
different RNA (TAR-RNA and A-site RNA) to see if the conformationally restricted
aminoglycosides will show any discrimination between different types of RNA. However, these
conformationally restricted aminoglycosides did not show any discrimination between TARRNA and A-site RNA, which suggests that the structure of target RNA and its flexibility also
play an important role for specific binding.
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Figure 1.13 Conformationally restricted aminoglycosides
1.6 Conclusion
According to the studies discussed so far, RNA-binding molecules containing two or
more 2-DOS analogs may be able to bind to target RNAs with strong binding affinity, while
those molecules containing one deoxystreptamine analog bind with only moderate affinity.
However, the studies mentioned did not address sequence specificity despite the promising
observation of 2-DOS in sequence-specific recognition of RNAs. Therefore, building dimeric
and trimeric 2-DOS compounds using the monomeric building block 1 (figure 1.8) may result in
small RNA-binding ligands with both strong binding affinity and sequence-specific recognition
capability.
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Chapter-2
Rational Design of Novel 2-DOS Mimics for Sequence Specific
RNA Recognition
2.1 Introduction
To date, few examples of RNA-binding molecules have been reported with their
structural basis on 2-DOS without an aminosugar subunit attached (ring 1 figure 2.2) 37-39. This is
likely because both the mechanism of action of aminoglycosides and the sequence specific mode
of the 2-DOS binding was reported only recently. Therefore, the potential of designing RNAbinding molecules based on this structural information is just beginning to unfold. Despite the
promising observation of sequence specific recognition of RNA bases by 2-DOS,

1

none of the

existing studies addressed sequence specificity or selectivity in the design of 2-DOS based
compounds. This may be attributed to the lack of novel linker strategies other than glycosidic
linkages between two or more 2-DOS subunits.
Upon close inspection of the crystal structures of aminoglucoside RNA complexes
mentioned in Chapter 1, it is evident that two amino functional groups at 1- and 3-positions in 2DOS participate in recognizing RNA bases through hydrogen bonding and electrostatic
interactions.2 In addition, glycosidic linkages at the 4- and 6- positions serve as linkers to extend
the aminoglycoside structures to the aminosugar subunits (Figure 2.1). In our research, we
propose that modification of the hydroxyl group (or connectivity unit) of 2-DOS would provide a
novel approach to generating more selective RNA binding motifs. In this chapter we will
describe our efforts to synthesize novel carboxylic acid and urea derivatives of 2-DOS that
enable additional linkers for generating selective RNA recognizing molecules based on the 2DOS framework. The hydroxyl functional group at position 5 was omitted in the design of 224

DOS mimics to increase the simplicity of chemistry used to synthesize our mimics. We expect
that this deletion of the should not cause loss of activity because subunits substituted on the 5position of 2-DOS project out of the target RNA helix and do not participate in elongation of the
unit along the helix axis.
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Figure 2.1 Simplified binding mode of 2-DOS to its target RNAs based on crystal structures of
various aminoglycosides mentioned in Figure 2.1. (b) Structure based rational design of novel 2DOS analog with peptidyl connectivity. (c) Structure based rational design of novel 2-DOS
analog with urea connectivity.
2.2 Rational for Proposed RNA Specific Analogs of 2-DOS
It is hypothesized that targeting RNA double helices containing certain GU-rich sequence
steps would be possible by connecting two or more of the monomeric 2-DOS building blocks
through amide bonds within or without the structural context of ring-I (Figure 2.2). This strategy
may provide several advantages in designing RNA-binding small molecules with high sequence
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specificity and strong binding affinity. First, the 2-DOS anolog is used as the exclusive building
block in the design of sequence-specific RNA-binding molecules. The free amino groups of the
aminosugar subunits in aminoglycosides are the source of the nonspecific binding characteristics
of aminoglycosides3 and are no longer present in our designed ligands. Instead, an additional
specific recognition unit (2-DOS) is introduced in place of the aminosugars, resulting in
molecules with fewer amino functional groups. This may limit the possibility of nonspecific
electrostatic interactions and promote specificity in binding.

Figure 2.2 Aminoglycoside connected amide bond showing ring I, ring II and ring III.
Second, the ambiguous binding characteristic of aminoglycosides originates not only
from the electrostatically driven mode but also from the conformational adaptability of
aminoglycosides 4. The glycosidic connection assumes a variety of conformations and permits
aminoglycosides to structurally adjust to diverse RNA targets. The glycosidic linkage in the
proposed targets is replaced by an amide connectivity, which introduces extra hydrogen bonding
donors and acceptors. The amide connectivity will restrict the flexibility of the RNA-binding
ligands through a network of extensive hydrogen bonds. This connectivity may also help
discriminate nucleotide bases upon binding to target RNAs. Hydrogen bonding has been shown
to play a key role in specific ligand recognition as observed with various aptamers for amino
acids, oligosaccharides, peptides, and proteins.5 Amide bonds were proven to be a very useful
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tool in differentiating DNA bases in the context of the Dervan`s polypyrrole and imidazole
DNA-binding agents in the minor groove and may play a similar role in the context of RNAbinding molecules.6, 7
Third, this strategy makes it possible to target certain RNA sequences that contain four or more
consecutive nucleotides such as 5-GUGU-3 for the first time. In order to recognize consecutive
RNA base steps, proper distance between the neighboring amino functional groups in the ligands
is essential. Introduction of an amide bond between the two neighboring 2-DOS building blocks
not only brings extra hydrogen bonding acceptors and donors but also provides the desired
distance between the amino functional groups in the adjoining monomeric building blocks
(Figure 2.3a). According to a model of the dimeric compound, the neighboring amino groups
adjacent to the monomeric building blocks are spaced by 5.1Å, which would be slightly different
depending on the degree of rotation between the two adjoining building blocks. In fact, the
nitrogen atoms of amino groups at 1- and 3- positions in 2-DOS are spaced by 4.93 A, which
allows hydrogen bonding with the G1494 (N7)-U1495 (O4) step of the free A-site RNA.8 The
average distance between the RNA steps in the A-site is known to be 5.2 ± 0.3 Å9 and is indeed
very close to the distance between the amines observed in the model of the dimer ligand (Figure
2.3b). Therefore, introducing the amide bond between the two building blocks may bring the
neighboring two amines to match the distance of the RNA bases, which is essential for sequence
recognition and discrimination of different RNA bases.
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Figure 2.3 (a) Distances between the two neighboring amino groups in the neighboring 2-DOS
analogs in the dimer. (b) Distances between the amino groups located at 1- and 3- positions of
the 2-DOS. (c) Average distance between the base stacks in A-site RNA.
Fourth, the proposed RNA binding molecules may slow down the emergence of
resistance. Aminosugar residues are the structural features most recognized by aminoglycoside
modifying enzymes.10 Therefore, the absence of those amino sugars in the designed molecules
may improve in vivo bioavailability of the ligands and can provide a novel strategy to combat
emergence of the prevalent viral and bacterial resistance in the clinic.
2.3 Synthesis of Novel 2-DOS Analog with Peptidyl and Urea Connectivity as Monomeric
Building Block
In this chapter, we will describe our synthesis of three 2-DOS mimics for application to selective
RNA recognition. Our synthesis of three designed RNA binding molecules relies on use of a
known diazide 411 to access the desired building blocks containing amine (8, Figure 2.4a) and
carboxylic acid (9, Figure 2.4b) functional groups. These monomeric building blocks will be
assembled either via amide bond formation (carboxylic acid) or through urea formation (amine)
to access our desired 2-DOS mimics 1–3 (Figure 2.5). These synthetic strudies will provide
access to dimeric 2-DOS mimics where two neamine core units are assembled through a rigid
amide bond (2), or a more flexible urea bond (3). In addition, we will explore the specificity of
the dimeric neamine core containing an aminosugar moiety (1)
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Figure 2.5 Compound 1: Dimeric 2-DOS connected by amide bond and aminosugar; 2: Dimeric
2-DOS connected by amide bond without sugar 3) Dimeric 2-DOS connected by urea bond.
2.3.1 Synthesis of Bis-Azide 4 as a Common Synthetic Intermediate
Our proposed synthesis of 2-DOS mimics relies on ready and scalable access to a bisazide intermediate that can be derivatized to provide the desired functional building blocks.
Jacques and coworkers previously reported a synthesis that uses cyclohexadiene to make bisazide 4.11 Cyclohexadiene is first converted to a cis-bis-epoxide, which is then ring-opened to
provide the racemic bis-azide intermediate shown below (Figure 2.6). Desymmetrization of the
diol with the candida rugose lipase in presence of vinyl acetate provided enantiopure bis-azide 4,
which was employed as a common intermediate for the synthesis of our 2-DOS mimics.
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2.3.2 Synthesis of the Amine containing monomeric 2-DOS analog building block 8
Compound 8 was prepared starting from asymmetric bis azide 4 following the procedures
shown in Scheme 1. Compound 4 was first protected as the methoxy methyl ether, then acetyl
deprotection and methylation of the resulting alcohol gave compound 5. MOM deprotection,
followed by hydrogenation of bisazide and Boc protection of both amines gave compound 6.
The hydroxyl group in compound 6 was epimerized to compound 7 using Mitsunobu reaction 12.
Compound 6 was first converted to benzoate ester via a Mitsunobu protocol followed by
hydrolysis of the ester gave compound 7. The hydroxyl group in the compound 7 was converted
to azide by the second Mitsunobu reaction with an azide nucleophile provided the azide with the
desired stereochemistry, reduction of azide using palladium on carbon in presence of hydrogen
gave our desired building block amine 8.
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Scheme 1 Synthesis of monomeric 2-DOS analog building block 8.
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2.3.3 Synthesis of the Acid Containing Monomeric 2-DOS Analog Building Block 9
Acid-containing compound 9 was prepared starting from the same asymmetric bisazide 4
following the procedures shown in Scheme 2. The hydroxyl group in the compound 4 was again
protected as the MOM-ether and the acetyl group was removed in the presence of LiOH to give
alcohol 10. Alcohol 10 was then treated with triflic anhydride and pyridine at -20 oC in the
presence of NaCN to give nitrile 11. The nitrile was next converted to ester 12 via hydrolysis
using H2SO4 in methanol. Reduction of the two azides in 12 with H2 gas and Pd/C was directly
followed by N-Boc protection of diamine to afford ester 13. Compound 13 was epimerized using
sodium methoxide in presence of methanol at 40 o C to provide the desired trans stereochemistry
at the carboxylic acid center. 12 Hydrolysis of ester to acid was then accomplished using lithium
hydroxide. The NHBoc groups were next converted back to azides by deprotection of the Boc
group (TFA in CH2Cl2), followed by treatment with trifluoromethanesulfonyl azide13 to give
compound 9 (Scheme 2).

N3

N3

HO

OAc

4

N3

1) MOM Cl, Et3N
2) LiOH, Methanol
91 % over 2 steps

MOMO

N3

1)Tf2O, Pyridine
CHCl3, -20 oC

OH

2) NaCN, DMF, rt
65 % over 2 steps

10

N3

HO

COOH

9

1) NaOMe
o
MeOH, 40 C

NHBoc

BocHN

2) LiOH, MeOH:H2O
3) TFA, TfN3, CuSO4
K2CO3, MeOH
30 % over 3 steps

COOCH3

HO

13

Pd/C, H2
Boc2O, Et3N
MeOH
89%

Scheme 2 Syntheses of monomeric analog acid building block 9.

31

CN

MOMO

11
45 %

N3

N3

N3

H2SO4
MeOH

N3

N3

HO

COOCH3

12

2.3.4 Synthesis of 2-DOS Mimic 1
Synthesis of our desired dimeric 2-DOS mimic 1 required coupling of our monomeric 2DOS analogs 8 and 9, followed by addition of the desired amino sugar and finally alcohol
deprotection followed by reduction of azides gave compound 1 (Scheme 3). The amino
compound 8 was coupled to acid compound 9 using HOAT and HATU as coupling agents at 40 o
C, followed by Boc deprotection and conversion of the resulting amines to azides using
trifluoromethanesulfonyl azide gave intermediate 14. The glycosylation reaction was performed
between compound 14 and protected sugar 15 using the procedure developed by Fugedi14 gave
compound 16. Protected sugar was prepared by a literature procedure15 from a commercially
available 2-acetamido-2-deoxy-D-glucopyranose. Compound 15 was finally deprotected, first
with potassium carbonate and methanol to remove the acetates and then with tributyl phosphine
to reduce all six azides, providing compound 1 in 63 % yield over 2 steps.
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2.3.5 Synthesis of 2-DOS Mimic 2
The synthesis of dimeric 2-DOS mimic required a simple coupling reaction followed by global
reduction of the 4 azides. The coupling of compounds 8a and 9 using HATU and HOAt provided
the dimer 45 % yield. Deprotection of Boc groups and conversion of amines to azides in the
presence of triflyl azide then gave tetra azide 14a. The tetra azide was then reduced to tetra
amine in the presence of palladium on carbon and hydrogen to give compound 2 (Scheme 4)
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2.3.6 Synthesis of 2-DOS Mimic 3
The synthesis of 2-DOS mimic 3 was accomplished via stepwise dimerization of amine 17 and
amine 8 with a phosgene equivalent (Scheme 4). Compound 17 was treated with phenyl
chloroformate in presence of triethyl amine at 0 o C gave carbamate 18. Intermediate 18 was then
condensed with amine 8 in presence of triethyl amine to give compound 19. Final deprotection of
the Boc groups with TFA provided the desired compound 3 with an overall yield of 65% from 17
(Scheme 5).
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Scheme 5 Syntheses of 2-DOS mimic 3
2.4 Conclusion
The synthesis of dimeric 2-DOS mimics 1-3 was readily accomplished due to the ease of access
of monomeric core structures 8, 9 and 17. These synthetic studies lay the ground work for the
synthesis of an entire library of 2-DOS mimics where the RNA binding activity can be modified
by changing the number of streptamine core units, the linker between units and the glycosylation
state of each scaffold structure. The next chapter will discuss RNA binding assays and antibacterial studies with compounds 1-3 to ascertain their potential to act as specific RNA binding
molecules for use as antibiotics.
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2.6 Experimental Procedures
2.6.1 Characterization of compounds synthesized
Di-tert-butyl ((1R,3S,4S,6R)-4-hydroxy-6-methoxycyclohexane-1,3-diyl)dicarbamate (6). To
a solution of compound 5 (1.1 g, 4.29 mmol) was dissolved in methanol (50 mL) and added
aqueous HCl (10 mL), the reaction mixture was heated to reflux for 1 h after completion of the
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reaction, it was cooled to room temperature, neutralized with sodium bicarbonate and extracted
with methylene chloride (3×100 mL), the combined extracts were dried over anhydrous MgSO4,
the solvent was concentrated to give the desired product as colorless liquid (0.8 g, 88%), which
was dissolved in methanol (40 mL) were added 10% Pd/C, triethylamine (1.3 mL, 9.43 mmol),
and di-t-butyl dicarbonate (2.47 g, 11.3 mmol). The reaction mixture was stirred for 12 h at room
temperature under hydrogen atmosphere. After completion of reaction, the catalyst was removed
by filtration using microfiber filter paper. Evaporation of solvent, followed by column
purification (1:1 hexanes: ethyl acetate) afford compound 6 as a white solid (1 g, 74%). 1H NMR
(500MHz, CDCl3) δ 4.75 (brs, 2H), 3.81 (brs, 1H), 3.42-3.35 (m, 3H), 3.36 (s, 3H), 3.14-3.04
(m,1H), 2.5-2.36 (m, 2H), 2.1-2.0 (m, 1H), 1.44 (s, 18H), 1.4-1.2 (m, 1H). 13C NMR (125MHz,
CDCl3) δ 155.9, 80.3, 79.5, 78.6, 56.3, 54.6, 53, 36, d 28. HRMS (ESI) m/z [M+H]+ cacld
361.2339, found 361.2331. [α]D24 = –37.14º (42 mg/6 mL DCM). mp 206- 208 ºC.
di-tert-butyl ((1R,3S,4R,6R)-4-hydroxy-6-methoxycyclohexane-1,3-diyl)dicarbamate (7). To
a solution of 6 (2.5 g, 6.93 mmol), PPh3 (5.45 g, 20.8 mmol), and 4-nitrobenzoic acid (3.47 g,
20.8 mmol) in dry THF (150 mL) was added DIAD (4 mL, 20.8 mmol) in one portion with
stirring at rt under Nitrogen. The resulting solution was refluxed for 2 h after which the solvent
was removed in vacuum. The crude mixture was dissolved in dry methanol (100 mL) to which
K2CO3 (10-15 equiv.) was added. After stirring for 30 min at room temperature, the solvent was
evaporated and reaction mixture was diluted with methylene chloride (200mL), the organic layer
was washed with water (2×100 mL) and dried over anhydrous MgSO4, Evaporation of solvent,
followed by column purification on silica gel (1:1 hexanes: ethyl acetate) yielded compound 7 as
a colorless oily liquid (2.2 g, 88%). 1H NMR (500 MHz, CDCl3) δ 5.17 (brs, 1H), 4.9 (brs, 1H),
4.14-4.0 (m, 1H), 3.71-3.58 (m, 1H), 3.54-3.36 (m, 2H), 3.35 (s, 3H), 3.32-3.18 (m, 1H), 2.3436

2.26 (m, 1H), 2.1-2.0 (m, 1H), 1.76-1.61 (m, 1H), 1.44 (s, 9H), 1.43 (s, 9H). 13C NMR (125MHz,
CDCl3) δ 155.8, 155.4, d 79.4, 76.8, 68.1, 56.5, 53, 51, 34.7, 31.8, 28.4, 28.3. HRMS (ESI) m/z
[M+H]+ cacld 361.2339, found 361.2338. [α]D 24 = –31.4o (65mg/6 mL DCM). mp 86−88 oC
di-tert-butyl ((1R,3S,4S,6R)-4-amino-6-methoxycyclohexane-1,3-diyl)dicarbamate (8). To a
solution of 7 (900 mg, 2.5 mmol), PPh3 (1.96 g, 7.5 mmol), and DPPA (1.6 mL, 7.5 mmol) in
dry THF (150 mL) was added DIAD (1.47 mL, 7.5 mmol) in one portion with stirring at rt, under
nitrogen. The resulting solution was refluxed for 3 hours. The solvent was removed in vacuum
and the crude reaction mixture was purified by flash chromatography (3:1 hexanes: ethyl acetate)
to give product as colorless oil, which was dissolved in MeOH (30 mL) and added Pd/C (100
mg). The mixture was stirred for 12h at room temperature under hydrogen atmosphere and the
catalyst was removed by filtration using microfiber filter paper. Evaporation of the solvent
followed by column purification on silica gel (1:1 MeOH: ethyl acetate) yielded compound 8 as
white crystalline solid (400 mg, 44%). 1HNMR (500MHz, CDCl3) δ 3.44-3.38 (m, 1H), 3.37 (s,
3H), 3.21 (t, 1H J = 10Hz), 3.08 (dt, 1H, J = 5Hz, 10 Hz), 2.5 (dt, 1H, J = 5Hz, 10Hz), 2.40-2.26
(m, 1H), 2.05 (d, 1H, J = 15Hz), 1.34-1.06 (m, 2H). 13CNMR (125MHz, CDCl3) δ 156.8, 156.6,
79.7, 78.7, 55.9, 54.6, 52, 48, 36, 27.4, 27.3. HRMS (ESI) m/z [M+H]+ cacld 360.2499, found
360.2580. [α]D 24 = –9.28o (110 mg/6mL methanol). mp 168-170 oC
(1R,2R,4S,5S)-2,4-diazido-5-(methoxymethoxy)cyclohexanol (10). To a solution of 4 (6 g, 25
mmol) in dry dimethylformamide and dry triethylamine (8.7 mL, 62.5 mmol) was added
methoxymethylchloride (3.8 ml, 50 mmol) was added under argon gas and the reaction mixture
was refluxed for 1hour. The reaction mixture was cooled down, solvent was concentrated under
high vacuum and the product was dissolved in dichloromethane (2×100 mL). Organic layer was
washed with water and brine and dried over anhydrous MgSO4 and the solvent was removed
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under vacuum to give compound as yellow oil. (6.1 g, 85% yield). The crude product was (6.1 g,
21.45. mmol) was dissolved in methanol and the reaction mixture was cooled to 0 oC and LiOH
was added ( 1g, 44.0 mmol) and stirred for 1 hour, solvent was removed and crude product was
dissolved in dichloromethane. Organic layer was washed with water and dried over anhydrous
MgSO4 and the solvent was removed under vacuum to give compound 10 as yellow oil (4.95 g,
95% yield). 1H NMR (500 MHz, CDCl3) δ 4.78 (m, 2H), 3.50-3.40 (m, 3H), 3.40 (s, 3H), 3.30
(m, 1H) 2.60 (br s, 1H), 2.40 (dt, 1H, J = 13.18, 3.91 Hz), 2.20 (dt, 1H, J = 13.18, 3.91 Hz), 1.50
(q, 1H, J = 11.48 Hz), 1.35 (q, 1H, J = 11.48 Hz); 13C NMR (125 MHz, CDCl3) δ 96, 76, 71, 64,
62, 56, 36, 32; HRMS (ESI) found 243.12 [M + H]+ , calcd 242.11; [α]D 24 = -31.09° (c 1.22,
CHCl3).
(1S,2R,4S,5S)-2, 4-diazido-5-(methoxymethoxy)cyclohexanecarbonitrile (11). To a solution
of 10 (6 g, 24.7 mmol) in dry dichloromethane was cooled to −20 oC, then pyridine (10 mL,
123.5 mmol) was added, followed by drop wise addition of trifluormethanesulfonic anhydride
(16.6 mL, 99 mmol) under argon gas, after complete consumption of starting material, the
reaction mixture was washed with ice water and the organic layer was dried over anhydrous
MgSO4 and the solvent was removed under vacuum with no heat to give the product as orange
liquid (8.5 g 92 %) The crude product was (8.5 g, 22.7 mmol) was dissolved in Minimal amounts
of dimethylformamide (20 mL), followed by the addition of excess sodium cyanide (10-15
equiv) at 0 oC. The reaction was allowed to stir for 2h at room temperature, the solvent was
removed under high vacuum. The resulting reaction mixture was then dissolved in
dichloromethane and washed with water and brine until all the dimethylformamide was removed.
The dichloromethane layer was dried over anhydrous MgSO4, the solvent was removed under
vacuum and the crude product was purified by flash chromatography to give compound 11 (4.2
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g, 73% yield); 1H NMR (500 MHz, CDCl3) δ 4.70 (dd, 2H, J = 10.73, 6.38 Hz), 3.75-3.65 (m,
2H), 3.45 (m, 1H), 3.40 (s, 3H), 3.20-3.10 (br q, 1H, J = 3.72 Hz), 2.40 (dt, 1H, J = 14.16, 5.77
Hz), 2.25 (dt, 1H, J = 13.67, 3.15 Hz), 1.85 (m, 1H), 1.65 (dt, 1H, J = 12.38, 3.9 Hz); 13C NMR
(125 MHz, CDCl3) δ 118, 96, 75, 61, 56, 55, 32,31,30; HRMS (ESI) found 252.12 [M + H]+ ,
calcd 251.11; [α]D 24 = -10.2° (c 0.570, CHCl3).
(1S,2R,4S,5S)-methyl 2,4-diazido-5-hydroxycyclohexanecarboxylate (12) To a solution of
Compound 11 (2 g, 7.96 mmol) in methanol was added few drops of conc. sulfuric acid and
heated the reaction mixture to reflux for 15 hours, the solvent was removed under vacuum and
the crude reaction mixture was neutralized with saturated NaHCO3 and the product was extracted
with dichloromethane, the dichloromethane layer was washed with water, dried over anhydrous
MgSO4, the solvent was removed under vacuum and the crude product was purified by flash
chromatography to give compound 12 as yellow oil (780 mg, 45 %). 1H NMR (500 MHz,
CDCl3) δ 3.78-3.63 (m, 2H), 3.5 (m, 1H), 3.4 (s, 3H), 3.19 (br d, 1H, J = 3.42 Hz), 2.45-2.40 (dt,
1H, J = 13.94 Hz, 4.16 Hz), 2.38-2.30 (br dt, 1H, J = 13.94, 2.93 Hz), 1.95 (q, 1H, J = 11.25 Hz),
1.65 (m, 1H), 1.25 (bs, 1H);
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C NMR (125 MHz, CDCl3) δ 172, 69, 62, 58, 52, 42, 30, 29;

HRMS (ESI) found 263.0863 [M + Na]+ , calcd 240.09; [α]D 24 = +34.02° (c 0.088, CHCl3).
Methyl(1S,2R,4S,5S)-2,4-bis((tert-butoxycarbonyl)amino)-5-hydroxycyclohexane-1carboxylate (13). To a solution of compound 12 (800 mg, 3.33 mmol) in methanol (20 mL)
were added 10% Pd/C, triethylamine (1.3 mL, 9.43 mmol), and di-t-butyl dicarbonate (2.47 g,
11.3 mmol). The reaction mixture was stirred for 12 h at room temperature under hydrogen
atmosphere. After completion of reaction, the catalyst was removed by filtration using microfiber
filter paper. Evaporation of solvent, followed by flash chromatography on silica gel (1:1
hexanes: ethyl acetate) afford compound 13 as a white solid (1.15 g, 89 %). 1H NMR (500 MHz,
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CDCl3) δ 5.43 (br s, 1H), 4.71 (br s, 1H), 3.83-3.76 (ddd, J = 3, 8, 13 Hz, 2H), 3.70 (s, 3H), 3.45
(ddd, J = 3, 11, 13 Hz, 1H), 3.35 (ddd, J = 2, 10, 11 Hz, 1H), 2.93 (ddd, J = 4, 5, 8 Hz, 1H),
2.40-2.37 (ddd, J = 2, 4, 14 Hz, 1H), 2.03-2.00 (ddd, J = 3, 3, 13 Hz, 1H), 1.78-1.71 (ddd, J = 13,
13, 13 Hz, 1H), 1.65-1.59 (ddd, J = 5, 10, 14 Hz, 1H), 1.42 (s, 9H), 1.41 (s, 9H); 13C NMR (125
MHz, CDCl3) δ 174.1, 157.4, 155.3, 80.6, 79.8, 71.9, 55.1, 52.1, 48.3, 43.2, 34.4, 33.9, 28.6,
28.5; HRMS (ESI) Found 388.2232 for [M]+ ; calcd. 388.2209.
2,4-diazido-5-hydroxycyclohexane-1-carboxylic acid (9). To a solution of 13 (1 g, 2.57 mmol)
in methanol (50 ml) at 0°C was added a solution of sodium methoxide (486 mg, 9 mmol) in
methanol (50 ml) and heated the reaction mixture to 40°C for 6 h. The reaction mixture was
made acidic using Amberlite resin and then filtered. The filtrate was concentrated and the
compound was purified by flash chromatography to give epimer (400 mg, 40%). To a solution of
the epimer (400 mg, 1.03 mmol) in methanol (10 mL) was added LiOH (75 mg, 3.1 mmol)
solution dissolved in 5 mL water and stirred the reaction mixture at room temperature for 6
hours, the solvent was removed under vacuum and pH was adjusted to 2 using 1M HCl and the
product was extracted with chloroform. Evaporation of solvent affords the product as a white
solid. (220 mg, 57 %). To a solution of the crude product (220 mg, 0.587 mmol) in methylene
chloride was added TFA (270 μl, 3.52 mmol) at room temperature and stirred the reaction
mixture for 2 h, after completion of the reaction, reaction mixture was concentrated to afford
desired product as yellow oil (210 mg, 100%), which was dissolved in methanol (15 mL), and
added potassium carbonate (405 mg, 2.93 mmol), triflyl azide solution (prepared from sodium
azide (16 equiv.) and triflic anhydride (12 equiv. in methylene chloride and water) at 0 oC and
stirred the reaction mixture at room temperature for overnight and concentrated the solvent,
diluted the reaction mixture with methylene chloride (100 mL), washed the organic layer with
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water (2×50 mL) and dried over anhydrous MgSO4, evaporation of solvent followed by column
purification on silica gel (1:1 hexanes: ethylacetate) afford compound 9 white solid. Yield: 30%.
(1R,2R,4S,5S)-2,4-diazido-N-((1S,2S,4R,5R)-2,4-diamino-5-methoxycyclohexyl)-5hydroxycyclohexanecarboxamide (14). To a solution of 8 (300 mg, 0.83 mmol) and 9 (207 mg,
0.92 mmol) in dry DMF (10 mL) were added HOAt (340 mg, 2.5 mmol), HATU (878 g, 2.5
mmol) and DIPEA (875 μl, 5.0 mmol) at room temperature and heated the reaction mixture to 50
o

C for 3 h. The reaction mixture was concentrated in vacuo. The resulting crude was purified by

column chromatography on silica gel (3:1 hexanes: ethyl acetate) to afford compound 7 as pale
yellow liquid (200 mg, 42%). The compound (200 mg, 0.35 mmol) in methylene chloride was
added TFA (270 μl, 3.5 mmol) at room temperature and stirred the reaction mixture for 2 h, after
completion of the reaction, reaction mixture was concentrated to afford desired product as yellow
oil (210 mg, 100%), which was dissolved in methanol (15 mL), and added potassium carbonate
(195 mg, 1.41 mmol), triflyl azide solution (prepared from sodium azide (16 equiv.) and triflic
anhydride (12 equiv. in methylene chloride and water)) at 0 oC and stirred the reaction mixture at
room temperature for overnight and concentrated the solvent, diluted the reaction mixture with
methylene chloride (100 mL), washed the organic layer with water (2×50 mL) and dried over
anhydrous MgSO4, evaporation of solvent followed by column purification on silica gel (1:1
hexanes: ethylacetate) afford compound 14 as colorless oily liquid (100 mg, 68%). 1HNMR
(300MHz, CDCl3) δ 7.47 (d, 1H, J = 8.7Hz), 4.5 (brs, 1H), 3.88-3.65 (m, 2H), 3.52-3.36 (m,
4H), 3.3 (s, 3H), 3.26-3.13 (m, 1H), 2.36-1.9 (m, 6H), 1.57 (q, 1H, J = 12.3 Hz), 1.42-1.13 (m,
2H); 13CNMR (75MHz, CDCl3) 205.6, 80.8, 72.3, 64, 62, 61, 59, 56, 50, 48.5, 35, 34.6, 34, 33.6.
HRMS (ESI) m/z [M+H]+ cacld 420.1969, found 420.2054. [α]D24 = +9.47o (95 mg/6mL
DCM).
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(2R,3R,5R,6S)-5-azido-2-(azidomethyl)-6-(((1S,2S,4R,5R)-2,4-diazido-5-(((1S,2S,4R,5R)2,4-diazido-5-methoxycyclohexyl)carbomoyl)cyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diyl
diacetate (16). To a solution of compound 14 (95 mg, 0.226 mmol) in 5:2 diethyl ether:
methylene chloride was added compound 15 (110 mg, 0.271 mmol), activated 4Å powdered
molecular sieves (1g). The reaction mixture was stirred at room temperature for 2 h, followed by
the addition of 1 M solution of Me2S2-Tf2O reagent (408 μL, 0.34 mmol), stirred the reaction
mixture for 20 min, quenched the by the addition excess triethylamine, diluted with CH2Cl2 (100
mL), filtered, and washed with water. The organic layer was dried over anhydrous MgSO4, and
concentrated, the residue was purified by column chromatography on slilica gel (1:1 hexanes:
ethylacetate) to afford compound 9 as colorless oily liquid (40 mg,). 1HNMR (300 MHz, CDCl3)
δ 5.96 (d, 1H, J = 8.4Hz), 5.5 (t, 1H, J = 9.6Hz), 5.1 (m, 1H), 5.0 (t, 1H, J = 9.9Hz), 4.28 (q, 1H,
J = 10Hz), 3.98-3.73 (m, 2H), 3.63-3.5 (m, 2H), 3.45 (s, 3H), 3.43-3.16 (m, 5H), 2.58-2.15 (m,
5H), 2.08 (s, 3H), 2.06 (s, 3H), 1.53 (t, 2H, J = 11Hz), 1.366 (t, 3H, J = 12Hz);
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CNMR

(75MHz, CDCl3) δ 170.7, 169.88, 169.82, 94.5, 80.5, 76, 70, 69.6, 69.3, 61.3, 61.2, 60.6, 60.5,
58.9, 57.6, 51, 50.3, 48.4, 35, 33.3, 32.7, 30, 20.6. HRMS (ESI) m/z [M+H]+ cacld 716.2838,
found 716.2908. [α]D24 = +20o (45 mg/6 mL DCM).
(1R,2R,4S,5S)-2,4-diamino-5-(((2S,3R,4R,5S,6R)-3-amn-6-(aminomethyl)-4,5dihydroxytetrahydro-2H-pyran-2-yl)oxy)-N-((1S,2S,4R,5R)-2,4-diamino-5methoxycyclohexyl)cyclohexanecarboxamide (1). To a solution of compound 16 (90 mg,
0.126 mmol) in methanol (10 mL) was added potassium carbonate (70 mg, 0.504 mmol), stirred
the reaction mixture at room temperature for 15 min. concentrated the solvent in in vacuo.
Diluted the reaction mixture with methylene chloride (25 mL) washed with water (2×15 mL),
dried the organic layer over anhydrous MgSO4, the solvent was concentrated to give the desired
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product as colorless liquid (70 mg, 87%), which was dissolved in methanol (5 mL) and water (5
mL), added tributylphosphine (450 μL, 2.2 mmol) and stirred the reaction mixture for overnight
at room temperature. After completion of the reaction, reaction mixture was concentrated in in
vacuo. Diluted the reaction mixture with water (25 mL), washed the water layer with methylene
chloride (4×20 mL), removed the water by lyophilization to afford desired compound (1) as
white solid (14 mg, 27%). 1H NMR (500MHz, CDCl3) δ 3.6 (s, 3H), 3.55-3.32 (m, 2H), 3.303.04 (m, 4H), 3.0-2.80 (m, 1H), 2.79-2.65 (m, 1H), 2.64-2.46 (m, 2H), 2.30-1.97 (m, 1H), 1.521.21 (m, 3H), 1.20- 0.9 (m, 3H), 0.84-0.68 (m, 1H). HRMS (ESI) m/z [M+H]+ cacld 476.3197,
found 476.3163.
(1R,2R,4S,5S)-2,4-diazido-N-((1S,2S,4R,5R)-2,4-diazido-5-hydroxycyclohexyl)-5hydroxycyclohexane-1-carboxamide (14).To a solution of 8 (300 mg, 0.83 mmol) and 9 (207
mg, 0.92 mmol) in dry DMF (10 mL) were added HOAt (340 mg, 2.5 mmol), HATU (878 g, 2.5
mmol) and DIPEA (875 μL, 5.0 mmol) at room temperature and heated the reaction mixture to
50 oC for 3 h. The reaction mixture was concentrated in vacuo. The resulting crude was purified
by column chromatography on silica gel (3:1 hexanes: ethyl acetate) to afford compound 7 as
pale yellow liquid (200 mg, 42%). The compound (200 mg, 0.35 mmol) in methylene chloride
was added TFA (270 μL, 3.5 mmol) at room temperature and stirred the reaction mixture for 2 h,
after completion of the reaction, reaction mixture was concentrated to afford desired product as
yellow oil (210 mg, 100%), which was dissolved in methanol (15 mL), and added potassium
carbonate (195 mg, 1.41 mmol), triflyl azide solution (prepared from sodium azide (16 equiv.)
and triflic anhydride (12 equiv. in methylene chloride and water) at 0 oC and stirred the reaction
mixture at room temperature for overnight and concentrated the solvent, diluted the reaction
mixture with methylene chloride (100 mL), washed the organic layer with water (2×50 mL) and
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dried over anhydrous MgSO4, evaporation of solvent followed by column purification on silica
gel (1:1 hexanes: ethylacetate) afford compound 14 as colorless oily liquid (100 mg, 68%).
(1R,2R,4S,5S)-2,4-diamino-N-((1S,2S,4R,5R)-2,4-diamino-5-hydroxycyclohexyl)-5hydroxycyclohexane-1-carboxamide (2). To a solution of compound 14 (25 mg, 0.55 mmol) in
methanol was added Pd/C (20 mol %) and stirred the reaction mixture under hydrogen
atmosphere and the catalyst was removed by filtration using microfiber filter paper. Evaporation
of the solvent afford compound 2 (15 mg, 81 %) as white solid. 1H NMR (500MHz, CDCl3) δ
3.39 (td, J = 4, 8 Hz, 1 H), 3.14 (qd, J = 4, 8.5 Hz, 2 H), 2.78 (td, J = 4, 7.5 Hz, 1H), 2.5 (td, J =
4, 7.5 Hz, 1H), 2.42 (qd, J = 4, 8Hz, 2H), 1.99 (td, J = 3, 9.5 Hz, 1 H), 1.92-1.78 (m, 4H), 1.32
(q, J = 11.5 Hz), 1.18, (q, J = 12 Hz, 1H), 0.975 (q, J = 12 Hz, 2 H); 13CNMR (75MHz, CDCl3) δ
176.1, 74.1, 73.3, 53.6, 53.4, 51.6, 51.4, 49.4, 39.4, 38.0, 36.6, 35.1, 23.3.
1-((1S,2S,4R,5R)-2,4-diamino-5-hydroxycyclohexyl)-3-((1R,2R,4S,5S)-2,4-diamino-5methoxycyclohexyl)urea (3). To a solution of compound 17 (50 mg, 0.128 mmol) in CH2Cl2
was added trimethylamine (54 µL, 0.384 mmol) followed by dropwise addition of Phenyl
chloroformate (20 µL, 0.154 mmol) at 0 oC, stirred the reaction mixture for 1hour at room
temperatuure, removed the solvent under vacuum and to the crude reaction mixture in DMSO (2
mL) was added triethyl amine (54 µL, 0.384 mmol) followed by drop wise addition of compound
8 (55.3 mg, 0.154 mmol) by dissolving in small amount of DMSO, stirred the reaction mixture
for 2 hours, diluted the reaction mixture with CH2Cl2 (20 mL), washed with water (2×15 mL)
dried the organic layer, removed the solvent under vacuum and purified the product by flash
chromatography on silica gel, the boc groups were deprotected with trifluoroacetic acid (6 equiv)
to afford compound 3 as brown solid. 1HNMR (300 MHz, CDCl3) δ 3.6-3.38 (m, 3H), 3.3 (s,
3H), 3.25-3.13 (m, 1H), 2.98-2.75 (m, 3H), 2.3- 2.22 (m, 1H), 2.21-2.05 (m, 3H), 1.45-1.29 (m,
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4H), 1.22-1.10 (m, 2H); 159.8, 82.9, 73.4, 66.4, 56.3, 55.2, 53.8, 53.6, 53.4, 52.0, 51.8, 51.6,
38.1, 37.9, 22.9, 23.1.
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Chapter-3
RNA Binding Studies and Antibacterial
deoxystreptamine Antibiotic Mimics

Activity

of

2-

3.1 RNA Binding Studies and Anti-bacterial Activity
In chapter 2 we discussed the design and synthesis of a new class of molecules based on a 2deoxystreptamine core with the potential to display high selectivity in RNA binding. These new
classes of 2-deoxystreptamine mimics have the potential to act as antibiotics by selectively
targeting and binding with bacterial RNA. In this chapter we will briefly discuss several assays
used for evaluating selectivity of RNA binding for compounds 1–3 (Figure 3.1), their RNA
affinity for binding specific regions in RNA, their antibacterial activity. We will also discuss the
correlation between RNA binding affinity and antibacterial activity.
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Figure 3.1 Structures of Compounds 1, 2 and 3
3.2 Evaluating RNA Binding
The in vitro binding affinity of RNA binding ligands cannot be determined through use of
a direct enzymatic assay because the target RNAs used for in vitro studies usually does not have
catalytic activity. However, several quantitative methods are available for the assessment of
small molecule-RNA interactions 1. One of the commonly used methods for evaluating RNA
binding affinity is NMR-based analysis.2 In this method, the direct binding of a ligand to a RNA
target is monitored by determining changes in the chemical shifts of protons in the nucleotide
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bases. Differences in the chemical shifts of the nucleotide bases between the free ligand and the
bound state provide information on both the strength and the region of binding. The drawback of
this method is that large quantities of RNA are required for analysis of the chemical shifts. The
second approach is to use an electrospray ionization (ESI) mass spectrometry-based method. 3 In
this method, the molecular weight shift is determined for free RNA, the RNA-binding ligand,
and the bound RNA-ligand complexes in the gas phase. A third method involves fluorescent
ligand displacement-based assays 4. In this method, a fluorescent molecule is attached to the
ligand and is titrated with RNA and a change in the fluorescence spectrum is recorded. Finally,
fluorescently labelled RNA can be used to titrate binding with specific ligands.5 In this method,
RNA oligonucleotides are made fluorescent by attaching a fluorophore to one end or by
incorporating fluorescent nucleotides within or adjacent to the small molecule binding site. The
most commonly used fluorescent nucleotide for this assay is 2-aminopurine. This method allows
for site-specific binding analysis. In an RNA molecule containing multiple secondary structures,
the selective incorporation of 2-aminopurine into one of the secondary structures can allow for
detection of binding to only that site of interest. Our investigation into the binding affinity and
specificity of our novel RNA binding 2-DOS mimics, we chose to use the latter method
involving incorporation of a fluorescent nucleotide into our desired RNA binding partner. Thus,
these assays would provide information about the affinity of our 2-DOS mimics (1–3) for RNA
binding, and about the specificity of our ligands for specific regions of RNA.
3.2.1 RNA Binding Studies of Compound 1
The highly conserved binding interaction of rings I and II of neamine with RNA (Figure
3.2a) and its consistent recognition of the same 5’-GU-3’ nucleotides in a variety of
aminoglycosides makes neamine a valuable structural scaffold from which sequence specific
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RNA binding molecules can be built. Our design of novel neamine mimics for selective RNA
binding hinges on the use of the 2-deoxystreptamine core of neamine and incorporating new ring
structures capable of introducing additional binding interactions to improve selectivity and
binding affinity. Specifically, we introduced an additional 2-deoxystreptamine ring to ring I and
II or neamine via an amide bond and a urea bond (compounds 1–3). Our design of sequence
specific RNA binding molecules was based on the hypothesis that by extending one or more of
the monomeric building blocks (2-deoxystreptamine) onto ring I of neamine, greater specificity
for could be obtained for longer sequences of RNA. In particular, we believed that an additional
neomiane rinc could recognize dsRNAs that contain 5’-GUGU-3’ sequence steps next to
traditional binding location (A-site). Our neamine derivatives were tested to see if these
extensions would be capable of recognizing extended 5’GU-3/3’-UG-5’ base pairs (see Figure
3.2b) and other random sequences. In our studies, we obtained both the binding affinity and the
specificity of our compounds toward a variety of RNA structures.

Figure 3.2 Design of sequence specific RNA binding molecules.
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Compound 1 was tested for its sequence specific binding against the native A-site RNA
sequence (RNA-1) and its mutants (RNA 2-8) (Figure 3.3). Each of these RNA sequences
contains a 2-aminopurine (2-AP) fluorescence probe at the A-site (replacing A1492) to monitor
binding. All of the RNA mutants (RNA 2–8) were purchased commercially and contain random
sequences that replace the 5’-CG-3/5-GC-‘3 pair of native A-site RNA. Neamine binds to several
nucleotides of A-site RNA through four hydrogen bonds and two electrostatic interactions
(Figure 3.4).6 All six interactions are conserved when other bulkier aminoglycosides (gentamycin
B, kanamycin A, ribostamycin, lividomycin A, and neomycin B) bind to the same A-site RNA.
In addition, all of these aminoglycosides contain neamine as a part of their structure. The
neamine sub unit recognizes the same RNA sequence in the context of all these aminoglycosides
(Figure 3.4).6 Based on this observation, our studies focused on structures where neamine was
used as a base to which additional neamine and glycosides were appended. Thus, neamine was
employed as an anchor to bring its attached 2-deoxystreptamine (2-DOS) mimic into close
proximity with the mutated sequences. Therefore, the library of A-site RNA mutants will serve
as a good tool to study preferred sequence binding by the 2-DOS mimics attached to neamine in
the context of fully base-paired dsRNA.
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Figure 3.3 Sequences of RNA targets.
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Hydrogen bonding
Electrostatic interaction

Figure 3.4 Conserved H-bonding and electrostatic interactions between aminoglycosides and
RNA.
To see if 2-aminopurine-modified A-site RNA could be used for our binding assays, we
titrated neomycin against RNA 1. Neomycin is known to form a 1:1 complex with A-site RNA.
The titration gave a typical sigmoidal curve with a Kd value of 1.5 µM by scatchard analysis
(Figure 3.5a). This result is in good agreement with the literature reported Kd of 0.5 µM for the
complex of neomycin and A-site RNA.7 RNA 3, 5 and 7 were also treated with neomycin to see
if mutations outside of the A-site would affect the binding affinity. All the titrations of RNAs
with neomycin showed sigmoidal curves with Kd values between 1.1 to 2.4 µM. This result
suggests that mutations to our target RNA outside of the A-site recognized by neomycin
minimally affected the binding affinity of the RNAs. Compound 1 was next titrated against each
RNA target to determine the binding affinity and sequence selectivity towards different RNA
sequences. All the RNAs demonstrated sigmoidal curves as shown in a sample binding curve
between RNA 2 and compound 1 (Figure 3.5b). The Kd values were between 0.5 and 2.9 µM
(Table 3.1). It was found that RNA 5 is the preferred target for compound 1 and demonstrated
six times stronger binding affinity compared to RNA 7. This result demonstrates that compound
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1 does show some slight preference for specific DNA pairs adjacent to the A-binding site of
RNA1.
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Figure 3.5 (a) titration curve between RNA 1 and Neomycin. (b) Sample titration curve between
RNA 2 and Compound 1
Table 3.1. Kd values (µM) for compound 1 against mutant RNA.
entry

RNA1 RNA 2 RNA 3 RNA 4 RNA 5 RNA 6 RNA 7 RNA 8

Compound 1 2.2

1.5

2.2

1.7

0.5

1.4

2.9

1.4

3.2.2 RNA Binding Studies of Compound 2
Compound 2 was titrated similar to compound 1 against RNA 1 (native A-site RNA) and
its mutants RNA 2-8 (Figure 3.6). As observed with compound 1, all the RNAs showed
sigmoidal regression curves, as shown in a sample binding curve between RNA 6 and compound
2 (Figure 3.4b). The Kd values ranged between 0.4 and 3.8 µM (Table 3.2), which were
comparable to that observed with neomycin. RNA 1 is the preferred target for compound 2 and
demonstrated 10 times stronger affinity compared to RNA 7. Both compound 1 and 2 showed
lowest binding affinity towards RNA7. These results provide additional evidence that specific
sequence binding can be influenced by the addition of additional rings to the neamine core
structure.
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Figure 3.6 (a) Titration curve between RNA 1 and Neomycin. (b) Sample titration curve
between RNA 6 and Compound 2
Table 3.2 Kd values (µM) for Compound 2 against RNA mutants
entry

RNA1 RNA 2 RNA 3 RNA 4 RNA 5 RNA 6 RNA 7 RNA 8

Compound 2 0.4

3.2

3.6

1.2

0.68

3.4

3.8

2.2

3.2.3 RNA Binding Studies of Compound 3
Compound 3, which contains a urea bond linking the dimeric 2-DOS mimics, was next
tested for binding affinity and sequence selectivity against different RNA sequences. All the
RNAs demonstrated sigmoidal binding curves as shown in the sample binding curve between
RNA 6 and compound 3 (Figure 3.7b). The Kd values for compound 3 range from 0.36 to 7.7
µM (Table 3.3). Compound 3 showed strong binding affinity towards RNA 3, 4 and 5. RNA 5 is
the preferred target for compound 3 and demonstrated 21 times stronger binding affinity
compared to RNA 8.
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Figure 3.7 (a) titration curve between RNA 1 and Neomycin. (b) Sample titration curve between
RNA 6 and Compound 3
Table 3.3 Kd values (µM) for Compound 3.
entry

RNA1 RNA 2 RNA 3 RNA 4 RNA 5 RNA 6 RNA 7 RNA 8

Compound 3 2.5

3.6

0.67

0.65

0.36

4.95

1.18

7.7

The results of these RNA binding studies demonstrate that our 2-deoxystreptamine
mimics 1–3 do demonstrate selectivity towards binding different sequences of RNA. Each of
our mimics shows specificity for different sequences of RNA adjacent to the standard binding
location (A-site), confirming our hypothesis that extension of the aminoglycoside to include
additional rings can be used as a strategy for designing new RNA binding molecules that bind to
specific sequences. In addition, these results confirm that the structure of the 2-DOS mimic can
impact the specificity of binding for different sequences.
3.3 Antibacterial Activity
3.3.1 Antibacterial Activity of Novel 2-DOS Mimics 1–3
Compounds 1, 2, and 3 were next tested for antimicrobial activity against E. Coli TOP10,
Klebsiella pneumoniae and Acinetobacter baumannii. These strains of bacteria are known to be
resistant to aminoglycoside antibiotic. We first tested compound 1 against E. coli TOP10, K.
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pneumoniae JHCK1, and Acinetobacter baumannii. Concentrations of compound 1 were 0.05
and 0.25 mg/ml. We did not see any activity against any of these strains with compound 1. We
did not test a full range of concentrations for compound 1 due to the lack of antibacterial activity
shown in initial experiments and because of a lack of material with compound 1. Compound 2
was next tested, and was shown to have no activity against Acinetobacter baumannii. It does,
however, show some activity against E. Coli TOP10, and Klebsiella pneumonia. Concentrations
of compound 2 were 1, 2, 4, and 8 mg/ml. We then tested compound 3 against E. coli TOP10, K.
pneumoniae JHCK1, and Acinetobacter baumannii. Concentrations of compound 3 were 0.5, 1,
2, 4, and 8 mg/ml. Compound 3 is active against all the three strains. Klebsiella pneumoniae
JHCK1 and Acinetobacter baumannii A155 are resistant to several amino glycosides including
amikacin, kanamycin, tobramycin.
In conclusion, we have prepared dimeric 2-DOS mimics (1–3) by conjugating two
monomeric units by an amide and urea bonds. Their binding affinity was comparable to that of
neomycin in RNA binding studies with a variey of mutant RNAs. They demonstrated weak
antibacterial activities but show some promising results against K. Pneumoniae JHK1, which is
known to be resistant to many aminoglycosides. Thus, our novel 2-DOS mimics may be used as
templates to build more potent antibiotics.
3.3.2 Comparison of RNA binding Affinity and Antibacterial Activity
In this section we will discuss the correlation between the antibacterial studies and RNA
binding affinity studies of aminoglycoside antibiotics. In our recent paper13 we published results
comparing the binding affinity of eight members of the pyranmycin class of antibiotics (TC001,
TC002, TC003, TC005, TC007, TC0012, RR501 and pyrankacin) and two members of
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neomycin class (NEOF004 and neokacin) with their antibacterial activity (Figure 3.8). We
titrated all the ten aminoglycosides against RNA1 and RNA 3 (see Figure 3.3) under the same
conditions used for titrations with our 2-DOS mimics presented in the previous section

14

. The

minimum inhibitory concentrations (MIC’s) against Escherichia coli (ATCC 25922) and
Staphylococcus aureus (ATCC 25923), have been determined previously for all the compounds
tested.8-11
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Figure 3.8 Members of pyranmycin and neomycin family used to compare antibacterial activity
and binding affinity.
Generally aminoglycosides with more hydrophilic groups (NH2 or OH) will have higher
binding affinity (lower Kd value) towards the target RNAs. For example TC003 with six amino
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groups showed the highest binding affinity compared to other pyranmycin members, but TC003
showed less antibacterial activity compared to other members (Table 3.4). RR501 on the other
hand has two less hydroxyl groups at 3` and 4` positions and thus shows lower binding affinity.
Yet it shows superior antibacterial activity. Similar difference between Kd`s and MIC`s has also
been previously reported.12 Compounds TC005, TC007 and neokacin did not show sigmoidal
binding curve with RNA 1, instead they show an increase in the fluorescence reading as the
concentration of each aminoglycoside is increased. The other members of pyranmycin and
neomycin family of antibiotics demonstrated sigmoidal binding curves. This means that these
three pyranmycin members may interact differently in the region of RNA1 potentially by nonspecific interactions due to the presence of non-natural 2-aminopurine. However, using
structurally similar RNA3 (see Figure 3.3), normal binding mode was observed for all the tested
aminoglycosides, including TC005, TC007 and neokacin. Since neomycin showed very similar
binding affinities toward both RNA1 and RNA3, we believe that the abnormal binding of
TC005, TC007 and neokacin toward RNA1 is due to the presence of the 2-aminopurine.
However pyrankacin showed the highest binding affinity and highest antibacterial activity.
NEOF0004, which has a much larger hexadecanoyl (C16) group at the 5` position showed
stronger binding affinity than several other pyranmycin members and even neomycin, which is
interesting since the high lipophilicity of the hexadecanoyl group is not expected to interact
closely with the highly charged RNA’s. As additional evidence for the disconnect between RNA
binding affinity and antibacterial activity, our 2-DOS mimics 1, 2 and 3 showed stronger binding
affinities compared to neomycin. However, all the three 2-DOS mimics showed little
antibacterial activity compared to neomycin.
Table 3.4 Binding affinity (Kd = µM) a and minimum inhibitory concentrations (MIC’s)
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Binding

Binding

E. coli

S. aureus

Affinity

Affinity

(ATCC 25922)

(ATCC 25923)

RNA1

RNA3

MIC

MIC

Neomycin

1.148

1.270

4.4

1.1

TC001

9.667

0.608

92.4

44.4

TC002

26.05

0.845

35.1

14.8

TC003

3.720

0.261

41.8

29.6

TC005

No Binding

0.556

19.8

11.0

TC007

No Binding

1.152

57.2

59.2

TC012

5.675

2.827

44.0

29.6

RR501

1.331

1.203

26.0

6.50

Pyrankacin

0.650

1.357

5.59

2.80

NEOF004

1.269

0.737

4.69

2.35

Neokacin

No Binding

1.642

8.59

2.15

Compound

3.4 Conclusion
Our results presented in this chapter suggest that our novel approach to aminoglycoside-based
RNA binding molecules could indeed lead to the design of specific and selective RNA binding
molecules. These results also imply that the RNA constructs can accommodate diverse structural
entities attached onto the naturally occurring aminoglycosides, which can be used as a strategy
for developing more specific binders to any RNA sequence. However, our antibacterial studies
demonstrate an strong disconnect between the RNA binding capabilities of an aminoglycoside
mimic and the actual antibacterial properties. Thus, the use of simple RNA constructs and
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binding affinities alone may not be sufficient to predict the actual behavior of synthetic
aminoglycosides inside bacteria.
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3.6 Experimental Procedures
3.6.1 Fluorescence Binding Assay Condition, Procedures, and Titration Curves
Purification of the compound 1 and neomycin: The compound 1 and neomycin were
purified and isolated as the free base form using anion exchange resin (DOWEX
MONOSPHERE 550A (OH). Each (50-100 mg) was loaded on the resin column that had been
pre-equilibrated with water. Then, each was eluted using ddI-H2O water and fractions containing
the free base were identified by ninhydrin staining on TLC plate and were combined &
lyophilized.
Determination of RNA concentration: Each RNA was purchased from Dharmacon
PAGE- purified, 2’-deprotected, & desalted. They were used directly without further
purification. RNA constructs were quantified in 50 mM phosphate buffer (pH 7.5) with the
following extinction coefficient (260 nm) values (in units of L/mol.cm): RNA1 (ε = 244,200),
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RNA2 (ε = 247,300), RNA3 (ε = 242,200), RNA4 (ε = 249,600), RNA5 (ε = 258,900), RNA6 (ε
= 245,400), RNA7 (ε = 255,200), RNA8 (ε = 239,100).
3.6.2 Fluorescence Binding Assay
Fluorescence binding assay was performed in a pH7.0 buffer (150 mM sodium
cacodylate, 5 mM MgCl2). Each 2-AP labeled RNA was excited at 300 nm and emission
spectrum was monitored at 330 to 420 nm (emission max at 370 nm). Following is the detailed
procedure for the assay: the fluorescence spectrum of a 222.8 μL buffer solution was recorded as
the blank. This background fluorescence was observed minimal and subtracted from all
subsequent emission spectrum of each binding titration. To the blank buffer was added each
RNA labeled with 2-aminopurine (2.25 μL of 50 μM) to give the final 0.5 μM RNA
concentration and the fluorescence was recorded. Subsequent aliquots of 0.9 μL of aqueous
solution of neomycin or the compound 1 (0.05 μM – 5 mM) was added and the fluorescence
spectrum were recorded after each aliquot. The decrease in fluorescence was observed with the
addition of each aliquot. Over the entire range of titration, the emission maximum at 370 nm did
not significantly vary (<1.0 nm). No “background emission” was observed near 370 nm. As
small, concentrated volumes of the ligands were titrated in, the total volume of the sample never
changed more than 5%. Titration experiment performed at lower ionic strength used a pH 7.0
buffer containing 20 mM sodium cacodylate, 25 mM KCl, 2 mM MgCl2.
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Chapter-4
Polymer-Supported Nanoparticle Catalysts for Organic Synthesis
4.1 Introduction
The design and synthesis of nanostructured materials has emerged as a major research
direction in several areas such as optics and electronics, sensing, medicine, and catalysis. For
each of these applications, the properties of the nanomaterials can be altered by changing their
size (surface area), molecular structure and shape, and matrix or support. These types of
modifications to nanostructured materials (nanoparticles) are particularly important in the area of
catalysis where chemical reactions that occur at the surface of the nanoparticles are highly
influenced by the surface composition and physical properties1. Catalysis has a broad impact on
many areas important to modern society, including the development of new medicines
(pharmaceuticals), energy (photovoltaics, petroleum utilization), materials (polymers), and
agriculture (pesticides, fungicides). Thus, the development of highly reactive and selective
nanoparticle catalysts can accelerate the advancement of our modern society in important ways.
Transition metal catalysis is divided into two general classes: heterogeneous catalysts
where the catalyst and reactants are in different phases (generally solid/liquid or solid/gas) and
homogeneous catalysis where both catalysts are in the same phase (generally dissolved in
solvent). Several practical considerations make heterogeneous catalysts more attractive,
including their ease of separation, recovery, and reuse, and their high temperature stability.
However, heterogeneous catalysis suffers from a general lack of mechanistic understanding that
could aid in the development of more selective and efficient catalysts.2 Homogeneous catalysis,
on the other hand, is very efficient and selective and the electronic and steric properties of the
metal catalyst can be tuned by changing the structure of the supporting ligands. In addition,
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many reaction mechanisms are known for homogeneous transition metal catalysts that enable
rational design of more efficient catalysts. The limitations with homogeneous catalysis include
low turnover numbers, low thermal stability, and the difficulty of catalyst separation and
recovery 1. Based on the advantages and disadvantages of these two classes of catalysis, it would
be highly advantageous to develop catalysts at the interface between homogeneous and
heterogeneous catalysis that offer both catalyst stability and recyclability while maintaining
selectivity and catalyst tunability.
Nanoparticle catalysis represents a bridge between heterogeneous and homogeneous
catalysis for several significant reasons.3 First, the small size and high surface of nanoparticles
makes them more reactive than traditional heterogeneous catalysts. Second, product selectivity,
catalytic efficiency, and catalyst stability can often be controlled by adding stabilizers (organic
ligands or polymers), or by adsorbing the nanoparticles on a solid support such as TiO2, Al2O3,
SiO2, CeO2, ZrO2,4 porous zeolites or carbon nanotubes.5 Nanoparticles can also be encapsulated
in dendrimers5 or polymers.5 Third, the desired nanoparticle catalysts often remain heterogeneous
in the reaction mixture, especially when adsorbed onto a solid support, and thus can be easily
separated from the reaction mixture and reused without loss of activity. Finally, nanoparticle
catalysis is environmentally friendly because the catalysts can be often reused.
This chapter will discuss the design and synthesis of nanoparticle catalysts for
applications in organic synthesis. A wealth of knowledge is available on the development of
transition metal nanoparticles on solid supports and the application of these nanocatalysts to
industrial processes such as Fischer Tropsch hydrocarbon synthesis.6 These applications of
nanoparticle catalysis have been previously reviewed.60 The focus of this chapter is recent
advances in the development of tunable nanoparticle catalysis and their application to organic
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reactions used in fine chemical synthesis. In general, the mechanisms of these processes are well
understood, and corresponding homogeneous catalysts have been developed. Specifically, the
formation of unsupported homogeneous nanoparticle catalysts will be discussed, followed by the
synthesis and application of supported nanoparticles, including polymer-supported nanoparticle
catalysts.
4.2 Preparation Strategies for Nanoparticle Catalysts
While various methods exist for preparing nanostructured materials, the typical procedure
for preparation of nanoparticle catalysts is reduction of a homogenous solution of a high valent
metal salt in the presence of stabilizers. The reducing agent reduces the corresponding metal ion
to zero valent metal, which then aggregates to form nano-sized clusters. Synthesis of
nanocatalysts in this way requires no special equipment or instrumentation, making this class of
catalyst accessible to any synthetic chemistry laboratory. Chemical reductions are the simplest
and most common method of preparing nanoparticles, including the use of metal hydride
reductants such as sodium borohydride7 or hydrogen gas.8 In the latter method, hydrogen gas is
either bubbled into a solution containing the metal salt or the reduction is carried out under
elevated pressures of hydrogen to reduce the metal salts to zero valent metal atoms. Reduction of
metal salts in alcohol9 solvents is another common reduction method, where reduction of the
metal salt occurs under refluxing conditions. In this reaction, the alcohol acts as the reductant
and is subsequently oxidized to the corresponding carbonyl compound. The other common
reductants for nanoparticle formation include hydrazine, 10 and sodium citrate solutions.11
During the reduction of metal salts for nanoparticle formation, the addition of stabilizers
is often necessary to control particle size and shape, and to prevent formation of bulk
heterogeneous metal. Nano-sized metal particles have much higher surface area than bulk
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metals, have highly curved surfaces, and often have edges and ridges, all of which can be
important to catalytic activity. The addition of stabilizers or heterogeneous supports, which can
bind to the surface of nanoparticles or sequester small particles to prevent further aggregation, is
often used as a strategy to improve catalytic efficiency. The nature of the support and or
additives can influence not only the size, but also the shape of the particles and the electronic
properties of the metal surface. The next section will discuss specific examples of how size,
shape, and the nature of the support can influence the catalytic performance of the nanoparticle
catalysts.
4.3 The Impact of Nanoparticle Structure on Catalytic Activity
4.3.1 Nanoparticle Size and Catalytic Activity
The size of the nanoparticle has a tremendous impact on the catalytic activity and
selectivity of a reaction and can often be optimized to improve catalyst performance.12 In
general, nanoparticles with small size are more catalytically active compared to larger ones
because of their higher surface area per unit volume. However sometimes optimization of the
ideal particle size is necessary for better catalytic activity. For example, Goodman et al.13
prepared Au nanoparticles on TiO2 for CO oxidation with diameters ranging from 2−6 nm. They
found that the highest catalytic activity was achieved not with the smallest nanoparticles
synthesized, but when a particle size of 3.5 nm was obtained. Several groups have similarly
found that gold nanoparticles exhibit maximum catalytic activity when the size of the
nanoparticles is between ~2−3 nm. Gangula et al. also showed that the catalytic activity of gold
nanoparticles in 4-nitrophenol reduction decreases as the size of the particle increases.15
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Nanoparticle size not only affects catalytic activity, but can also affect the selectivity of a
catalyst for different products. Somorjai et al. 14 showed that reduction of pyrrole using platinum
nanoparticles on SBA-15 mesoporous silica exclusively forms n-butyl amine when the size of
the nanoparticle is more than 2 nm (Figure 4.1). When the size of the platinum nanoparticle was
decreased to about <2 nm, reduction of pyrrole generated pyrrolidone selectively.

N
H

<2nm. Pt/SBA-15
H2, 140 o C

>2nm. Pt/SBA-15
H2, 140 o C

N
H

Pyrrolidine

NH2

n-Butyl amine

Figure 4.1 Hydrogenation of pyrrole over platinum NPs of different sizes.
4.3.2 Nanoparticle Shape and Catalytic Activity
Nanoparticles exhibit different catalytic activity and selectivity on different exposed
facets at the surface of the particle.16 As the number and types of facets change on a particle
surface, the shape also changes as a direct result. Synthetic methods have been developed that
generate metal nanoparticles of different shapes, including spheres, cubes, tetrahedrons,
octahedrons, rods, wires, and prisms.17 McGlacken et al.

18

prepared palladium nanoparticles

with cubic, cuboctahedral, and octahedral morphologies (Figure 4.2) and compared the catalytic
performance for Suzuki-Miyaura coupling reactions. These palladium nanocubes were
synthesized from Na2PdCl4 using poly(vinylpyrrolidone) (PVP) as a stabilizing agent and
ascorbic acid as reducing agent at 80 oC. Octahedral and cuboctahedral nanocrystals were
prepared from cubic palladium seeds using PVP as a stabilizing agent and ascorbic acid as
reducing agent at 80 o C, followed by the addition of varying amounts of Na2PdCl4 dissolved in
deionized water. The prepared nanocrystals were separated by centrifugation, immobilized on a
heterogeneous carbon support, and then dried in vacuum at 120 oC. In the catalytic studies, they
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showed that palladium nanocrystals with {100} surface facets showed superior catalytic activity
compared to {111} facets.
B(OH)2

Br

Pd NPs on Carbon
+

EtOH:H2O, K2CO3, rt

OMe

MeO

Cubic

Cuboctahedral

Octahedral

Increasing reactivity

Figure 4.2 Shape sensitivity in palladium nanoparticle-catalyzed Suzuki-Miyaura cross coupling
reaction.
Similar to the McGlacken work described thus far, El-Sayed et al.19 prepared tetrahedral
and spherical platinum nanocrystals for Suzuki-Miyaura coupling reaction (Figure 4.3). In their
manuscript, they demonstrated that the tetrahedral nanocrystals showed catalytic activity, while
spherical nanocrystals did not show any catalytic activity.19b A significant drawback to designing
nanoparticle catalysts with structure-based reactivity is that the shape of the nanoparticle may not
be preserved during the reaction.19 Thus, catalytic performance can either increase or decrease as
the result in changes to the metal surface during catalysis.

I

B(OH)2

+

Tetrahedral Pt NPs
o
NaOAc, H2O, 100 C

Figure 4.3 Tetrahedral Pt NPs catalyzed Suzuki- Miyaura coupling reaction.
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4.3.3 Supporting Ligands and Catalytic Activity
Colloidal (Homogeneous) Nanoparticle catalysis: The use of colloidal or homogeneously
dispersed metal nanoparticle catalysts is an attractive approach in nanoparticle catalysis because
the nanoparticles are generally freely accessible to reagents in the reaction solution. Thus,
excellent catalytic efficiency and selectivity is observed, as compared to supported metal
nanoparticle catalysts. However, catalyst recycling is difficult compared to supported,
heterogeneous nanoparticle catalysts. Colloidal metal nanoparticles can be prepared via the
reduction methods described above from homogeneous metal salt solutions. In colloidal metal
nanoparticle synthesis, stabilizers are necessary to prevent nanoparticle agglomeration, which
can cause the catalyst to precipitate from solution. Common classes of stabilizers include
polymers such as polystyrene,20 polyvinylpyrrolidone (PVP),21 ionic polymers,22 polyvinyl
alcohol (PVA),23 and poly (acrylamide) (PAA),24 and surfactants25 like cetyltrimethylammonium
bromide (CTAB) and N-alkyl-N-(2-hydroxyethyl)ammonium salts (Figure 4.4).

Phosphine

ligands,26 dendrimers27 have also been employed. Specific examples of the synthesis of this
class of nanoparticle and the impact of ligand structure on catalytic properties will be discussed
in the following section.
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Figure 4.463 Schematic representation of stabilization of nanoparticles using different protecting
groups.
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Supported nanoparticle catalysis: In heterogeneous catalysis, metal nanoparticles are adsorbed
on inorganic oxides such as TiO2, Al2O3, CeO2, SiO2, or carbon, or can be encapsulated by
polymers followed by cross linking.28 The adsorption process involves preparing a colloidal
suspension of the transition metal nanoparticles and adsorbing these colloidal nanoparticles onto
the support. Alternatively, performing the nanoparticle reduction/formation in the presence of
the inorganic oxide can lead to formation of the nanoparticle on the support. A significant
advantage of supported nanoparticles over colloidal nanoparticles is that catalyst recovery and
recycling is very straightforward and can often be accomplished with simple filtrations. In
addition, leaching of the metal nanoparticle into solution can be minimized by controlling the
concentration of the nanoparticle on the support, or by making modifications to the support. One
disadvantage is that the reactivity of supported nanoparticle catalysts can be diminished because
the nanoparticle is sequestered in the support (polymers) and or in a separate phase from the
reagents. Metal nanoparticles composed of platinum, gold, palladium, ruthenium, nickel and
cobalt, among others, 29 have been supported on inorganic oxides. These supported catalysts are
widely used in synthesis for hydrogenations,

30

oxidations of CO31 and alcohols,

32

NO

reductions, 33 nitroarene reduction, 34 coupling reactions, 35 and Fischer-Tropsch synthesis.36
The main advantage of using organic polymer supports over inorganic supports is that
organic polymers can be easily functionalized by incorporating ligands on the polymer.37 This
approach allows for tuning of the metal nanoparticles steric and electronic properties, which in
turn can control the reactivity and selectivity of the desired transformation. In this fashion,
polymer-supported nanoparticle catalysts most closely resemble their homogeneous metal
complex counterparts because the reactivity of the nanoparticles can be optimized and tuned by
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variation of the polymer ligand structure. Specific examples of the synthesis and catalytic
applications of polymer-supported nanoparticle catalysts will be presented below.
4.4 Preparation and Catalytic Performance of Nanoparticle Catalysts for Organic
Synthesis
4.4.1 Preparation and Catalytic Activity of Unsupported Metal Nanoparticles
This section provides specific examples of methods to synthesize unsupported ligandstabilized colloidal metal nanoparticles in liquid phase and in the absence of a solid support. The
main emphasis is on the synthesis of nanoparticles for catalytic applications and their reactivity
towards different organic reactions. Key to the synthesis and use of homogeneous colloidal
nanoparticles is selection of the appropriate stabilizer that not only prevents nanoparticle
aggregation and precipitation, but also maintains or enhances the desired catalytic activity. The
reports on the synthesis of colloidal metal nanoparticles are extensive, and thus here we only
discuss the synthesis of gold, palladium, and silver nanoparticles because they have found the
most wide spread application in organic synthesis.
Preparation and Catalytic Activity of Unsupported Gold Nanoparticles: Bulk gold metal is
catalytically inactive and historically was not considered as a viable metal for heterogeneous
catalysis. Haruta and coworkers were the first to report that gold nanoparticles (NPs) with
particle size <10 nm are chemically active in oxidation of CO.61 Since this initial report,
significant attention has been given to the synthesis of catalytically active gold nanoparticles.
Gold nanoparticles are generally non-toxic, as compared to other transition metals, and thus
much interest has been demonstrated in their potential as catalysts for pharmaceutical synthesis,
and as supports for drug delivery applications59. Herein we will describe several examples of the
synthesis and catalytic applications of gold nanoparticles.
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Tsukuda et al.

38

prepared monodisperse Au NPs having a mean diameter of 1.3 nm and

studied their catalytic activity for the aerobic oxidation of benzylic alcohols (Figure 4.5). Gold
nanoparticles were prepared by rapid addition of aqueous NaBH4 into an aqueous solution of
HAuCl4 containing polyvinylpyrrolidone (PVP) as a stabilizer at room temperature. They also
prepared Au NPs having a mean diameter of 9.5 nm by reducing HAuCl4 with sodium sulfite in
the presence of 1.3 nm gold NPs prepared previously and compared the catalytic activity of both
the nanoparticles of different sizes. Nanoparticles having mean diameter of 1.3 nm showed
superior activity compared to the one nanoparticles of 9.5 nm diameter. The authors attributed
the improved catalytic activity to the difference in surface area.

OH
HO

2 atom % Au:PVP
300 mol % K2CO3
H2O, air, RT

O
HO

N

n
O

PVP

Figure 4.5 PVP stabilized gold NPs catalyzed oxidation of benzyl alcohol
Dyson et al.39 prepared Au NPs by NaBH4 reduction of HAuCl4 in water with water
soluble ionic polymer poly-(3-((2,4-divinylcyclopentyl)methyl)-1,2-dimethyl-1H-imidazolium
methanesulfonate) as a stabilizer. They then studied the catalytic activity of the nanoparticles for
the reduction of p-nitrophenol (Figure 4.6) and hydrogenation of cinnamaldehyde. In the
preparation of the nanoparticle catalysts, they demonstrated that the size of the nanoparticle
could be controlled by adjusting the ratio of polymer to gold nanoparticle. When a polymer/Au
ratio of 50:1 was employed, the particle size distribution was in the range of 1.8 to 2.8 nm. If the
ratio of polymer to Au was decreased to 3:1, the resulting particle size distribution changed to
the range of 2 to 12 nm. The Au NPs catalyst having polymer/Au ratio of 50:1 showed the best
activity toward reduction of p-nitrophenol.
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Figure 4.6 Ionic polymer stabilized Au NPs for 4-nitrophenol reduction.
Prati et al.40 studied the catalytic activity and stability of Au NPs in the presence of
various

stabilizing

agents,

including

polyvinyl

alcohol

(PVA),

tetrakishydroxypropylphosphonium chloride (THPC) and citrate (Figure 4.7).

The PVA

stabilized Au NPs were prepared by the reduction of aqueous solution of HAuCl4 by NaBH4.
THPC and citrate stabilized Au NPs were prepared by reducing the aqueous solution of HAucl4
with THPC or citrate as the reductant. The size and catalytic activity of the Au NPs in different
stabilizers were then compared. It was found that the size of the Au NPs (2.0 to 2.45) were
smaller when sterically bulky stabilizing groups were used (PVA and THPC), and the size of the
Au NPs when citrate was used was 9.76 nm. In the catalytic oxidation of glycerol, they found
that higher catalytic activity was observed with the smaller particle sizes (Figure 4.7). There was
significant difference in the catalytic between PVA and THPC stabilized Au NPs. This result
shows that bulky stabilizer (PVP, THPC) was more effective at controlling particle size and thus
provide more reactive catalysts for aerobic oxidations.
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Figure 4.7 PVA, THPC, Citrate stabilized Au NPs for aerobic oxidation of glycerol.
Preparation and Catalytic activity of Unsupported Palladium Nanoparticles: Palladium is one of
the most widely used metals in homogeneous transition metal catalysis. In fact, the importance
of palladium catalysis to modern chemistry was recently demonstrated when the 2010 Nobel
Prize in chemistry was awarded for palladium-catalyzed cross couplings in organic synthesis.
Thus, the development of highly active and selective palladium nanoparticle catalysts has the
potential to impact a wide range of reactions in organic synthesis, including cross coupling
reactions, hydrogenations, and oxidations.
El-Sayed et al.41 prepared the Palladium NPs for applications to Suzuki cross coupling
reactions (Figure 4.8). They prepared their nanoparticle catalysts by heating an aqueous solution
of H2PdCl4 in the presence polyvinyl pyrrolidone (PVP) as a stabilizer and ethanol as a reducing
agent. The mean diameter of the synthesized Pd NPs was 3.6 nm. In catalytic studies, they found
that the nanoparticles were capable of performing the Suzuki cross coupling reaction in high
yields. However, the catalytic activity of Pd NPs slowly decreased during the course of the
reaction because the nanoparticles were shown to agglomerate and precipitate from solution. The
authors hypothesized that the high temperatures (100 °C) necessary for the reaction caused the
nanoparticles to escape from the polymer matrix and agglomerate, leading to precipitation.
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Figure 4.8 PVP-Pd NPs catalyzed Suzuki cross coupling
Fujihara et al.42 prepared chiral palladium NPs for enantioselective biaryl formation via
asymmetric Suzuki-Miyaura couplings at room temperature (Figure 4.9). The nanoparticles
were synthesized from K2PdCl4 using chiral, enantioenriched mono and bisphosphines as
stabilizers and sodium borohydride as a reducing agent. The mean diameter of the chiral Pd NPs
were 1.2 -1.7 nm. The yields and enantiomeric excess of the reaction were moderate to good, the
yields and enantioselectivities in the reaction were influenced remarkably by the protective
ligand on the chiral Pd NPs (Figure 4.9).
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Figure 4.9 Chiral Phosphine stabilized Pd NPs for enantioselective Suzuki-Miyaura coupling
reactions.
Reetz et al.43 prepared palladium NPs for application to the Heck cross coupling reaction.
The nanoparticles were synthesized from PdCl2, Pd(OAc)2, or Pd(NO3)2 using excess of
tetraalkylammonium carboxylates as reducing and stabilizing agent (Figure 4.10a). The tetra73

alkyl ammonium carboxylates stabilize colloidal nanoparticles by forming a monolayer around
the metal core (Figure 4.10a) thus preventing them from forming agglomerates. The palladium
nanoparticles were shown to have a diameter of 2 nm. The prepared Pd NPs were used for Heck
reaction and were found to have high reactivity (Figure 4.10b).
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Figure 4.10 (a) Tetraalkylammonium carboxylate-stabilized Pd NPs for Heck reactions. (b)
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Preparation and Catalytic activity of Unsupported Ruthenium Nanoparticles: Rousseau et al.44
prepared ruthenium NPs and explored their activity in the regio and stereoselective deuteration
of pyridines (Figure 4.11).

The nanoparticles were prepared from Ru(COD)(COT) in the

presence of PVP as stabilizer and hydrogen gas as a reducing agent.

Nanoparticles thus

prepared were shown to have high catalytic activity for a variety of substrates, including
pyridines, quinoliines, indoles and alkyl amines when deuterium gas was employed at room
temperature (Figure 4.11).
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Leeuwen et al.45 prepared ruthenium (Ru) NPs and explored their reactivity in the
hydrogenation of o-methylanisole (Figure 4.12). The nanocatalysts were again prepared from
Ru(COD)(COT) in the presence of different phosphine ligands as stabilizers and hydrogen gas as
a reducing agent. The authors prepared various “roof-shaped” diphosphines and monophosphine
ligands containing aryl and alkyl groups and studied the effect of phosphine ligands on the size,
stability and catalytic activity of the corresponding Ru NPs. The size distribution of alkyl
phosphorous stabilized NPs were between 1.35-1.5 nm, whereas the size distribution of aryl
phosphorous stabilized NPs were between 1.5-2 nm.
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Figure 4.12 Aryl and alkyl groups containing phosphine stabilized Ru NPs for Hydrogenation
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The authors found that phosphines containing alkyl groups showed superior catalytic
activity compared to phosphine ligands containing aryl groups. The stability is mainly due to
strong bond with alkyl phosphorous and weak π- π interaction between the aromatic backbone of
the ligand and the ruthenium atoms.
4.4.2 Preparation and Catalytic Applications of Supported Nanoparticles
In supported nanoparticle catalysis, metal nanoparticles are stabilized by absorption onto
insoluble solid supports. The insoluble supports are of two types: 1) inorganic supports such as
metal oxides and mesoporous silica 2) organic supports such as polymers. One of main
advantages of supported nanoparticle catalysts is that separation of the catalyst from the reaction
mixture is easy.

In addition, the recovered catalysts can often be recycled and perform

subsequent reactions with the same reactivity and selectivity. This latter advantage minimizes the
use of expensive metals and also decreases the metal-containing waste produced. A final
advantage of supported nanoparticle catalysts is that in many instances, no supporting ligands in
addition to the support are necessary. In this section we will briefly discuss several preparation
methods and catalytic applications of nanoparticles supported on inorganic and polymer-based
supports.
Nanoparticles Supported on inorganic supports – Fischer-Tropsch synthesis: Supported metal
nanoparticles have found widespread application in catalysis related to the petrochemical
industry, including for Fischer-Tropsch synthesis and hydrogenations. Fischer-Tropsch synthesis
is a process for conversion of CO/H2 into liquid hydrocarbon fuels and chemicals. A significant
body of research has been generated on the development of catalysts, including nanoparticle
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catalysts, for Fischer-Tropsch synthesis.60 Thus, only a recent example will be presented here
that demonstrates the impact of the solid support identity on catalytic performance.
Wang et al.46 reported preparation of cobalt (Co) nanoparticles supported on SiO2, Al2O3,
Zeolite H-Y, Zeolite Na-Y, Zeolite H-meso-Y and Zeolite Na-meso-Y for Fischer-Tropsch
synthesis. The authors prepared Co NPs by mixing Co(NO3)2∙6H2O and solid support using melt
infiltration technique at 60 oC followed by thermal treatment in a gas flow of 5 % NO/He at 400
o

C. The catalytic activity and product selectivity for C10-20 hydrocarbons of these nanocatalysts

was then compared. Zeolite Na-meso-Y supported Co NPs showed better selectivity for C10-20
hydrocarbon compared to other supports. The higher selectivity is due small size of Co NPs and
small mesopore size of the support.
Nanoparticles Supported on Inorganic Supports for Organic Synthesis:
Somorjai and Toste et al.47 prepared platinum nanoparticles of different sizes (1.5, 2.9
and 5.0 nm) for applications in alkene – alkyne cycloisomerization reactions (Figure 4.13). The
nanocatalysts were prepared from H2PtCl6 with either NaBH4 or ethylene glycol/NaOH as the
reducing agents.

The nanoparticles were generated with polyvinylpyrrolidone (PVP) and

hydroxyl-terminated polyamidoamine (PAMAM) dendrimers as capping agents.

After

nanoparticle formation, the resulting stabilized catalysts were deposited on SBA-15 and MCF-17
mesoporous silica at 100 oC for 24 hours. The supported nanoparticles then were tested for the
catalytic activity in various cyclization reactions (Figure 4.13). The authors showed equivalent
or superior selectivity could be obtained with the heterogeneous catalysts as with previously
developed homogeneous catalysts. They also demonstrated that the size of the nanoparticles had
a large impact on the catalytic activity, where nanoparticles of small size showed superior
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reactivity. The authors also commented that the pores on the mesoporous silica prevent catalyst
aggregation and contribute to the high stability of the catalysts.
2.5 mol% Pt NPs/PVP/silica
7.5 mol% PhICl2
o
Toluene, 100 C

MeO

MeO

3:1 para:ortho
73 % yield

Figure 4.13 Silica supported Platinum NPs for Hydroarylation.
Porco et al.48 prepared silica supported silver (Ag) NPs having a mean diameter of 4.5 nm
and studied their catalytic activity for the Diels-Alder cycloadditions of 2’-hydroxychalcones
(Figure 4.14). The Ag NPs were prepared by addition of tetrabutylammonium borohydride into
a solution of silver tetra fluoroborate (AgBF4) in CH2Cl2 in the presence of silica gel. The solid
was filtered and dried at 160 oC for 12 hours to give silica supported Ag NPs. The nanoparticles
had both high reactivity and high selectivity in the Diels-Alder reaction of highly advanced
synthetic intermediates. The authors did the same Diels-Alder reaction under homogeneous
conditions using AgBF4, the yields and selectivity for endo:exo were slightly better than silica
supported Ag NPs , with AgBF4 (Yield: >99%, endo/exo: 78:22), with silica supported Ag NPs
(Yield: 98%, endo/exo: 65:35), however the silica supported Ag NPs are reusable.
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Figure 4.14 Silica supported silver NPs for Diels-Alder reactions.
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Shiraishi et al.49 prepared TiO2 and CeO2 supported gold (Au) NPs for application to
catalytic aerobic oxidation reactions in the presence of UV-Visible light (Figure 4.15). The Au
NPs were prepared by adding TiO2 (P25) to a solution of water containing HAuCl4.H2O. The
solution PH was adjusted to 7 with 1M NaOH and the mixture stirred at 80 o C for 3 hours. The
Au NPs were recovered by centrifugation and solid was dried under air at 80

o

C for 12 hours

and powders were calcined in air at 200 o C to 600 o C. The resulting nanoparticles had a mean
diameter of 3.7 to 45.3 nm. The size of the nanoparticles was controlled by changing the ratio of
the supports.

Au/CeO2 nanoparticle catalysts were prepared in a similar manner. The

nanoparticles with <5 nm showed better catalytic activity in aerobic oxidations compared to
nanoparticles of larger size (Figure 4.15).
OH

Au/TiO2 (rutile/anatase)

O

Toluene, O2 (1atm)
Light irradiation

Figure 4.15 TiO2 supported gold NPs catalyzed aerobic oxidation of alcohols.
Synthesis and Catalytic Activity of Polymer Supported Nanoparticles: Organic polymers offer
some advantages over inorganic supports. Organic polymers can be easily functionalized by
incorporating supporting ligands onto the polymer. Thus, polymer-modification can be used to
tune the electronic and steric properties of the metal nanoparticles. Polymer-supported
nanoparticles can act as both homogeneous and heterogeneous catalysts where the homogeneous
polymers (such as those supported in polyvinyl pyrrolidone) can be easily separated from the
reaction by adjusting the polarity of the solvent, leading to catalyst precipitation. The use of
homogeneous polymer supported nanoparticle catalysts was previously discussed in section
4.4.1. The most common polymer used in polymer supported nanoparticle synthesis is
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polystyrene because it is easy to synthesize and can be easily functionalized to introduce
supporting ligands. Polystyrene-based polymers can also be cross-linked by adding small
amounts of divinylbenzene as a cross linker.50 Cross-linking in this manner generates insoluble
polymer supports, which can be easy to separate from the reaction mixture. Alternatively,
polystyrene-based polymers can be cross linked by introduction of reactive groups52 that can
react with one another and cross-link the polymer upon heating. This section discusses the
synthesis and catalytic activity of insoluble polymer supported nanoparticles.
Somorjai et al.51 and others have reported that organic molecules such as benzene can
weakly interact with gold surfaces through formation of weak interactions between the πelectrons of the benzene ring and the metal surface. Kobayashi et al.52 prepared gold nanoclusters
in polystyrene based polymers to see if the benzene rings of the polymers can stabilize the gold
nanoclusters through interaction with the π-electrons. They first prepared gold nanoclusters from
PPh3AuCl in THF using sodium borohydride as reducing agent without any stabilizing agent.
After addition sodium borohydride, the solution immediately turned from colorless to wine red,
which suggest the formation of gold (0) particles. However, after stirring the solution for several
minutes, aggregation of nanoclusters occurred to afford a black precipitate. They next reduced
PPh3AuCl under the same conditions and in the presence of polystyrene to see if nanoparticle
stabilization would result. In this case, the solution remained a deep red color, indicating
nanoparticle formation, but no black precipitate was observed, even after stirring the solution for
12 hours. This suggests that gold nanoclusters can be stabilized by the π-electrons of the benzene
rings in polystyrene.
Using polystyrene supported nanoparticles, Kobayashi and coworkers developed
heterogeneous polymer-supported gold nanoparticle catalysts for aerobic oxidation reactions
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(Figure 4.16). In their report, they co-polymerized epoxide- and alcohol-containing styrene
monomers to generate a cross-linkable polymer support.

After the introduction of gold

nanoparticles into the polymer by sodium borohydride reduction, the catalyst was heated to
initiate cross-linking via epoxide opening reactions. The authors were able to show that the
resulting cross-linked polymers remained heterogeneous in the reaction, had high catalytic
activity in aerobic oxidation reactions, and that cross-linking prevented the leaching of the gold
nanocluster from the polymer into solution (Figure 4.17).
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Figure 4.16 Aerobic oxidation of1-phenylethanol using polymer incarcerated gold NPs
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Kobayashi and coworkers53 also reported the synthesis of phosphinated cross-linkable
polymers capable of stabilizing palladium nanoparticle catalysts (Figure 4.18). These palladium
nanoparticle catalysts were later applied to Suzuki-Miyaura coupling reactions where addition
exogenous phosphine was unnecessary for high catalytic activity. The authors reported the
synthesis several polystyrene-based polymers containing diphenylphosphine groups attached to
the polystyrene.

The cross-linkable polymers (epoxide-containing) were synthesized with
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different ratios of the copolymers to vary the amount of phosphine and cross-linking agent in the
polymer. The catalyst was prepared by adding Pd(PPh3)4 to a solution of copolymer in THF at
room temperature, followed by stirring at room temperature for 24 hours. The polymer
encapsulated palladium nanoparticles were precipitated from the solution by addition of hexanes
and the polymer was cross linked by heating at 120 oC for 2 hours. The catalytic activity of
polymer-incarcerated nanoparticles was excellent when the ratio of diphenylphosphino groups to
palladium in the polymer was 2:1. The authors also synthesized a polymer without phosphine
groups and did the reaction by the addition of external triphenylphosphine. Importantly, the
addition of exogenous phosphine did not lead to high catalytic activity compared to the
diphenylphosphine-containing polymer.
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Figure 4.18 schematic representation of copolymer used to prepare Pd NPs for Suzuki-Miyaura
coupling
The Kobayashi group also reported the synthesis nickel nanoparticles stabilized by
polystyrene containing N-heterocyclic carbene ligands for use in the Corriu-Kumada-Tamao
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reaction (Figure 4.19).54 The polymer-incarcerated nickel nanoparticles was prepared by adding
NiBr2(PPh3)2 to a solution of THF containing an imidazole-containing copolymer and ketjen
black. The catalyst was then reduced using lithium triethylborohydride. The solid formed was
then filtered, washed, and dried.

Cross-linking of the polymer was then accomplished by

reaction of the imidazole with an alkyl bromide upon heating to 150 oC for 12 hours under argon.
The resulting imidazolium-containing polymer contained the requisite N-heterocyclic carbene
(NHC) precursor that was hypothesized to activate nickel for cross coupling during the reaction.
The resulting nickel nanoparticles have a mean diameter of 1-4 nm. The authors then compared
the reactivity of the nickel nanoparticles stabilized in the imidazolium-containing polymer
(Figure 4.20a) to nickel nanoparticles stabilized by their original cross-linked polystyrene
polymer (Figure 4.20b). They reported that the polymer that has no N-heterocyclic carbene on
the polymer is inactive whereas the polymer that has N-heterocyclic carbene highly is active in
cross coupling reactions (Figure 4.19).

Br

+ Ph-MgCl

Yield for Ni NPs in NHC containing polymer = 98%

NHC-Ni NPs (0.25 mol%)
THF, rt, 12 h

Ph

Figure 4.19 Corriu-Kumada-Tamao reaction
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Yield for original polymer with no NHC= 45%

Figure 4.20 (a) Ni NPs in original cross-linked polymer with no N-heterocyclic carbene. (b)
Nickel NPs stabilized in the cross-linked imidazolium-containing polymer with N-heterocyclic
carbene (NHC) formation.
Guo et al.55 prepared highly stable gold (Au) NPs of different sizes (1.0, 2.0 and 5.0 nm)
supported on poly (2-aminothiophenol) (PATP) for Suzuki-Miyaura cross coupling reactions
(Figure 4.21). The PATP-stabilized gold NPs were prepared by stirring 2-aminothiophenol in an
aqueous HCl solution, followed by the addition of an aqueous solution of HAuCl4. After stirring
the reaction mixture for 24 hours at room temperature, the PATP supported Au NPs were
precipitated, filtered, washed with deionized water, and dried under vacuum at 60 oC.
Nanoparticles with sizes 1nm, 2nm and 5nm was prepared by altering the molar ratio of HAuCl4
to 2-aminothiophenol. The conjugated π-electrons of benzene rings and thiol groups of the PATP
significantly control the size and stability of the gold NPs. The authors reported that both the
size of the nanoparticles and the percent loading of the nanoparticles in polymer played an
important role in catalytic activity of gold NPs in Suzuki-Miyaura cross-coupling reaction. They
found that the catalytic was highest when the small particles were used, and that the higher
weight percent of nanoparticle in the polymer also led to higher catalyst activity.
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Figure 4.21 PATP-Stabilized Gold Nanoparticle Catalysts for Suzuki-Miyaura Coupling of
Chlorobenzene and Phenylboronic Acid
Diaconescu et al.56 prepared palladium NPs supported on polyaniline nanofibers for
Suzuki coupling reactions (Figure 4.22). Palladium NPs supported on polyaniline were prepared
by adding palladium (II) nitrate to a suspension of polyaniline in water, followed by incubation
for one day. The resulting solution was purified by dialysis to remove any remaining palladium
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(II) nitrate. These polyaniline-supported Pd NPs prepared via this protocol showed good yields
and selectivity`s in the cross coupling reaction. (Yield: 88 to 99%, time: 2-6 h)
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Figure 4.22 Polyaniline supported Pd NPs for Suzuki coupling
Synthesis of Polymer Supported Bimetallic Nanoparticle catalyst: An alternative strategy for
improving the reactivity of polymer-supported nanoparticle catalysts is incorporating a second
metal into the polymer to form a bimetallic nanoparticle. Three different classes of bimetallic
nanoparticle catalysts can be formed, depending on the procedure and type of metals employed.
First, bimetallic alloys may form; second, bimetallic core shell nanoparticles may form; and
third, mixtures of monometallic nanoparticles may form. The alloy form has different properties
compared to monometallic nanoparticles, bimetallic core shell nanoparticles, and mixtures of
individual monometallic nanoparticles. In addition, different catalytic activity and selectivity can
be observed for each type of catalyst. This section discusses the synthesis and catalytic
applications of some important polymer supported bimetallic nanoparticles.
Kobayashi et al.57 reported the synthesis the synthesis of amides from alcohols and
amines under aerobic conditions using polymer incarcerated carbon black (PICB) supported
bimetallic gold/iron, gold/nickel and gold/cobalt nanoparticles (Figure 4.23). The bimetallic
nanoparticles were prepared by reducing the corresponding the solution of precatalysts
(PPh3AuCl, NiF2, FeCl2, and CoCl2) in diglyme using sodium borohydride followed by filtering
the precipitate by adding diethyl ether and cross linking the polymer at 150 oC for 4 hours. When
monometallic gold nanoparticles were used to make the amide from benzyl alcohol and benzyl
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amine, only 45 % of the amide was formed. Incorporating inexpensive metals like Iron, nickel,
cobalt nanoparticles led to improved yield and selectivity for amide product formation when
compared to monometallic gold nanoparticles. In addition, the ratio of M1 and M2 had a huge
impact on the selectivity and yield. Gold/cobalt bimetallic nanoparticles (2.36 nm) showed better
selectivity and yield compared to gold/iron or gold/nickel nanoparticles.
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Figure 4.23 Polymer incarcerated (PI) Au/Co NPs for amide synthesis from alcohols and
amines.
Kobayashi et al.58 also reported the aerobic oxidations of alcohols to form aldehydes,
ketones and esters using polymer incarcerated carbon-supported (PICB) bimetallic gold/platinum
and gold/palladium nanoparticles (Figure 4.24). The polymer incarcerated bimetallic
nanoparticles were prepared by the reducing the corresponding metals salts (PPh3AuCl,
Na2PtCl6.6H2O, Pd(OAc)2 in diglyme using sodium borohydride followed by filtering the
precipitate by adding diethyl ether and cross linking the polymer at 150 oC for 4 hours. Under
neutral reaction conditions, monometallic polymer incarcerated gold, palladium and platinum
nanoparticles did not show any catalytic activity in the aerobic oxidation of alcohols. However,
bimetallic gold/platinum nanoparticles showed excellent activity and selectivity for aerobic
oxidation of alcohols to aldehydes and ketones in benzotrifluoride/water solvent. Under basic
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conditions, alcohols were converted selectively to acids with the same nanoparticle catalysts.
With methanol as solvent, alcohols were converted to methyl esters in good yields. Bimetallic
gold/palladium nanoparticles did not show any catalytic activity for aerobic oxidation of alcohols
under neutral or basic conditions.
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Figure 4.24 Selectivity to different products using bimetallic nanoparticles
4.5 Conclusion and Outlook
Nanoparticle catalysis is now well advanced, with the development of several preparation
methods and modern characterization techniques. Nanoparticle catalysts are tunable, recoverable
and recyclable catalysts, thereby acting as bridge between homogeneous and heterogeneous
catalysis. Several different preparation methods, supports, and stabilizers are available to make
metal nanoparticles. Bimetallic nanoparticles are often more efficient than single metal
nanoparticles, and the shape of the nanoparticle has huge impact on catalytic activity. Polymer
supported nanoparticles have the added advantage over traditional inorganic supports in that the
electronic properties of the particle can be tuned by attaching ligand to the polymer, like in
homogeneous catalysis.
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My work in the Michaelis laboratory has focused on the use of polymer-supported
nanoparticle catalysts for the development of highly reactive and selective catalysts for organic
synthesis. We are interested in the potential of the polystyrene to act as a tunable ligand capable
of tuning catalytic activity and selectivity in catalysts. Several of the examples presented above
demonstrated that incorporation of supporting ligands into the polymer structure can be used to
vary catalytic activity. In addition, the use of mixed-metal nanoparticles is also a viable strategy
for generating highly effective catalysts. In our research, we have focused on the potential to
change the steric and electronic structure of the polystyrene itself in order to vary the strength of
the metal-polymer interaction. Our hypothesis is that subtle changes to the strength of the
interaction between the π-electrons of the polymer and the metal surface can influence catalyst
activity and lead to more reactive and selective catalysts.
In our recent first publication on the topic62, we showed that both modification of the
polystyrene support structure and varying the M1:M2 ratios in a bimetallic nanoparticle led to
enhanced reactivity in nitroarene reductions with ruthenim-cobalt nanoparticle catalysts. This
dual optimization approach produced highly active and chemoselective catalysts for nitroarene
reductions (Figure 4.25).

We also demonstrated for the first time that polymer electronic

structure could significantly impact catalyst activity.
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Figure 4.25 Modifying the nanoparticle composition and tuning the metal-support interaction
for nitro reduction
88

Further work in our laboratory has demonstrated that highly chemoselective azide
reductions can be facilitated by polystyrene-supported ruthenium, even in the presence of highly
reactive nitro functional groups.

We have also demonstrated that modification of the

nanoparticle catalyst activity can lead to selective partial reduction of nitroarenes to provide
diarylhydrazine products in high yield (Figure 4.26). These works are currently being prepared
for publication.
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Figure 4.26 Selective reduction of azides in the presence of nitro group and partial reduction of
nitro group to form diarylhydrazine product.
Although nanoparticle catalysis has emerged as an effective approach to catalyst
development, the application of these catalysts to organic synthesis is still in its infancy. The
application of nanoparticle catalysts to the synthesis of complex molecules and pharmaceuticals
reduce the cost, waste associated with chemical synthesis, while at the same time providing
processes with higher efficiency that maintain high levels of selectivity. Thus, the application of
nanoparticle catalysis to organic synthesis will continue to be an important research pursuit in the
decades to come.
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Chapter-5
A Dual Nanoparticle Approach to Bimetallic Nanoparticle Catalysis:
Impact of M1:M2 Ratio and Supporting Polymer on Reactivity in
Nitroarene Reductions
5.1 Introduction
The development of highly reactive, tunable, recoverable, and recyclable heterogeneous
nanoparticle catalysts has the potential to make a significant impact in organic synthesis.1 The
challenge associated with traditional heterogeneous catalysts is the difficulty of designing
catalysts that are highly reactive and at the same time selective. Nanoparticle catalysts could
potentially address this challenge because of the ability to modify nanoparticle reactivity and
selectivity by varying the properties of the nanoparticle support. Inorganic supports such as metal
oxides (TiO2, Al2O3, CeO2, ZrO2) and porous zeolites are commonly used for supporting metal
nanoparticles, which help control the nanoparticle size and agglomeration state.2 While
modifications to these inorganic supports can impact catalytic activity, it is often difficult to
predict how these modifications will impact catalysis.
Recent developments in the synthesis of polymer-supported nanoparticle catalysts has
demonstrated that organic polymers can be used to control nanoparticle size and reactivity. Our
group is interested in the potential of polymer supports to tune the reactivity of supported
nanoparticles via formation of metal-polymer interactions. Our main objective is to develop
nanoparticle catalysts where reactivity and selectivity can be controlled by modifying the
electronic and steric properties of the polymer support. In this chapter, we will discuss the
development of polystyrene-supported bimetallic ruthenium-cobalt nanoparticles for nitroarene
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reductions where the electronic properties of the polymer support are shown to influence catalyst
activity in a predictable way.
Several literature reports demonstrate that variations to a nanoparticle support material can
affect the size, shape, and electronic state of the metal nanoparticles, thereby effecting the
catalytic activity.3 Somorjai et al.4 reported the preparation of platinum nanoparticles of uniform
size on mesoporous SiO2, CeO2, MnO2, Fe2O3, NiO and Co3O4 supports for methanol oxidation.
They found that the Pt/MnO2 catalyst was 135 times less active and the Pt/CeO2 catalyst was 12
times more active than Pt/SiO2. Song et al.5 reported the preparation of platinum nanoparticles
supported on CeO2, Nb2O5, TiO2 and SiO2 having uniform size. These nanoparticle supported on
different metal oxides were tested for activity in the carbon monoxide oxidation reaction. The
catalytic activity showed the general trend of CeO2 > Nb2O5 > TiO2 > SiO2. Ebatani et al.6
reported the preparation of hydrotalcite-supported platinum nanoparticles for aerobic oxidations
using starch, Polyvinylpyrrolidone and polyvinyl alcohol as stabilizers to generate nanoparticles
with uniform particle size (Figure 5.1). These nanoparticles were then tested in the oxidation of
1, 2-propanediol to lactic acid. Nanoparticles stabilized using starch showed better catalytic
activity than polyvinyl alcohol, and polyvinyl alcohol showed better catalytic activity compared
to polyvinyl pyrrolidone. The authors reasoned that the starch-stabilized nanoparticles showed
better catalytic activity because of an increased number of free hydroxyl groups that can donate
electrons to the platinum nanoparticles. This enhanced donation makes oxygen activation more
efficient and enhances the catalytic activity (Figure 5.1). These results show that interactions
between the metal nanoparticle and the inorganic support or the polymer stabilizer can be used to
enhance the catalytic activity of metal nanoparticles.
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Figure 5.1 Possible electron donations from polymers to platinum nanoparticles
The Kobayashi laboratory recently reported a strategy for developing polymer-stabilized
metal nanoparticle catalysts. In these catalysts, the catalytic activity and selectivity of the polymer
supported nanoparticle can be optimized by incorporating supporting ligands into the polymer
structure,7 or by formation of bimetallic nanoparticle catalysts.8 Formation of mixed-metal
nanoparticle catalysts is a widely used approach in nanoparticle catalysis, where the second metal
can either enhance the catalytic activity or change the selectivity of a reaction by changing the
electronic properties or the crystal structure of the first metal.9 In traditional polymer-supported
nanoparticle catalysis, polymers are used as supports to control the size and prevent aggregation
and precipitation of the metal nanoparticles. The polymer is also used to facilitate recovery and
recycling of the catalyst. In our laboratory, we are interested in developing tunable polymersupported nanoparticle catalysts where modification to the structure and electronic properties of
the polymers can be used to enhance catalytic activity and selectivity. The ability to tune
nanoparticle catalysts in predictable ways would mimic ligand optimization in homogeneous
transition metal catalysis where electronic properties of the metal can be tuned by ligand
modification13. The ability to predictably tune nanoparticle catalysts would greatly enhance the
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utility of nanoparticle catalysts and accelerate the development of highly reactive and selective
heterogeneous catalysts for organic synthesis.
In this section we will discuss the development of polystyrene-supported Ru-Co bimetallic
nanoparticles as catalysts for nitroarene reductions. We will present a dual optimization approach
where modification of the bimetallic nanoparticle composition (M1:M2 ratio) and the electronic
properties of the supporting polymer generate exceptional catalysts for room temperature
nitroarene reductions with hydrazine hydrate. (Figure 5.2). We will demonstrate that variation of
the electronic character of the aryl rings on the polymer support via incorporation of electrondonating and electron-withdrawing substituents can lead to predictable changes in catalytic
activity.14 We will also show that the polymer structure can affect not only the rate of nitroarene
reductions, but can also influence the mechanism of the reaction. To the best of our knowledge,
this is the first example of using the electronic properties of a polystyrene polymer to influence
the activity of the nanoparticle catalysts in a predictable way.

n
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composition
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Figure 5.2 Polymer supported nanoparticle catalysts
The chemoselective reduction of nitro compounds to amines is an important reaction for
the preparation of pharmaceuticals, pesticides and dyes.10 Nanoparticle-catalyzed reductions
represent a particularly attractive approach to aniline formation because the catalysts exhibit
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exceptional reactivity, are easily recovered after the reaction, and can often be recycled.14 While a
variety of nanoparticle catalysts have been developed for nitroarene reductions, these methods
suffer from several drawbacks, including low yields, high reaction temperatures, and a lack of
functional group tolerance. The nitro reduction reaction was selected as a model reaction for our
polymer optimization studies due to importance of this reaction in the synthesis of
pharmaceutically important compounds. An important aspect of these studies is the modification
of polymer structure to generate highly selective catalyst for nitroarene reductions to anilines that
proceed in the presence of easily reducible functional groups15. The main objective of this work is
to prepare inexpensive, easily synthesized and recyclable catalyst for nitroreductions at room
temperature16.
5.2 Results and Discussion
5.2.1 Catalyst Optimization Studies
We first prepared monometallic ruthenium (Ru) nanoparticles supported on polystyrene
for nitroarene reductions. The nanoparticles were prepared according to a reported procedure
using sodium borohydride as the reducing agent and in the presence of a homogeneous solution of
polystyrene (MW 35,000) (Figure 5.3)

17

. The polymer-supported nanoparticles were then

precipitated from solution, washed with deionized water to remove salts and unsupported
nanoparticles, and dried under vacuum. The black powder obtained through this process can be
easily recovered from the reaction mixture by simple filtration. Bimetallic nanoparticle catalysts
were also synthesized via this method by addition of the reducing agent to a homogeneous
solution containing both metal salts.
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THF/EtOH
commercially available
polymer support

Polymer-supported
bimetallic nanoparticle
catalyst
no processing
required

Figure 5.3 Synthesis of bimetallic nanoparticle catalysts
The ruthenium nanoparticle catalyst was first tested for catalytic activity in the
chemoselective reduction of 3-nitrostyrene with hydrazine hydrate as the stoichiometric reductant
(Table 5.1).

The monometallic ruthenium nanoparticles showed good chemoselectivity for

reduction of the nitro functional group in the presence the easily reduced olefin. However the
yield of the transformation was low because of the formation of partially reduced byproducts
(entry 1). We next explored the potential of bimetallic Ru-M nanoparticles to increase the
catalytic activity and chemoselectivity through metal-metal cooperativity (entries 2–5)8. While
incorporation of copper and nickel did not improve the catalytic activity of the nanoparticles, both
iron and cobalt provided nanoparticles with enhanced reactivity (entries 4 and 5). At this stage,
we decided to focus our optimization studies on Ru-Co bimetallic nanoparticles because Ru-Fe
bimetallic nanoparticles provided lower selectivity with a variety of substrates (see experimental
section). We next investigated the impact of the Ru to Co ratio in the nanoparticle on catalytic
activity. These studies showed that a higher percentage of ruthenium to cobalt was beneficial for
obtaining a highly active catalyst when the loading of ruthenium was held constant in the reaction
at 2 mol% (Table 1, entries 5–9). The Ru-Co bimetallic catalysts (5.1 %(81Ru19Co)/PS) is among
the most active nanoparticle catalysts for nitroarene reductions, leading to complete and selective
reduction of the nitro functionality in just 2 hours at room temperature.
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Table 5.1 Catalyst Optimization Studies

2% Ru:M–PS
NH2NH2•H2O
(3 equiv)
NO2

1a

NH2

H
N

2a

4

EtOH, r.t., 4h

Me

NH2

3

N

N
H

N
O

5

entrya

catalyst

catalyst
compositionb,c

% conv.d

selectivity
(2:3:4:5)c

1

Ru

6.7%(100Ru)/PS

100

60:0:18:22

2

Ru : Cu

5.4%(51Ru49Cu)/PS

100

63:4:32:1

3

Ru : Ni

6.7%(44Ru56Ni)/PS

100

41:2:32:25

4

Ru : Fe

7.0%(24Ru76Fe)/PS

100

95:4:0:1

5

Ru : Co

5.6%(46Ru54Co)/PS

100

83:14:0:3

6

Ru : Co

3.6%(61Ru39Co)/PS

100

28:10:14:48

7

Ru : Co

5.7%(35Ru65Co)/PS

100

45:8:0:47

8

Ru : Co

7.8%(23Ru77Co)/PS

100

17:8:25:50

9

Ru : Co

5.1%(81Ru19Co)/PS

100

97:3:0:0

a

Reactions conditions: 1a (0.4 mmol), catalyst (2 mol% wrt Ru), and NH2NH2•H2O (3 equiv) in
EtOH at room temp. b Catalyst composition represented as n%(xM1yM2)/support, where n is
total wt% metals in support, and x and y are the relative wt% of M1 and M2. c Metal ratios
determined by ICP analysis (see supporting information). d Determined by 1H NMR analysis of
the crude reaction mixture. PS = polystyrene, MW 35,000.
After optimizing the Ru:Co bimetallic catalyst, we next studied the substrate scope and
chemoselectivity with various substrates containing easily reduced functional groups (Figure 5.4).
We showed that efficient and selective reductions can be performed in the presence of alkenes,
stilbenes, allyl ethers, alkynes, propargyl ethers, halides, nitriles, phenols, carboxylic acids and
ketones. Nitro groups on heteroaromatic compounds can also be easily reduced with Ru-Co
bimetallic compounds. Each of these reactions was performed on 0.4 mmol scale with 2 mol% Ru
106

loading (2.5:1 Ru:Co in polystyrene), and NH2NH2•H2O (3 equiv) in ethanol (2 mL) at room
temperature.

The typical reaction time for this reduction was about 2 hours. In all the cases

tested, the products were isolated in near quantitative yield by simply removing the catalyst by
filtration and then evaporating the solvent. No chromatography was needed due to the high purity
of the crude aniline products.
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Selectivity = 99
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NH2
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Selectivity = 99

Figure 5.4 Substrate Scope of Nitroarene Reduction
5.2.2 Recyclability studies
We next studied whether the heterogeneous polystyrene supported Ru:Co nanoparticles
could be recycled without loss of activity. We found that our nanoparticle catalysts could be
recycled various times by simply filttering off the reaction mixture, washing the heterogeneous
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catalyst with ethanol, and then re-adding reagents for the subsequent reaction.

No catalyst

reactivation step was required. We also found that our catalysts could be reused up to five times
without significant loss in product yield or reaction chemoselectivity (Scheme 5.1).
2% Ru: Co PS
NH2NH2 H2O (3 equiv)
NO2

EtOH, r.t., 2h

NH2

1a

yield/selectivity

2a

Run
1

Run
2

Run
3

Run
4

99/97 99/96 98/97 96/96

Reactions conditions: 1a (0.4 mmol), catalyst (2 mol% wrt Ru, 2.5:1 Ru:Co), and NH2NH2•H2O
(3 equiv) in ethanol at room temp.
Scheme 5.1 Catalyst Recyclability Studies
5.2.3 Leaching Studies
We next investigated the leaching of Ru-Co bimetallic nanoparticles into solution to see if
the reaction was catalyzed by homogeneous nanoparticles that leached from the polymer matrix.
The reaction mixture was filtered off after completion of the reduction and the metal content of
the filtered solution was determined by ICP-MS analysis. We found that 1.2 % of the ruthenium
and 1.3 % of the cobalt nanoparticles (with respect to original catalyst added) was leached out
into the reaction mixture from the polymer matrix. We also removed the catalyst from the reaction
after partial conversion by filtering through a sintered glass funnel. After removal of the catalyst,
no further conversion of the starting material (monitored by NMR) was observed (Figure 5.5).
When the catalyst was added back to the reaction mixture after several hours the reduction
reaction resumed (similar to Cat-in-a-Cup test)
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18

. These results suggest that heterogeneous

polymer supported nanoparticles are responsible for the observed catalysis and not homogeneous
metal nanoparticles that have leached from the polymer matrix.

Figure 5.5 Test for homogeneous nanoparticles. Catalyst was removed by filtration at time points
indicated with *. Catalyst was added back to the reaction mixture at time points indicated by .
5.2.4 Effect of Polymer Structure on Catalyst Activity
We next studied the effect of the polymer structure on the rate and selectivity of the RuCo bimetallic nanoparticle catalysts. Previous reports suggest that metal nanoparticles supported
by polystyrene polymers are stabilized by weak interactions with the π-electrons of the benzene
rings of the polymer 19. We hypothesized that these weak interactions could be tuned by changing
the electronic properties of the aromatic rings. To test our hypothesis, we synthesized several
polymers containing electron-donating and electron-withdrawing substituents as supports for RuCo bimetallic nanoparticles. We found that these variations had a dramatic effect on the catalytic
activity of Ru-Co bimetallic nanoparticles
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(Figure 5.6).

Electron deficient

poly(4-

trifluoromethylstyrene) supported bimetallic nanoparticles catalyzed the nitroarene reductions in
just 20 minutes at room temperature, while electron rich poly(4-methylstyrene) and poly(4methoxystyrene) supported bimetallic nanoparticles took 10 h and 5.5 h, respectively, to go to
completion. We believe that this effect on reactivity is caused by two potential factors. First, the
weak interaction between the π-electrons of benzene ring of the polymer and nanoparticle surface
could lead to arene ligand dissociation from the nanoparticle surface, opening up more catalytic
metal sites to facilitate reductions. Second, the electronic property of the polymer could change
the electron density at the metal surface, thus making the catalyst more reactive.
2% Ru: Co PS
NH2NH2 H2O (3 equiv)
EtOH, r.t., 100 % conv

NO2

1a

NH2

2a

H

6a
1.8 h

CF3

Me

OMe

6b
20 min

6c
10 h

6d
5.5 h

Figure 5.6 Electronic effects of polymer supports
We next synthesized polymers containing donating heterocycles with subtle differences
between their Lewis basic characters. This included polymers containing amide, urea, and amine
functional groups (Figure 5.7). These functionalized polymers were designed to mimic the
properties of poly (N-vinyl-2-pyrrolidone) (PVP), which is widely used as polymer support in the
nanoparticle synthesis. PVP stabilizes and influences the nanoparticle catalytic activity through
coordination of Lewis basic amide oxygen with the nanoparticle surface. These heterocyclic
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polymer supported bimetallic nanoparticles (6e-6g) also showed similar trends to what we
observed for polystyrene polymers (6a-6d). The pyrrolidinone-containing polymer (6e) led to
complete conversion in 8 h, while imidazolidinone polymer (6f) took 10h. The most Lewis basic
amine-containing polymer (6g) required 10 h to reach 60% conversion. Thus, the most electron
donating polymers led to the slowest catalysis, as observed for the most donating polystyrene
polymers discussed above. These results suggest that the electronic properties of the polymer can
be used to tune the reactivity of the nanoparticle catalysts in predictable ways.
2% Ru: Co PS
NH2NH2 H2O (3 equiv)
EtOH, r.t., 100 % conv

NO2

1a

NH2

2a

O
N

6e
8 h (89%)

O
N

NMe

6f
10 h (89%)

N

6g
10 h (60%)

Figure 5.7 Electronic effects of Lewis basic functional groups on catalysis
5.2.5 Mechanism of Nitroarene Reduction
We next studied the reaction mechanism for reduction of 3-nitrostyrene using electron
deficient and electron rich polymer supported bimetallic nanoparticles (6a-6d). When the
reduction of 3-nitrostyrene 1a was conducted with Ru:Co bimetallic catalysts supported on 6a, 6c,
6d and 6e, the starting material 1a is converted to intermediate hydrazine 4 before a significant
amount of

product 2a is formed (Scheme 5.2).
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However, when the electron-withdrawing

polymer supported Ru-Co bimetallic nanoparticles (6b) was used, no hydrazine intermediate 4
was observed during the course of the reaction. With this catalyst, starting material directly
converts to product 2a. The observed difference in the reaction might be because of the fast
reduction of hydrazine 4 to 2a by catalyst 6b or due to inability of the catalyst 6b to catalyze
formation of 4. These results also support the hypothesis that the electronic properties of the
nanoparticles can be influenced by the electronic structure of the polymer.

2% Ru: Co PS
NH2NH2 H2O (3 equiv)
NO2

H
N

EtOH, r.t.

N
H

4

1a

NH2

2a

Scheme 5.2 Intermediate formation in nitroarene reduction
5.2.6 Analysis of Nanoparticles
To characterize our catalysts, we first measured the size of the Ru-Co nanoparticles using
scanning transmission electron microscopy (STEM). One goal was to see if the difference in the
reactivity of our different polymer-supported nanoparticles was because of the difference in the
size of the nanoparticles. STEM images showed that the size of the nanoparticles in polymers
(6a-6d) were between ~1-2 nm in diameter. In addition, the nanoparticles are in the form of
agglomerates in the polymer matrix that range from single particles to 30-40 nm bundles (Figure
5.8a). Statistical analysis of the nanoparticle size distribution for polymers 6a-6d shows nearly
equal size distribution (CF3 = 2.0 nm, H = 1.9 nm, OMe = 1.75 nm and Me = 1.50 nm) for all the
four polymers. The subtle difference in the nanoparticle size may be responsible for the catalytic
activity but, that does not explain the observed change in reaction mechanism. Therefore, we
believe that the observed difference in the catalytic activity of our polymer supported bimetallic
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nanoparticles is due to a combination of subtle differences in size and variations in the strength of
metal-polymer interactions. These results suggest that the catalytic activity of polymer supported
metal nanoparticles can be enhanced by changing the supporting polymer structure, similar to
homogeneous catalysis where the electronic properties of a metal can be tuned by modifying the
ligands.

Figure 5.8 Nanoparticle Characterization. (a) STEM image showing agglomerate size variation
(b) STEM image showing EDS line scan location

Figure 5.8 (c) Energy-dispersive X-ray spectroscopy (EDS) Line scan of Ru-Co nanoparticles in
polystyrene.
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We also used STEM, energy-dispersive X-ray spectroscopy (EDS) to study to see if the
Ru-Co bimetallic nanoparticles are individual particles or in alloy form. EDS line scan shows that
ruthenium and cobalt are localized within the particle, but not individual monometallic
nanoparticles (Figure 5.8b, 5.8c). The localization of both ruthenium and cobalt in a single
nanoparticle might be responsible for the increased catalytic activity of the bimetallic
nanoparticles. We also estimated the Ru:Co ratio at various locations of the bimetallic
nanoparticle sample and found that the ratios of Ru to Co is consistent throughout the sample. Xray photoelectron spectroscopy (XPS) analysis of bimetallic nanoparticle catalysts shows that
ruthenium is in metallic (0) form while cobalt is in oxide form. This suggests that ruthenium is
completely reduced and cobalt is not completely reduced during nanoparticle formation. We also
used time of flight secondary ion mass spectrometry (Tof-Sims) to confirm the presence of
ruthenium and cobalt in our sample. Tof-Sims confirmed the presence of both ruthenium and
cobalt in the polystyrene polymer matrix.
5.3. Conclusion
Our dual optimization approach to nanoparticle catalysis is an attractive strategy for
catalyst optimization due to the ability to predictably control reaction rates and selectivities. We
have demonstrated that the electronic properties of the polymer and the nanoparticle composition
can be tuned to enhance the catalytic activity of the nanoparticles for nitroarene reductions.
Rational design of the polymer structures that lead to predictable changes in the catalytic activity
is an attractive strategy for improving the catalytic activity and selectivity of a reaction. The
preparation of our bimetallic nanoparticles is very straightforward and required only
commercially available materials.

Thus, the catalysts are easily accessible to chemists for

nitroarene reductions. In addition, the catalysts can be easily recovered and reused after
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completion of the reaction by simple filtration without significant loss in the catalytic activity.
Thus, our Ru-Co bimetallic nanoparticles showed exceptional catalytic activity, high
chemoselectivity and high yields towards nitroarene reductions.
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5.5 Experimental Section
General Information
All reactions were carried out in oven-dried glassware with magnetic stirring, unless otherwise
indicated. All the reagents were used as obtained unless otherwise noted. Analytical thin-layer
chromatography was performed with 0.25 mm coated commercial silica gel plates (E. Merck,
DC-Plastikfolien, kieselgel 60 F254). Flash Chromatography was performed with EM Science
silica gel (0.040-0.063µm grade) Proton nuclear magnetic resonance (1H-NMR) data were
acquired on a Inova 300 (300 MHz) or on a Inova-500 (500 MHz) spectrometer. Chemical shifts
are reported in delta (δ) units, in parts per million (ppm) downfield from tetramethylsilane.
Carbon-13 nuclear magnetic resonance (13C-NMR) data were acquired on a Inova 500 at 125
MHz. Signals are reported as follows: s (singlet), d (doublet), t (triplet), q (quartet), dd (doublet of
doublets), qd (quartet of doublets), brs (broad singlet), m (multiplet). Coupling constants are
reported in hertz (Hz). Chemical shifts are reported in ppm relative to the center line of a triplet at
77.23 ppm for chloroform-d. Mass spectral data were obtained using ESI techniques (Agilent,
6210 TOF). The content of all metals in the final material was determined by ICP analysis using a
Shimadzu ICPS-7510 instrument. STEM images and EDS analyses were obtained using a JEOL
JEM-2100F instrument operated at 5.0 kV. All STEM specimens were prepared by placing a drop
of a homogeneous chloroform solution of the respective polymer-nanoparticle composite on a
carbon coated copper grid and allowed to dry in air without staining. Polystyrene (MW 35,000)
and cobalt (II) chloride hexahydrate were purchased from Aldrich. Ruthenium (III) chloride
hydrate was purchased from Oakwood Chemicals.
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Synthesis of 4-Methyl polystyrene (6b)
To a stirred solution of 4-Methyl styrene (5 g, 42.3 mmol) in 15 mL of chloroform was added
AIBN (347 mg, (2.11 mmol) and the mixture was heated to reflux for 12 h. The resulting polymer
solution was poured into methanol. The precipitated polymer was filtered and washed with
methanol several times and dried under vacuum to afford desired polymer as white solid (4.8 g,
96 % yield). 1H NMR (500 MHz, CDCl3): 7.15-6.15 (br m, 4H), 2.4-2.16 (br m, 3H), 2.0-1.2 (br
m, 3H).
Synthesis of 4-Methoxy polystyrene (6c)
To a stirred solution of 4-methoxystyrene (5 g, 37.26 mmol) in 15 mL of chloroform was added
AIBN (306 mg, (1.86 mmol) and the reaction was heated to reflux for 12 h. The resulting polymer
solution was poured into methanol. The precipitated polymer was filtered and washed with
methanol several times and dried under vacuum to afford the desired polymer as white solid (4.5
g, 90 % yield). 1H NMR (500 MHz, CDCl3): 7.0-6.2 (br m, 4H), 3.82-3.63 (br m, 3H), 1.85-1.2
(br m, 3H).
Synthesis of 4-Trifluoromethyl polystyrene (6c)
To a stirred solution of 4-(trifluoromethyl) styrene (2 g, 11.61 mmol) in 15 mL of chloroform was
added AIBN (95.4 mg, (0.55 mmol) and the reaction was heated to reflux for 36 h. The resulting
polymer solution was poured into diethyl ether. The precipitated polymer was filtered and washed
with methanol several times and dried under vacuum to afford desired polymer as white solid (1.8
g, 90 % yield). 1H NMR (500 MHz, CDCl3): 7.6-6.4 (m, 4H), 2.0-1.4 (m, 3H).
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Synthesis of Ruthenium-Polystyrene nanoparticles
Polystyrene (1g) was added to 25 mL of THF and 8 mL of ethanol and the mixture was stirred
using a Teflon-coated magnetic stir bar until polystyrene was completely dissolved. Ruthenium
(III) chloride hydrate (100 mg, 0.482 mmol) anhydrous basis was added and the mixture was
stirred until the solution became homogenous. Sodium borohydride (182.5 mg, 4.82 mmol) was
then added portion wise. The reaction was stirred under argon atmosphere for 10 h giving a black
homogeneous solution, indicating the formation of nanoparticles. The solvent was then
evaporated and millipore water was added to the resulting solid and the mixture was stirred for 15
minutes then filtered. The solid was then washed with millipore water (20 mL× 5) and dried under
vacuum to give a black solid, which was finely ground with a mortal and pestle before use.
Synthesis of Ru-Co NP`s@Polystyrene.
General Procedure for Bimetallic nanoparticle Synthesis: Polystyrene (1g) was added to 25
mL of THF and 8 mL of ethanol and the mixture was stirred using a Teflon-coated magnetic stir
bar until polystyrene was completely dissolved. Ruthenium (III) chloride hydrate (100 mg, 0.482
mmol) anhydrous basis and Cobalt (II) chloride hexahydrate (50 mg, 0.21 mmol) were added and
the mixture was stirred until the solution became homogenous. Sodium borohydride (223 mg,
5.89 mmol) was then added portionwise. The reaction stirred under and argon atmosphere for 10
h giving a black homogeneous solution, indicating the formation of nanoparticles. Solvent was
evaporated, millipore water was added to the resulting solid and the mixture was stirred for 15
minutes then filtered. The solid was then washed with millipore water (20 mL× 5) and dried under
vacuum to give a black solid, which was finely ground with a mortal and pestle before use.
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The same procedure was followed to prepare Ru-Co nanoparticles in poly(4-methylstyrene),
poly(4-methoxystyrene), poly(4-trifluoromethylstyrene) with similar metal loadings and Ru:Co
ratios. See Table S1 for Ru:Co loadings and rations.
The general procedure was followed to prepare Ru-M2 (M2 = Ni, Cu, Fe and Au) nanoparticles in
polystyrene. The respective amounts of metal salts used in the synthesis of nanoparticle-polymer
conjugates with 1 g of polystyrene are listed below. The yields for each bimetallic nanoparticle
composite are also provided. Metal loadings for each polymer and M1:M2 ratios, as determined
by ICP analysis, are listed in Table S1.
RuCl3.XH2O (100 mg): NiCl2.6H2O (210 mg)
RuCl3.XH2O (100 mg): Cu(OAc)2 (100 mg)
RuCl3.XH2O (100 mg): FeCl2 (210 mg)
Synthesis of 1-(4-polyvinylbenzyl) pyrrolidine (6g)
To a stirred solution of pyrrolidine (512 mg, 7.2 mmol) in DMF (20 mL) was added 60% sodium
hydride (363 mg, 10.8 mmol), and the reaction was stirred for 10 minutes at room temperature. A
solution of poly (vinylbenzyl chloride) (1 g, 6.55 mmol) in DMF (15 mL) was added drop wise
and the reaction mixture was stirred at room temperature for 8 h. The reaction was then diluted
with H2O (25 mL), the precipitated solid was filtered and concentrated under vacuum to afford 1(4-polyvinylbenzyl) pyrrolidine as off-white solid (1.1 g, 90 %). 1H NMR (500 MHz, CDCl3):
7.2-6.2 (br m, 4H), 3.65-3.2 (br m, 2 H), 2.6-2.2 (br, m, 4H), 1.85-1.6 (br m, 4H), 2.0-1.2 (br m,
3H).
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Synthesis of 1-(4-polyvinylbenzyl) pyrrolidin-2-one (6e)
To a stirred solution of 2-pyrrolidone (613 mg, 7.2 mmol) in DMF (20 mL) was added 60%
sodium hydride (363 mg, 10.8 mmol), and the reaction stirred for 10 minutes at room
temperature. A solution of poly (vinylbenzyl chloride) (1 g, 6.55 mmol) in DMF (15 mL) was
added drop wise and the reaction mixture was stirred at room temperature for 8 h. The reaction
was then diluted with H2O (25 mL) and the aqueous phase was extracted with CH2Cl2 (3 × 30
mL). The combined organic layers were concentrated under vacuum to afford 1-(4polyvinylbenzyl) pyrrolidin-2-one as white solid (1.0 g, 77 %). 1H NMR (500 MHz, CDCl3): 7.26.2 (br m, 4H), 4.5-4.2 (br m, 2 H), 3.4-3.0 (br, m, 2H), 2.5-2.3 (br m, 2H), 2.1-1.9 (br m, 2H),
1.8-1.0 (br m, 3 H)
Synthesis of 1-methyl-3-(4-polyvinylbenzyl) imidazolidin-2-one. (6f)
To a stirred solution of 1-methyl imidazolidin-2-one (722 mg, 7.2 mmol) in DMF (20 mL) was
added 60% sodium hydride (363 mg, 10.8 mmol) and the mixture was stirred for 10 minutes at
room temperature. A solution of poly (vinylbenzyl chloride) (1 g, 6.55 mmol) in DMF (15 mL)
was then added drop wise and the reaction mixture was stirred at room temperature for 8 h. The
reaction was diluted with H2O (25 mL) and the aqueous phase was extracted with CH2Cl2 (3 × 30
mL). The combined organic layers were concentrated under vacuum to afford 1-methyl-3-(4polyvinylbenzyl) imidazolidin-2-one as white solid (1.12 g, 79 %). 1H NMR (500 MHz, CDCl3):
7.2-6.2 (br m, 4H), 4.4-4.1 (br m, 2 H), 3.4-3.0 (br, m, 4H), 2.9-2.7-1.6 (br s, 3H), 2.0-1.0 (br m,
3H).
The ratio of M1:M2 are shown in ICP table
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Preparation of the sample for ICP-analysis
To 10 mg of polymer-nanoparticle catalyst was added 1 ml conc. H2SO4 and the mixture heated at
140 oC. HNO3 was then slowly added and the solution was heated for 10 min. 1 ml of aqua regia
was then added and the mixture cooled to room temperature and diluted to 500 mL in a
volumetric flask. Metal concentrations where then determined by ICP analysis by comparison to
standard solutions.
Table S5.1 Loading of catalysts determined by ICP
Catalyst

Rutheniu
M2 conc.
m
conc.
(M1)

Ratio
M1:M2

Catalyst Clasification

Ru: Ni

0.295
mmol/g

0.637
mmol/g

1:2.1

6.7%(44Ru56Ni)/polystyrene

Ru: Cu

0.272
mmol/g

0.416
mmol/g

1:1.5

5.4%(51Ru49Cu)/polystyrene

Ru:Fe

0.170
mmol/g

0.949
mmol/g

1:5.5

7.0%(24Ru76Fe)/polystyrene

Ru: Co

0.256
mmol/g

0.506
mmol/g

1:2

5.6%(46Ru54Co)/polystyrene

Ru: Co

0.219
mmol/g

0.242
mmol/g

1:1.1

3.6%(61Ru39Co)/polystyrene

Ru: Co

0.198
mmol/g

0.625
mmol/g

1:3.1

5.7%(35Ru65Co)/polystyrene

Ru:Co

0.176
mmol/g

1.03
mmol/g

1:5.8

7.8%(23Ru77Co)/polystyrene

Ru:Co (6a)

0.408
mmol/g

0.159
mmol/g

2.5:1

5.1%(81Ru19Co)/polystyrene

Ru:Co

0.285
mmol/g

0.123
mmol/g

2.3:1

3.6%(80Ru20Co)/6b

0.370
mmol/g

0.152
mmol/g

2.4:1

4.6%(81Ru19Co)/6c

(4-CF3-polystyrene) (6b)
Ru:Co
(4-Methyl-polystyrene)
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(6c)
Ru:Co
(4-OMe-polystyrene) (6d)
Ru:Co
(1-(4-polyvinylbenzyl)
pyrrolidin-2-one (6e)
Ru:Co
(1-methyl-3-(4polyvinylbenzyl)
imidazolidin-2-one (6f)
Ru:Co
(1-(4-polyvinylbenzyl)
pyrrolidine (6g)

0.341
mmol/g

0.135
mmol/g

2.5::1

5.6%(81Ru19Co)/6d

0.288
mmol/g

0.169
mmol/g

1.7: 1

3.9%(75Ru25Co)/6e

0.374
mmol/g

0.201
mmol/g

1.86:1

5.0%(76Ru24Co)/6f

0.284
mmol/g

0.157
mmol/g

1.8:1

3.8%(76Ru24Co)/6g

Optimization studies with Ru:Fe catalysts.
We initially performed optimization studies with Ru:Fe bimetallic nanoparticle catalysts. There
studies showed that a bimetallic catalyst of composition 11.4%(16Ru84Fe)/polystyrene performed
nitroarene reduction of 1a in 30 minutes with a nitroarene concentration of 1.3M in Ethanol and 1
mol% ruthenium loading (99% yield, 99% selectivity).

However, substituted nitroarenes

containing ketones (2m) or fluorine (2f) led to decomposition of the products and low yields in
the presence of the Ru-Fe catalysts.

Thus, optimization studies were focused on Ru-Co

nanoparticles, which display much higher chemoselectivity and avoid these decomposition
products.
Reuse experiments of Ru-Co-Polystyrene nanoparticles.
The reduction of 3-nitropolystyrene was performed under the typical reaction conditions in a flask
containing a frit of medium porosity and a bottom stopcock. After completion of the reaction, the
solution was removed via filtration through the frit. The flask was then rinsed with EtOH (3 ml)
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and the filtrate evaporated and the isolated yield and selectivity were determined.

To the

remaining nanoparticle catalyst was added a new set of reagents and solvents and the reaction was
allowed to proceed for the same time. This procedure was repeated 5 times, and the results are
presented in Scheme 1.
Leaching studies
After completion of the reaction, polymeric catalyst was filtered off through a plug of cotton and
the flask and nanoparticles were rinsed with 1 ml EtOH to collect all reaction materials. The
solvent was then removed from the filtrate. 0.5 ml of conc. H2SO4 was then added to the resulting
residue and the mixture heated to 140

o

C for 30 min. 0.5 ml of conc. HNO3 was then slowly

added and the solution was heated for 10 min at the same temperature. 1 ml of aqua regia was
then added and the mixture cooled to room temperature and diluted to 10 ml in a volumetric flask.
Metal concentrations where then determined by ICP analysis by comparison to standard solutions.
The concentrations were then compared to the original amount of Ru–Co polymer added to the
reaction, and the percent leaching was calculated.
Amount of Ruthenium leached: 1.2 %
Amount of Cobalt leached: 1.28%
In order to test for the presence of active homogeneous nanoparticle catalysts that could
potentially leach from the polymer support, catalyst was removed part way though the reaction
via filtration and reaction progress monitored. This procedure mimics the Cat-in-a-Cup protocol
described previously. As noted in Figure S1 below, after removal of the nanoparticle catalyst by
filtration through a sintered glass funnel of medium porosity, all reaction progress is halted.
Readdition of the catalyst after several hours leads to further consumption of starting material.
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This study confirms that the polymer-supported nanoparticles are the active catalyst and that
homogeneous nanoparticles that have leached from the polymer matrix are not responsible for
catalysis.

Figure S5.1 Nanoparticle Leaching study. Conversion determined by 1H NMR of the crude
reaction mixture at each time point.

To 5-nitroindole (150 mg, 0.925 mmol) in a round bottom flask was added 6 mL of ethanol,
polystyrene supported Ruthenium nanoparticles (82 mg, 4mol %) and hydrazine hydrate (180 µL,
3.7 mmol, 4 equiv). The reaction vessel was then closed with a septum septum and allowed to
react at room temperature. Small aliquots (~0.1 ml) of the reaction were removed at the time
points indicated in figure 5.9 and the aliquots were filtered through a small plug of silica gel and
eluted with 2 ml EtOH to remove any metal catalyst. The solvent was then removed and the
reaction conversion was determined by 1H NMR analysis. After removal of an aliquot at 80
minutes, the entire reaction was filtered through a sintered glass funnel of medium porosity into a
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new round bottom flask to remove any heterogeneous catalyst and 135 µL Three additional
equivalents of hydrazine hydrate (135 µL, 2.8 mmol, 3 equiv) was added to the reaction at this
stage and the flask was again capped with a septum. After a total of 140 min, 82 mg of catalyst
was added to the reaction just after removal of the aliquot used to determine reaction conversion.
The filtration (*)/catalyst readdition ( ) sequence was performed a second time at 220 min and
280 minutes respectively. The results of this study are presented in Figure S5.1
Reduction of 3-nitrostyrene (1a). 2
General Procedure: A typical procedure for the reduction of nitro compounds by Ru-Co (2.5:1)PS is as follows: 5.1%(81Ru19Co)/polystyrene catalyst (23 mg , 2 mol% wrt ruthenium) was
placed in a 25 mL test tube containing a Teflon-coated magnetic stir bar, followed by the addition
of ethanol (2.5 mL), 3-nitrostyrene (50 mg, 0.335 mmol), and dropwise addition of hydrazine
monohydrate (1 mmol, 48.8 µL, 3 equiv) at room temperature. The reaction vessel was then
sealed with a glass stopper and stirred for 3.5 h. After the reaction, the heterogeneous catalyst was
removed by filtration through a small plug of silica gel in a pipet, and the solids washed several
times with ethanol. The filtrate was collected, and the solvent removed under reduced pressure on
a rotary evaporator to provide the product (39.6 mg, 0.332 mmol, 99% yield, 97% selectivity) in
excellent purity, which did not require further purification. The selectivity of the reaction was
determined by 1H NMR analysis of the pure product obtained as described. Yield: 38.5 mg, 96 %
(96.7)
1

H NMR (300 MHz, CDCl3): 7.13 (t, J = 7.5 Hz, 1H), 6.83 (d, J = 7.5 Hz, 1H), 6.75 (br s, 1H),

6.64 (dd, J1 = 18.0 Hz, J2 = 10.0 Hz, 1H), 6.60 (d, J = 7.5 Hz, 1H), 5.71 (dd, J1 = 18.0 Hz, J2 =
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1.0 Hz, 1H), 5.22 (dd, J1 = 10.0 Hz, J2 = 1.0 Hz, 1H); 13C NMR (75 MHz, CDCl3): 146.5, 138.6,
137.0, 129.4, 116.9, 114.8, 113.6, 112.7.
1, 2-bis (3-vinylphenyl) diazene oxide (5) 2

N

N
O

1

H NMR (300 MHz, CDCl3):: δ 5.32 (d, J = 10.9 Hz, 1 H), 5.39 (d, J = 10.9 Hz, 1 H), 5.86 (t, J =

17.4 Hz, 2 H), 6.78 (ddd, J = 5.7, 10.9, 17.0 Hz, 2 H), 7.45 (m, 3 H), 7.58 (m, 1 H), 8.08 (dd, J =
3.2Hz, 5.8Hz, 1 H,), 8.18 (m, 2 H), 8.33 (d, J = 1.6Hz, 1 H) ppm. 13C NMR (75 MHz, CDCl3: δ
114.8, 115.9, 119.9, 121.4, 123.4, 124.6, 127.3, 128.8, 128.9, 129.2, 135.5, 136.2, 138.1, 138.6,
144.2
1, 2-bis (3-vinylphenyl) hydrazine (4) 3

H
N

1

N
H

H NMR (300 MHz, CDCl3): 7.29-7.16 (m, 4H), 6.67-6.59 (m, 2H), 6.82-6.77 (m, 2H), 6-68-6.60

(dd, J1 = 18.0 Hz, J2 = 10.0 Hz, 2H), 5.76 (dd, J1 = 18.0 Hz, J2 = 1.0 Hz, 2H), 5.26 (dd, J1 = 10.0
Hz, J2 = 1.0 Hz, 2H) ppm.

13

C NMR (75 MHz, CDCl3): δ 149.27, 138.9, 137.11, 129.7, 118.3,

114.1, 112.1, 110.1.
4-vinylaniline: Yield: 38.8 mg, 97% (97). Spectral data for the product matched literature
values.9
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2-vinylaniline: 10 Spectral data for the product matched literature values.
1

H NMR (500 MHz, CDCl3) δ 7.33 (d, J = 7.6 Hz, 1H), 7.12 (m, 1H, ArH), 6.80 (m, 2H), 6.70 (d,

J = 7.9 Hz, 1H), 5.66 (dd, J = 1.2, 17.4 Hz), 5.35 (dd, J = 1.3, 11.1 Hz, 1H), 3.8 (s, br, NH2). 13C
NMR (125 MHz, CDCl3) δ 143.6, 132.6, 128.7, 127.2, 124.0, 118.8, 116.0, 115.6. Yield: 38.7 mg
97 %, (97)
4-chloroaniline: 1 Spectral data for the product matched literature values.
1

H NMR (300 MHz, CDCl3): 7.10 (d, J = 8.5 Hz, 2H), 6.61 (d, J = 8.5 Hz, 2H), 3.34 (br s, 2H);

13

C NMR (75 MHz, CDCl3): 144.8, 129.0, 123.2, 116.2. Yield: 40 mg 98 %, (99)

2-chloroaniline: 1 Spectral data for the product matched literature values.
1

H NMR (300 MHz, CDCl3) 7.27 (d, J = 7.9 Hz, 1H), 7.09 (t, J = 7.09 Hz, 1H), 6.78 (d, J = 8.0

Hz, 1H), 6.72 (t, J = 7.9 Hz, 1H), 4.03 (s, 2H); 13C NMR (75 MHz, CDCl3) δ 142.9, 129.4, 127.6,
119.2, 119.0, 115.8. Yield: 40 mg, 98 %, (99).
4-fluoroaniline: 1 Spectral data for the product matched literature values.
1

H NMR (300 MHz, CDCl3): 6.83 (m, 2H), 6.60 (m, 2H), 3.51 (bs, 2H);

13

C NMR (75 MHz,

CDCl3): 157.9, 154.7, 142.3, 116.0,
115.9, 115.7, 115.4. Yield: 38 mg, 96 %, (99)
4-bromoaniline: 1 Spectral data for the product matched literature values.
1

H NMR (300 MHz, CDCl3): 7.23 (d, J = 8.5 Hz, 2H), 6.55 (d, J = 8.5 Hz, 2H), 3.55 (br s, 2H);

13

C NMR (75 MHz, CDCl3): 145.4, 132.0, 116.7, 110.2. Yield: 41.5 mg, 97 %, (99)
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4-iodoaniline: 1 Spectral data for the product matched literature values.
1

H NMR (300 MHz, CDCl3) δ 7.42 (d, J = 8.7 Hz, 2H), 6.48 (d, J = 8.7 Hz, 2H), 3.59 (s, J = 53.3

Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 146.0, 137.9, 117.3, 79.3. Yield: 49 mg, 98 %, (99)
4-aminobenzonitrile: 6 Spectral data for the product matched literature values.
1

H NMR (300 MHz, CDCl3): 7.83 (s, 1H), 7.37 (d, J = 8.79 Hz, 2H), 7.29 (bs, 1H), 6.87 (d, J =

8.24 Hz, 2H); 13C NMR (75 MHz, CDCl3): 154.5, 133.5, 132.9, 119.7, 114.1, 112.8, 102.1. Yield:
39 mg, 98 %, (99)
4-aminophenol: 1 Spectral data for the product matched literature values.
OH

NH2

1

H NMR (300 MHz, CD3OD): 6.65 (d, J = 9.0 Hz, 2H), 6.60 (d, J = 9.0 Hz, 2H); 13C NMR (75

MHz, CD3OD): 149.9, 138.6, 117.2, 115.4. Yield: 30.5 mg, 98 % yield, (99)
Methyl 4-aminobenzoate: 9 Spectral data for the product matched literature values.
O

O

NH2

1

H NMR (300 MHz, CDCl3): 7.83 (d, J = 8.5 Hz, 2H), 6.62 (d, J = 7.5 Hz, 2H), 4.10 (br s, 2H),

3.84 (s, 3H); 13C NMR (75 MHz, CDCl3): 167.2, 150.9, 131.5, 119.6, 113.7, 51.5. Yield: 41.5 mg,
99% (99)
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4-Amnobenzamide: 6 Spectral data for the product matched literature values.
H2 N

O

NH2

1

H NMR (300 MHz, DMSO-d6) δ 5.57 (bs, 2H), 6.50 (d, J = 8.2 Hz, 2H), 6.79 (bs, 1H), 7.47 (bs,

1H), 7.56 (d, J = 8.2 Hz, 2H); 13C NMR (75 MHz, DMSO-d6) δ 112.5, 121.0, 129.1, 151.7, 168.1.
Yield: 40.8 mg, 99% (99)
4-Aminoacetophenone: 6 Spectral data for the product matched literature values.
O

NH2

1

H-NMR (300 MHz, CDCl3) δ 7.84-7.78 (m, 2H), 6.68-6.62 (m, 2H), 4.11 (bs, 3H);

13

C-NMR

(125 MHz, CDCl3) δ 196.6. 151.0, 131.0, 127.9, 113.7, 26.1. Yield: 40 mg, 98% (99)
2-Aminoacetophenone: 8 Spectral data for the product matched literature values.
O
NO2

1

H NMR (300 MHz, CDCl3) δ 7.71 (1H, d, J = 8.0 Hz), 7.30 –7.10 (3H, m), 6.76 (1H, d, J = 8.0

Hz), 6.53 (1H, t, J = 8.0 Hz), 2.50 (3H, s); 13C NMR (125 MHz, CDCl3) δ 200.15, 151.04, 134.17,
132.22, 116.85, 114.38, 27.84 (+ one aromatic signal overlapping). Yield 40 mg, 98% (99).
Benzene-1, 4-diamine: 1 Spectral data for the product matched literature values.
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NH2

NH2

1

H NMR (300 MHz, CDCl3): 6.57 (s, 4H), 3.30 (br s, 4H);

13

C NMR (75 MHz, CDCl3): 138.5,

116.7.
Benzene-1, 2-diamine: 1 Spectral data for the product matched literature values.
NH2
NH2

1

H NMR (300 MHz, CDCl3): 6.6-6.56 (m, 2H), 6.48-6.45 (m, 2H), 4.40 (br s, 4H); 13C NMR (75

MHz, CDCl3): 134.3, 117, 114.2 Yield: 40.5 mg, 99%, (99).
4-Ethynylaniline: 4 Spectral data for the product matched literature values.

NH2

1

HNMR (300 MHz, CDCl3): δ 7.29 (d, 2H, J = 8.64 Hz), 6.59 (d, 2H, J = 8.67 Hz), 3.81 (s, 2H),

2.96 (s, 1H). 13CNMR (75 MHz, CDCl3): δ 146.98, 133.41, 114.53, 111.21, 84.36, 74.89. Yield:
38.6 mg, 97% (97).
4-(Ethynyloxy)) aniline: 9 Spectral data for the product matched literature values.
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O

NH2

Yield: 40.4 mg, 97% (97)
4-(Vinyloxy) aniline: 9 Spectral data for the product matched literature values.

O

NH2

1

H-NMR (300 MHz, CDCl3) δ 6.78-6.75 (m, 2H), 6.65-6.62 (m, 2H), 6.07-6.02 (m, 1H), 5.41-

5.37 (m, 1H), 5.27-5.25 (m, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 151.8, 140.2, 133.9, 117.3,
116.4, 116.0, 69.6. Yield: 40.8 mg, 98 (99).
(E)-4-Styrylaniline: 5 Spectral data for the product matched literature values.
Ph
H2 N

1

H-NMR (300 MHz, CDCl3) δ 7.50-7.44 (m, 2H), 7.37-7.29 (m, 4H), 7.24-7.17 (m, 1H), 7.03 (d,

J = 16.3 Hz, 1H), 6.91 (d, J = 16.3 Hz, 1H), 6.71.6.65 (m, 2H), 3.74 (bs, 2H) ppm; 13C NMR (125
MHz, CDCl3) δ 146.2, 137.9, 128.7, 128.6, 128.0, 127.8, 126.9, 126.1, 125.1, 115.2. Yield: 43
mg, 98 % (99).
5-Aminoindole: 1 Spectral data for the product matched literature values.
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H2 N
N
H

1

H NMR (300 MHz, DMSO-d6) δ 10.57 (s, 1H), 7.12 (t, J = 2.7 Hz, 1H), 7.09 (d, J = 8.5 Hz, 1H),

6.69 (d, J = 2.0 Hz, 1H), 6.49 (dd, J = 8.5, 2.1 Hz, 1H), 6.23 – 6.00 (m, 1H), 4.44 (s, 2H).

13

C

NMR (75 MHz, DMSO-d6) δ 141.4, 130.1, 128.9, 125.1, 112.2, 111.8, 103.6, 100.0. Yield: 40
mg, 98% (99).
8-Aminoquinoline: 1 Spectral data for the product matched literature values.
NH2

N

1

H NMR (300MHz, CDCl3) δ: 8.65 (d, J = 3.6, 1H), 7.89 (t, J = 8.2, 2H), 7.26 (m, 1H), 7.15 (d,

J= 8.0, 1H), 6.88 (d, J = 2.8, 1H), 3.88 (s, 2H). 40 mg, 97% (90).
5.6 Nanoparticle Characterization
Characterization of Ru-Co/polystyrene nanoparticles: Statistical analysis of the size
distribution of the nanoparticles was performed to demonstrate that the average particle size in
each of the 4 polymer supports (6a–6d) was similar, and that variations in nanoparticle size was
not principally responsible for variations in the catalytic activity of the nanoparticle catalysts. For
metal loadings in each polymer, see figure S5.2-5.5.
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a

b

Figure S5.2 STEM image Ru-Co polystyrene catalyst (6a). (a) STEM Image of polymerencapsulated nanoparticles. (b) Statistical analysis of nanoparticle size (average size: 1.9 nm).

a

b

Figure S5.3 STEM image of Ru-Co poly (4-Methylstyrene) catalyst (6c). (a) STEM Image of
polymer-encapsulated nanoparticles. (b) Statistical analysis of nanoparticle size (average size:
1.5 nm)
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a

b

Figure S5.4 STEM image Ru-Co (poly-4-methoxystyrene) catalyst (6d). (a) STEM Image of
polymer-encapsulated nanoparticles. (b) Statistical analysis of nanoparticle size (average size:
1.75 nm).

a

b

Figure S5.5 Ru-Co poly(4-CF3styrene) catalyst (6b). (a) STEM Image of polymer-encapsulated
nanoparticles. (b) Statistical analysis of nanoparticle size (average size: 2.0 nm).
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5.8 XPS and ToF-SIMS Studies:

Figure S5.6. XPS survey spectrum of Co-Ru nanoparticles in a polystyrene matrix. The peak
energies are labeled with their maxima from the corresponding narrow scans, with the exception
of the C 1s spectrum (see Figure 6.5).

Figure S5.7. XPS narrow scans of Co-Ru nanoparticles in a polystyrene matrix. (A) Carbon (C
1s), (B) Oxygen (O 1s), (C) Ruthenium (Ru 3p), and (D) Cobalt (Co 2p)
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Figure S5.6 is an X-ray photoelectron spectroscopy (XPS) survey scan of Co-Ru nanoparticles
dispersed in a polystyrene (PS) matrix, and Figure 6.5 shows the corresponding C 1s, O 1s, Ru
3p, and Co 2p XPS narrow scans. We now describe the analysis of this data below, element by
element, as follows:
•

Oxygen A modest O 1s signal is present in the survey spectrum along with its
corresponding KLL Auger signal at ca. 978 eV. The O 1s narrow scan was peak fitted. The
portion of the peak at 531 eV (see Figure S7B) is consistent with the presence of metal
oxide, and the shifted O 1s peak at 533 eV suggests oxygen bonded to carbon.1-3

•

Carbon The carbon 1s signal was complex. The small peak at ca. 280 eV in the C 1s
narrow scan is attributed to the Ru 3d5/2 signal. The overlap of the Ru and C signals at ca.
285 eV is well known. Accordingly, there should be a Ru 3d3/2 peak +4.17 eV from the Ru
3d5/2 signal,4 and theoretically these peaks should have a 3:2 area ratio. Excluding the
signal at ca. 294 eV, which was attributed to the carbon shake-up peak from aromatic
carbon in polystyrene, we attempted to fit the remainder of the C 1s envelope to a single C
1s signal and to two appropriately constrained Ru 3d signals. After a series of
unsuccessful attempts, we added an additional carbon signal. A good fit to the data was
obtained with these four peaks. It is not entirely clear what the source of the two C 1s
signals is. For example, there is the possibility that the catalyst is in some way interacting
with or altering the polystyrene matrix around it, leaving some of the carbon in a reduced
state and some of it in a more oxidized state. More work in this area will be needed to
fully understand these results. The positions of the peaks in the fit were: Ru 3d signals:
280.9 eV and 285.0 eV, and C 1s signals: 284.7 eV and 287.0 eV. It is very common to
reference XPS spectra to the C 1s peak position, which is often taken at 284.6 eV or 285.0
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eV. Unfortunately, due to the ambiguity inherent in peak fitting, the overlap of these
signals left us without a good reference point that we could apply to the remainder of the
data.
•

Cobalt A series of peaks for Co (3p at 63 eV, 3s at 104 eV, 2p3/2 at 781 eV, 2p1/2 at 796
eV, and 2s at 928 eV) is present in the survey spectrum, which leaves little doubt as to the
presence of this element. The peak shapes for the Co 2p signals in Figure S7 suggest that
Co is in a +2 or +3 oxidation state.3, 5-6 The presence of oxidized Co would be consistent
with at least some of the O 1s signal at ca. 531 eV.

•

Ruthenium A series of peaks for Ru (4p at 43 eV, 4s at 75 eV, 3p3/2 at 462 eV, and 3p1/2 at
484 eV) are present in the survey spectrum, which again provides strong proof for the
presence of this element in the sample.

Given the overlap of the Ru 3d and C 1s signals/lack of a clear reference point, we undertook the
following analysis to determine the oxidation states of Co and Ru in the sample. Table S1 gives
the peak positions for the Ru 3p and Co 2p signals from the reduced (metallic) metals, which
were obtained from the literature, and also from the Ru and Co narrow scans in Figure S7. For
metallic Co and Ru, the spacings between the Co 2p3/2 and Ru 3p3/2 peaks and between the Co
2p1/2 and Ru 3p1/2 peaks are 316 eV and 309 eV, respectively. The spacings between these peaks
in the narrow scans in Figure S7 are 318.7 eV and 312.1 eV, respectively. Given the fact that (i)
the Ru peaks in the spectra are within an eV of where they would be for metallic Ru, and (ii) the
Co peaks in the spectra are shifted about +3 eV from where they would be in metallic Co, we
believe that the shift between these peaks (+3 eV greater than the shift between the peaks in the
metallic elements) indicates that Co is in an oxidized state and that Ru is in a reduced state.
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Unfortunately, the literature is not entirely clear as to whether Co is in a +2 or a +3 oxidized
state.7
Overall, the sample composition of this material by XPS is 88.9 at.% C, 7.8 at.% O, 1.6 at.% Co,
and 1.7 at.% Ru.
Figure S8 is a positive ion time-of-flight secondary ion mass spectrometry (ToF-SIMS) spectrum
of the sample. The large peak at m/z = 59 is from cobalt (Co+), and the series of peaks from 96 to
104 are from isotopes of Ru, which are present in good agreement with their natural abundances
(see Table S4). Thus, ToF-SIMS provides a strong confirmation of the presence of Co and Ru in
this sample. The Na+ peak at m/z = 23 is attributed to sample treatment with NaBH4. The signals
at m/z = 91 (the tropylium cation), 103, and 105 are known fragments from the PS matrix (shown
in Figure S8).
Table S5.2. Positions of the Co 2p3/2, Co 2p1/2, Ru 3p3/2, and Ru 3p1/2 peaks in metallic Co and Ru
(from the literature), and from Co/Ru nanoparticles in a polystyrene matrix.

Peak

Co 2p3/2

Ru 3p3/2

Co 2p1/2

Ru 3p1/2

B. E.
Difference

B. E.
(experimental)/eV

781

462

319

B. E. (reference)/eV

778

462

316

B. E.
(experimental)/eV

797

485

312

B. E. (reference)/eV

793

484

309
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Figure S5.8 Positive ion time-of-flight (TOF)-secondary ion mass spectrometry of Co-Ru
nanoparticles in a polystyrene matrix.
Table S5.3 Natural abundances of Ru isotopes and experimental peak areas of Ru+ signals from
Co/Ru nanoparticles in a polystyrene matrix.
Isotope
96

Ru
Ru
99
Ru
100
Ru
101
Ru
102
Ru
104
Ru
98

Natural Abundance
5.54 %
1.87 %
12.76 %
12.60 %
17.06 %
31.55 %
18.62 %

ToF-SIMS Peak
Area
5.22 %
1.98 %
14.60 %
15.58 %
19.10 %
27.26 %
16.25 %

5.9 Instrumentation
X-ray photoelectron spectroscopy (XPS) XPS was performed with an SSX-100 instrument
(Surface Science, serviced by Service Physics, Bend, OR). Monochromatic Al Ka X-rays were the
excitation source, the take off angle was 35°, and a hemispherical analyzer was used. Sample
charging was controlled with an electron flood gun. The following parameters were used for high
resolution data acquisition: window width: 40 eV for C, O, and Ru, and 60 eV for Co, eV/step:
0.065 eV, resolution: 3 (pass energy: 100 eV), number of scans: 40, and spot size: 500 µm. The C
1s spectrum, including the Ru 3d signals were fitted as follows. A Shirley background was
employed. All of the peaks were constrained to have the same widths, which floated in the fit to a
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value of 2.1 eV. The peaks were 90:10 Gaussian: Lorentzians without asymmetry. The heights of
the Ru 3d signals were constrained to have their theoretical 3:2 ratio.
Static time-of-flight secondary ion mass spectrometry (ToF-SIMS) was performed on a TOFSIMS IV instrument (ION-TOF GmbH, Mϋnster, Germany) with a 25 keV Ga+ source over a 250
x 250 μm2 sample area. The sample was not observed to charge so no charge compensation
(electron flood gun) was employed. For each sample, three spots were analyzed in positive ion
mode and three in the negative mode. Care was taken not to analyze the same area of the sample
twice. The total ion flux (7.2 x 1011 ions/cm2) was controlled to keep the experiment within the
static limit.
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Chapter-6
Chemo and Regioselective Alkyl and Aryl Azide Reductions with
Recoverable Heterogeneous Nanoparticle Catalysts
6.1 Introduction
Amines are an important functional group in pharmaceuticals, dyes and polymers. One of
the most common routes to make amines is by reduction of the corresponding azide. Azides are
excellent nucleophiles and, due to their low Lewis basicity, act like protected amines that can be
easily deprotected via reduction.1-3 Selective reduction of azides in the presence of other easily
reducible functional groups is a significant challenge in organic synthesis because azides are
generally reduced near the end of a synthesis when other sensitive functional groups are present.
The two state-of-the-art approaches to azide reductions include hydrogenations in the presence of
transition metal catalysts like palladium and platinum (Figure 6.1a), and Staudinger reductions
with electron-rich phosphines4-5 (Figure 6.1b). Hydrogenation using transition metal catalysts is
an effective method to reduce azides to amines,11 but often proceeds with limited
chemoselectivity. Staudinger reductions are known to proceed with excellent chemoselectivity
compared to transition metal catalyzed hydrogenations, but Staudinger reductions generates
stoichiometric amounts of phosphines oxide waste, which is hazardous to the environment and
can require tedious separations to remove.

(a)

(b)

R

N3

R

N3

R = alkyl/ aryl

Palladium/Platinum on Carbon
Hydrogen gas, solvent
R 3P
H2O/ THF
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R

NH2 + R3P

R

O

NH2

Figure 6.1 Common methods used for azide reductions to amines
Recent developments in the design and synthesis of catalytically active transition metal
nanoparticle catalysts have demonstrated that polymer-supported nanoparticles can serve as
highly efficient catalysts for organic synthesis. Transition metal nanoparticles are highly efficient
catalysts due to their high surface to volume ratio, which increases the number of active sites at
the metal surface. Our group is particularly interested in the potential to tune not only the
reactivity of nanoparticle catalysts, but also influence the selectivity or reactions mediated by
these catalysts. In nanoparticle catalysis, selectivity and catalytic activity can potentially be
enhanced by modifying the nanoparticle composition, by control of size, shape and morphology,
and by careful selection of a suitable nanoparticle support/stabilizer. In the previous chapter, we
described our efforts to use polymer structure to control the catalytic activity of Ru-Co
nanoparticle catalysts for chemoselective nitroarene reductions. This chapter will discuss our
efforts to develop highly chemoselective and regioselective catalysts for azide reductions using
monometallic ruthenium nanoparticles supported on commercially available polystyrene.
Regioselective reductions of one azide in the presence of multiple azides is also demonstrated.
This report represents the first example of transition metal nanoparticle catalyzed regioselective
reduction of azides in the presence of multiple azides.
While several recent publications report that nanoparticle catalysts can perform azide
reduction reactions, these reductions require high temperature and/or stoichiometric amounts of
reducing metals. Kappe et al.6 reported the reduction of aromatic azides and nitro compounds to
amines using iron oxide nanoparticles in the presence of hydrazine hydrate as a reducing agent.
These reactions were shown to proceed rapidly at 150-170 oC under microwave irradiation
conditions (Figure 6.2). Chemoseletivity in this transformation was not demonstrated, and is
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presumed to be low due to the forcing reaction conditions. In addition, concerns arise regarding
the safety of heating the azide-containing compounds to such high temperatures on large scale.

N3

0.25 %Fe3O4 nanocrystals
NH2NH2.H2O (1.8 equiv)

NH2

o
Methanol, 150 C

97 -99 %

Figure 6.2 Reduction of azides to amines using iron oxide nanoparticles
Ranu et al.7 reported the reduction of aromatic azides to amines using copper
nanoparticles in the presence of ammonium formate as reducing agent at 100 oC (Figure 6.3).
While this reaction proceeded in high yield, the optimized conditions require significant metal
loadings (50 mol%), and no reductions alkyl azides or chemoselectivity studies were presented.
N3

R

Cu nanoparticles (0.5 equiv)
HCOONH4(5 equiv)

NH2

H2O, reflux

R

70- 90%

Figure 6.3 Reduction of azides to amines using copper nanoparticles
Garcia-Garibay et al.8 reported photocatalytic reductions of aromatic azides to amines
using cadmium sulfide (CdS) and cadmium selenide (CdSe) nanoparticles in the presence of
sodium formate (Figure 6.4). In this reduction, the yields of meta substituted compounds are
comparatively lower than ortho- and para-substituted compounds. In addition, this reduction was
only shown to proceed with aromatic azides, and no information on the potential synthetic utility
or chemoselectivity was provided.

147

N3

CdS/CdSe

NH2

Sodium formate
sunlight

Figure 6.4 Reduction of aromatic azides to amines using CdS/CdSe nanoparticles
In the examples presented above, the application of the nanoparticle catalysts is limited
because of low chemoselectivity for azide reduction, the need for high temperatures, and a lack of
information on the substrate scope of the transformations. Due to the limitations associated with
current methods for chemoselective azide reduction reactions, our goal was to demonstrate that
polymer-supported nanoparticle catalysts could act as highly efficient and chemoselective
catalysts for azide reductions that proceed under mild reaction conditions. In addition, we desired
to develop catalysts capable of performing both aliphatic and aromatic azide reductions. We also
desired to investigate whether our nanoparticle catalysts could achieve high regioselectivity in the
mono-reduction of bis and multi-azide containing molecules. This latter effect could provide an
attractive route to the synthesis of differentially-functionalized diamine products.
Our group recently demonstrated the utility of polymer-supported Ru-Co bimetallic
nanoparticles in nitro arene reductions9. In our report, we showed that catalytic activity could be
optimized by modification of the supporting polymer structure. During the course of these studies,
we found that the reduction of aryl azides could occur with high chemoselectivity in the presence
of an easily reduced nitro functional group (Figure 6.5). This exceptional chemoselectivity for
azide reduction has not been demonstrated in nanoparticle catalysis. In this chapter, we report
that polystyrene-supported ruthenium nanoparticles are highly chemoselective catalysts for azide
reductions and that selective mono reductions of multi-azide substrates can be attained with high
levels of regioselectivity.
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N3

2% Ru@PS
NH2NH2.H2O (1.5 equiv)

NH2

Ethanol, r.t. 2h
NO2

NO2

90 % yield

Figure 6.5 Reduction of 1-azido-4-nitrobenzene using Ru NPs supported on polystyrene
6.2. Results and Discussions
6.2.1 Catalyst Preparation
We prepared polystyrene supported ruthenium nanoparticles according to a modified
literature procedure via NaBH4 reduction of a homogeneous solution of ruthenium trichloride
hydrate and polystyrene (MW 35,000). The polymer supported nanoparticles were then
precipitated from solution, washed with deionized water and dried under vacuum. The black
powder thus obtained can be easily recovered and reused from the reaction mixtures by simple
filtration9. The preparation of ruthenium nanoparticles stabilized by polymers of differing
electronic properties was also prepared according to this method.
6.2.2 Catalyst Optimization Studies
The polystyrene-supported ruthenium nanoparticles prepared above were first tested for
catalytic activity and chemoselectivity in the reduction of 1-azidohex-3-ene (Table 6.1). With 3
mol% of our ruthenium catalyst and 3 equivalents of hydrazine hydrate, the azide reduction
reaction goes to completion in just 1 hour with nearly quantitative yield (entry 1). The ruthenium
nanoparticles showed good reactivity and chemoselectivity for reduction of the azide functional
group in the presence of an olefin. In our optimization studies, we found that efficient reduction
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could occur with as little as 1.5 equivalents of hydrazine hdrate (entries 1–3), and with as little as
1 mol% ruthenium catalyst (entries 4–8). For our optimized conditions, we found that reductions
in the presence of 2 mol% ruthenium and with 3 equivalents hydrazine hydrate provided the most
reproducible results over a wide range of substrates
Table 6.1 Optimization of the catalyst

N3
1a

entry
1
2
3
4
5
6
7
8

(X mol%) Ru NP`s

NH2.HCl

(Y equiv) H2N-NH2.H2O
EtOH, RT

Ru@PS
(X mol%)
3
3
3
2
2
2
1
1

NH2NH2.H2O
(Y equiv)
3
2
1.5
3
2
1.5
3
2

2a

Time
(h)
1
1.4
2.1
2
2.5
3.0
3.0
3.0

Yield
(%)
99
97
98
98
98
72
94
86

Reactions run using 0.37 mmol 1, X mol% ruthenium nanoparticles (0.401 mmol/g in polystyrene)
in 2 mL EtOH unless otherwise noted.

We next investigated the impact of the metal loading in the polymer and the composition
of the nanoparticle catalyst had on catalytic activity (Table 6.2). This study showed that the metal
loading in the polymer was inconsequential for catalytic activity (entries 1–4). Thus, the highest
polymer loading (0.4 mmol Ruthenium per gram of polystyrene) was chosen to minimize the
amount of polymer-supported nanoparticle that was required for efficient conversions. We also
investigated whether the Ru-Co nanoparticles used previously for nitroarene reductions were
better catalysts for azide reductions than monometallic ruthenium nanoparticles (entry 5). We
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found that incorporation of cobalt into the nanoparticle had negligible effects on catalytic activity,
and so pure ruthenium nanoparticle catalysts were used for the remainder of our studies.
Table 6.2 Effect of metal loading and nanoparticle composition on catalytic activity.
entry

Ru NPs
(mmol/g)

1
2
3
4
5b

0.4
0.3
0.2
0.1
0.4

a

Ru NPs
(Xmol
%)
2
2
2
2
2

NH2NH2.H2O
(equiv)

Time
(h)

Yield
(%)

3
3
3
3
3

2
2
2
2
2

97
97
96
94
97

a

Reactions run using 0.37 mmol 1, X mol% ruthenium nanoparticles (0.401 mmol/g in
polystyrene) in 1 ml EtOH unless otherwise noted. b Ru-Co (2.5:1) on polystyrene was used.
6.2.3 Substrate Scope of azide reduction
After developing optimal reactions conditions for azide reductions, we next studied the
functional group tolerance of the nanoparticle catalyst for the reduction of aromatic azides (Table
6.3). Thes studies showed that aromatic halides (entries1–3), amides (entry 4), carboxylic acids
(entry 5), esters (entry 6), anilines (entry 7), phenols (entry 8), cyanides (entry 9), ketones (entry
10), and allylic ethers (entry 11) could all be tolerated in the reaction and underwent no observed
reduction. Aromatic bis azides (entry 12) also readily reduce to give the di-aniline product in
high yield. In all the cases tested, the products were obtained in nearly quantitative yield after
removal of the catalyst by filtration and solvent removal.
Table 6.3 Aromatic compounds used in azide reduction. Yields/Selectivity
X

N3

X

2 mol % Ru@PS
NH2NH2.H2O (3 equiv)
EtOH, r.t.

NH2

2a

2
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Substrate

entrya

X

2

Yield/

Time
(h)

Select.b

1

4-Cl

2b

4

98/98

2

4-Br

2c

4

96/98

3

4-I

2d

4

96/97

4

4-CONH2

2e

5

98/99

4-COOH

2f

5

99/99

4-CO2Me

2g

5

99/100

4-NO2

2h

8

98/90

8

4-NH2

2i

5

99/99

9

4-OH

2j

4

98/99

10

4-CN

2k

4

94/99

11

4-Ac

2l

4

99/99

10

98/100c

6

98/100

5

X

6
N3

7

2m

O

12

N3

N3

O

13

2n

N
H
N3

a

Reaction conditions: 2 (0.38 mmol), catalyst (2 mol % Ru), NH2NH2.H2O

(3 equiv.) Ethanol (1mL) at ambient temp. bIsolated yields, c4 mol% catalyst,
NH2NH2.H2O (4 equiv.)
We also studied the chemoselectivity of azide reductions with more synthetically valuable
aliphatic substrates (Figure 6.6). These classes of substrates are easily accessed via substitution
reactions, and thus are widely used in the synthesis of amine-containing molecules. We found that
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benzylic azides containing alkene (3a and 3b) reduce in high yield with high chemoselectivity.
Primary (3o), secondary (3e, 3j), and tertiary (3m) azides are all efficiently reduced under our
standard conditions. Azides containing double bonds (1, 3b, 3p), triple bonds (3c, 3d, 3f), silyl
ethers (3h), alcohols (3j), and acetals (3i), all reacted in excellent yields and almost perfect
chemoselectivity. Azides are often common intermediates in the synthesis of complex, aminecontaining biomolecules, and thus we desired to investigate whether our method could be used in
the synthesis of these valuable intermediates. We found that cholesterol azides (3k), azido sugars
(3n, 3q), nucleosides (3l), and amino acids (3e) all reacted in high yield and with good
chemoselectivity. In all cases tested, the catalytic activity of our polystyrene supported ruthenium
nanoparticles was very good. One limitation to our methodology is that alkyne-containing
benzylic substrates reacted in only moderate yield and with slightly diminished chemoselectivity
(3c, 3d). However, the yield and selectivity of aliphatic alkynes is excellent (3f).
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98/100
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92 %
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N3
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N3
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O
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3h
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N
N3

N

O

O

N3

N3

O

N3

N3

N3

OH

90/98
3i

94/98
3j

N
N

N3

Ph
N3

O

BnO
BnO
H2 N

N3

O

N3

97/99
3k

98/98
3l

98/95
3n
N3

N3

N3

88/95
3o

99/100
3m
BnO
BnO

91 %

O
OBn

99/99
3q

3p

Figure 6.6 Aliphatic substrates used in azide reduction. Yield/Selectivity.
6.2.4 Recyclability studies
We next studied whether the heterogeneous polystyrene supported Ru nanoparticles could be
recycled without loss of activity. We found that our nanoparticle catalysts could be recycled
various times by simply filttering off the reaction mixture, washing the heterogeneous catalyst
with ethanol, and then re-adding reagents for the subsequent reaction. No catalyst reactivation
step was required. We also found that our catalysts could be reused up to six times without
significant loss in product yield or reaction chemoselectivity
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N3

2 % Ru NPs@PS
NH2NH2.H2O (3 equiv)

NH2.HCl

EtOH, r.t. 2h

Run
1

Run
2

Run
3

Run
4

Run
5

Run
6

yield/selectivity 97/100 98/100 96/100 97/100 95/100 91/100
Scheme 6.1 Catalyst Recyclability Studies
6.2.5 Leaching Studies
We next investigated the leaching of Ru nanoparticles into solution to see if the reaction
was catalyzed by homogeneous nanoparticles that leached from the polymer matrix. We removed
the catalyst from the reaction after partial conversion by filtering through a sintered glass funnel.
After removal of the catalyst was added another 4 equivalents of hydrazine hydrate and no further
conversion of the starting material (monitored by NMR) was observed. When the catalyst was
added back to the reaction mixture after several hours the reduction reaction resumed (similar to
Cat-in-a-Cup test) 18. These results suggest that heterogeneous polymer supported nanoparticles
are responsible for the observed catalysis and not homogeneous metal nanoparticles that have
leached from the polymer matrix (figure 6.7).
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Time Vs Conversion (%)
120

Conversion (%)

100
80
60

*

40
20
0
0
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150
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Time (min.)

Figure 6.7 Test for homogeneous nanoparticles. Catalyst was removed by filtration at time points
indicated with *. Catalyst was added back to the reaction at time points indicated by•.
6.2.6 Regioselectivity in Azide Reductions
The regioselective mono-reduction of substrates containing multiple azide functional
groups represents an attractive strategy for synthesizing differentially functionalized polyamine
products. Several groups have reported regioselective reductions of electronically different azide
functional groups with electron-rich phosphines.

For example, Wong et al.10 reported the

regioselective azide reduction of bis azide 3 using trimethyl phosphine at -78 oC to room
temperature (Figure 6.7). In this method, electronic factors play an important role in obtaining
high regioselectivity in the reduction of bis azides.

The azide closer to the more electron

withdrawing acetate functional groups was shown to reduce more quickly. In this section we
discuss our efforts to optimize both the reaction conditions and the catalyst structure to obtain
high regioselectivity in the mono-reduction of bis(azide) containing substrates. We show that
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high regioselectivity for reduction of the sterically most accessible azide is accomplished with our
nanoparticle catalysts.
N3

N3

HO

OAc

PMe3 (1.1 equiv)
BOC-ON (2.2equiv)
THF, -78 o C to r.t.

N3

NHBoc BocHN

HO

OAc

3

N3

HO

4
45 %

BocHN

OAc

NHBoc

HO

OAc

5

6

6%

7%

Figure 6.8 Regioselective reduction of bis-azides using trimethyl phosphine.
We initiated our investigations into regioselective azide reductions using proline-derived
azide bis(azide) 7, which contains both a primary and secondary azido group (Table 6.3). Under
previously-developed conditions for selective azide reductions with electron-rich phosphines, a
1:1 mixture of mono and bis reduced product was formed (entry 1). While our nanoparticle
catalysts did not react at low temperatures (entries 2–3), moderate conversions were observed at 0
°C (entries 4–5). When the reactions was initiated at 0 °C and then warmed to room temperature,
good yield and chemoselectivity was obtained for the mono-reduction of the most sterically
accessible primary azide (entry 6). These preliminary results confirm that regioselectivity can be
obtained for monoreduction of bis(azide) containing substrates.
Table 6.3 Optimization of regioselectivity by changing the temperature
N3

N3
N
Boc
7

entry
1

Ru NPs
(X mol %)
0

N3

1) x mol% Ru NPs@PS
H2N-NH2.H2O (Y equiv.)
EtOH
Et3N
Boc
O,
2)
2

NH2NH2.H2O
(Y equiv)
1.05eq PMe3

Temp.
(o C)
−78

Time
(h)
12
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BocHN
N
Boc

NHBoc

7a

SM recovered
(%Yield)
5

N
Boc

NHBoc

7b

7a
(% Yield)
54

7b
(%Yield)
29

2
3
4
5
6

4
4
4
4
4

4
4
4
4
4

̶ 78
̶ 78
0
0
0-rt

1
4
1
4
5 at rt

100
97
76
20
5

0
3
20
60
68

0
0
3
20
23

We next investigated the impact of polymer structure on the regioselectivity of our
nanoparticle catalysts. Our hypothesis was that by controlling the activity of the nanoparticle by
varying the electronic properties of the nanoparticle, higher selectivity for reduction of the
sterically less hindered azide could be achieved.

In our study, we found that the polymer

structure did in fact have a significant influence on the selectivity of the catalyst for mono azide
reduction (Figure 6.8). Unfortunately, the impact of electronic structure on the ratio of products
formed did not follow any clear trend. In addition, none of the functionalized polymers tested
provided higher selectivity that the corresponding polystyrene polymer. Thus, our additional
studies focused on the use of our polystyrene-supported ruthenium nanoparticles for
regioselective azide reductions.
N3

N3
N
Boc

N3

7

n

R

BocHN

1) 4 mol% Ru NPs
H2N-NH2.H2O (4 equiv.)
o
EtOH, 0 C-r.t. 5h
2) Boc2O, Et3N

N
Boc
7a

NHBoc

N
Boc
7b

70 %
23 %

22 %

R= OMe
R = t-Bu

22 %

38 %

5%

90%

R = Cl

53 %

R = COO i-Pr
R = CF3

44 %

54 %

19 %

28 %

68 %

R=H
R = Me

Figure 6.9 Effect of polymer support on regioselectivity
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73%

NHBoc

Having established that our nanoparticle catalysts are capable of regioselective azide
reductions, we explored the regioselectivity for reduction of primary over secondary azides in a
variety of substrates (Figure 6.9). Primary azides are readily reduced in the presence of
electronically activated benzylic azides (8a–8e). Aromatic azides also reduce with high
regioselectivity over alkyl azides (8g). This regioselective reduction is also amenable to monoreductions of azido sugars (8f) and alkyl bis-azides. In all cases, good yields and moderate to
excellent selectivities could be obtained for the mono-reduction product (Figure 6.10)
N3
O

N3
BnO

O

OBn

4% Ru-P.S
NH2NH2.H2O (3 equiv)

NH2
O

N3
BnO

EtOH 1 mL, 4hours

8f

O

OBn

95 %

N3

4% Ru-P.S
N3 NH2NH2.H2O (3 equiv)
EtOH 1 mL, 4hours

H
N
N
Boc

O

N3
H
N
N
Boc

8g
N3
N3

8f

NH2

O

95 %

2% Ru-P.S
NH2NH2.H2O (3 equiv)

N3

NHBoc
NHBoc

NHBoc

EtOH 1 mL, 5 hours
0 o C to r.t

68 %
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Figure 7.0 Regioselective reduction of bis-azides.
6.3 Conclusion
The chemoselective reduction of azides to amines in the presence of easily reducible
functional groups is an important reaction in organic synthesis. We have developed mild and
highly chemoselective reduction of azides that has broad substrate scope including sugars,
nucleosides, and steroids using polystyrene supported ruthenium nanoparticles. Our ruthenium
nanoparticles also show good regioselectivity for the reduction of primary azides over secondary,
primary azides over benzylic azides, aromatic azides over alkyl azides, and primary over
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secondary azides in sugars. In addition, our polystyrene supported ruthenium nanoparticles are
easily recoverable and recyclable after completion of the reaction by simple filtration.
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6.5 Experimental Section
General Information
All reactions were carried out in oven-dried glassware with magnetic stirring, unless otherwise
indicated. All the reagents were used as obtained unless otherwise noted. Analytical thin-layer
chromatography was performed with 0.25 mm coated commercial silica gel plates (E. Merck,
DC-Plastikfolien, kieselgel 60 F254). Flash Chromatography was performed with EM Science
silica gel (0.040-0.063µm grade) Proton nuclear magnetic resonance (1H-NMR) data were
acquired on a Inova 300 (300 MHz) or on a Inova-500 (500 MHz) spectrometer. Chemical shifts
are reported in delta (δ) units, in parts per million (ppm) downfield from tetramethylsilane.
Carbon-13 nuclear magnetic resonance (13C-NMR) data were acquired on a Inova 500 at 125
MHz. Signals are reported as follows: s (singlet), d (doublet), t (triplet), q (quartet), dd (doublet of
doublets), qd (quartet of doublets), brs (broad singlet), m (multiplet). Coupling constants are
reported in hertz (Hz). Chemical shifts are reported in ppm relative to the center line of a triplet at
77.23 ppm for chloroform-d. Mass spectral data were obtained using ESI techniques (Agilent,
6210 TOF). The content of all metals in the final material was determined by ICP analysis using a
Shimadzu ICPS-7510 instrument. STEM images and EDS analyses were obtained using a JEOL
JEM-2100F instrument operated at 5.0 kV. All STEM specimens were prepared by placing a drop
of a homogeneous chloroform solution of the respective polymer-nanoparticle composite on a
carbon coated copper grid and allowed to dry in air without staining. Polystyrene (MW 35,000)
were purchased from Aldrich. Ruthenium (III) chloride hydrate was purchased from Strem
Chemicals.
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Synthesis of Ru NP`s@Polystyrene
Polystyrene (1g) was added to 25 mL of THF and the mixture was stirred using a Teflon-coated
magnetic stir bar until polystyrene was completely dissolved then 10 mL of ethanol and
Ruthenium (III) chloride hydrate (100 mg, 0.482 mmol) anhydrous basis was added and the
mixture was stirred until the solution became homogenous. Sodium borohydride (182.5 mg, 4.82
mmol) was then added portion wise. The reaction was stirred under argon atmosphere for 10 h
giving a black homogeneous solution, indicating the formation of nanoparticles. The solvent was
then evaporated and millipore water was added to the resulting solid and the mixture was stirred
for 15 minutes then filtered. The solid was then washed with millipore water (20 mL× 5) and
dried under vacuum to give a black solid, which was finely ground with a mortar and pestle
before use.
Characterization of Ru/polystyrene nanoparticles:

Size Distribution of Ru NPs@PS
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Figure 7.1 STEM image of Ru NPs in polystyrene catalyst. (a) STEM Image of polymerencapsulated nanoparticles. (b) Statistical analysis of nanoparticle size (average size: 1.33 nm)
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Figure 7.2 EDS spectrum of the Ru nanoparticles showing the presence of the main components
Ru. Cu and C peak are background from the TEM support grid.

Preparation of the sample for ICP-analysis
To 10 mg of polymer-nanoparticle catalyst was added 1 ml conc. H2SO4 and the mixture heated at
140 oC. HNO3 was then slowly added and the solution was heated for 10 min. 1 mL of aqua regia
was then added and the mixture cooled to room temperature and diluted to 500 mL in a
volumetric flask. Metal concentrations where then determined by ICP analysis by comparison to
standard solutions.
Reuse experiments of Ru NP`s@Polystyrene
The reduction of (E)-1-azidohex-3-ene was performed under the typical reaction conditions in a
flask containing a frit of medium porosity and a bottom stopcock. After completion of the
reaction, the solution was removed via filtration through the frit. The flask was then rinsed with
EtOH (3 ml), 2.0 M HCl in diethylether was added and the filtrate evaporated, to the filtrate
chloroform was added and filtered the solid (unreacted hydrazine), evaporated the filtrate and the
isolated yield and selectivity were determined. To the remaining nanoparticle catalyst was added a
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new set of reagents and solvents and the reaction was allowed to proceed for the same time. This
procedure was repeated 6 times (scheme 6.1)
Reduction of (E)-1-azidohex-3-ene (1a)
General Procedure:
A typical procedure for the reduction of azido compounds by Ru NPs@Polystyrene is as follows:
Ru NPs@Polystyrene (17 mg, 2 mol% wrt ruthenium) was placed in a 10 mL test tube containing
a Teflon-coated magnetic stir bar, followed by the addition of ethanol (1 mL), (E)-1-azidohex-3ene (50 mg, 0.399 mmol), and dropwise addition of hydrazine monohydrate (1.19 mmol, 58 µL, 3
equiv) at room temperature. The reaction vessel was then sealed with a glass stopper and stirred
for 2 h. After the reaction, Ru NPs@Polystyrene was removed by filtration through a small plug
of silicagel in a pipet, and the solids washed several times with ethanol. The filtrate was collected,
and the solvent removed under reduced pressure on a rotary evaporator to provide the product
(39.6 mg, 0.332 mmol, 98% yield, and 100% selectivity) in excellent purity, which did not require
further purification. The selectivity of the reaction was determined by 1H NMR analysis of the
pure product obtained as described. (2a) 1H NMR (500 MHz, CDCl3): 8.2 (br m, 4H), 4.4-4.1
(brs, 1 H), 5.7-5.6 (m, 1H), 5.38-5.33 (m, 1H), 3.13-2.91 (m, 2H), 2.58-2.35 (m, 2H), 2.0 (t, 2H, J
= 6.9 Hz), 0.98 (t, 3H, J = 7.2Hz); 13C NMR (125 MHz, CDCl3): 137.2, 122.5, 39.7, 30.5, 25.5,
13.4. Yield: 98 % (100)
N3

3p
1

H NMR (500 MHz, CDCl3) δ 4.85−4.79 (d, 2H), 3.38 (t, J = 7.2 Hz, 2H), 2.31 (t, J = 7.2 Hz,

2H), 1.76 (s, 3H); 13C NMR (125 MHz, CDCl3): 141.7, 112.6, 49.4, 36.7, 22.25.
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NH2.HCl

1

H NMR (500 MHz, CDCl3) δ 4.88 (d, 2H), 3.14 (t, J = 7.2 Hz, 2H), 2.49 (t, J = 7.2 Hz, 2H), 1.77

(s, 3H); 13C NMR (125 MHz, CDCl3) δ 140, 113.7, 37.9, 35.2, 22.2. Yield: (92 % (100).
N3
NHBoc

1

H NMR (500 MHz, CDCl3) δ 7.44−7.30 (m, 5H), 4.86 (brs, 1H), 4.75−4.67 (m, 1H), 3.33−3.19

(m, 1H), 1.46 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 155.7, 137.1, 128.9, 128.8, 128.6, 128,
126.5, 79.8, 65.6, 55.6, 46.11, 28.35. Yield: 70 %
NHBoc
NHBoc

1

H NMR (500 MHz, CDCl3) δ 7.41−7.25 (m, 5H), 5.55 (brs, 1H), 4.94−4.67 (m, 2H), 3.59−3.32

(m, 2H), 1.47 (s, 9H), 1.44 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 128.7, 127.6, 126.3, 80.5,
55.9, 45.8, 28.36. Yield: 21 %
N3
NHBoc
Me

1

H NMR (500 MHz, CDCl3) δ 7.13 (s, 4H), 4.81−4.71 (m, 1H), 4.63−4.54 (m, 1H), 3.44−3.30 (m,

1H), 3.20−3.10 (M, 1H), 2.28 (s, 3H), 1.37 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 155.7, 138.5,
134, 129.6, 126.9, 65.4, 46.0, 28.3, 21.1. Yield: 65 %
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NHBoc
NHBoc
Me

1

H NMR (500 MHz, CDCl3) δ 7.15 (s, 4H), 5.47 (brs, 1H), 4.89 (brs, 1H), 4.71 (brs, 1H),

3.56−3.20 ( m, 2H), 2.33 (s, 3H), 1.44 (s, 9H), 1.42 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 156.8,
155.7, 137.2, 129.4, 126.2, 79.6, 55.6, 45.9, 28.3, 21.1. Yield: 18 %
N3
NHBoc
MeO

1

H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 9 Hz, 2H), 6.95 (d, J = 8.8 Hz, 2H), 4.84 (brs, 1H),

4.71−4.58 (m, 1H), 3.84 (s, 3H), 3.53−3.39 (m, 1H), 3.32−3.18 (m, 1H), 1.47 (s, 9H); 13C NMR
(125 MHz, CDCl3) δ 159.8, 129, 128.2, 127.7, 114.3, 114.2, 65.2, 55.3, 46.0, 28.2. Yield: 79 %
NHBoc
NHBoc
MeO

1

H NMR (500 MHz, CDCl3) δ 7.20 (d, J = 8 Hz, 2H), 6.88 (d, J = 9 Hz, 2H), 5.39 (brs, 1H), 4.82

(brs, 1H), 4.74−4.64 (m, 1H), 3.8 (s, 3H), 3.55−3.25 (m, 2H), 1.45 (s, 9H); 13C NMR (125 MHz,
CDCl3) δ 159, 127.5, 114.11, 113.8, 55.29, 45.8, 29.7, 28.3, 28.2. Yield: 10 %
N3
NHBoc
Br

1

H NMR (500 MHz, CDCl3) δ 7.53 (d, J = 8.5 Hz, 2H), 7.21 (d, J = 8 Hz, 2H), 4.85 (brs, 1H),

4.72−4.65 (m, 1H), 3.49−3.39 (m, 1H), 3.25−3.14 (m, 1H), 1.45 (s, 9H); 13C NMR (125 MHz,
CDCl3) δ 155.6, 136.2, 132.1, 128.6, 122.6, 80.0, 65.0, 55.4, 46.1, 28.3. Yield: 67 %
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NHBoc
NHBoc
Br

1

H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.4 Hz, 2H), 5.6 (brs, 1H),

4.8 (brs, 1H), 4.76−4.60 (m, 1H), 3.53−3.27 (m, 2H), 1.47 (S, 9H), 1.43 (s, 9H); 13C NMR (125
MHz, CDCl3) δ 157.0, 155.6, 131.8, 128.1, 121.4, 80.0, 55.8, 45.6, 28.3, 28.1. Yield: 25 %
N3
NHBoc
F3C

1

H NMR (500 MHz, CDCl3) δ 7.7−7.2 (m, 2H), 7.51−7.43 (m, 2H), 4.89 (brs, 1H), 4.81 (brs, 1H),

3.54−3.45 (m, 1H), 3.28−3.19 (m, 1H), 1.44 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 155.6, 154.9,
141.2, 130.9, 130.6, 130.3, 127.3, 126.9, 125.9−15.77 (m), 80.0, 65.0, 55.4, 46.2, 28.3. Yield: 66
%
NHBoc
NHBoc
F3C

1

H NMR (500 MHz, CDCl3) δ 7.63 (d, J = 8.1 Hz, 2H), 7.43 (d, J = 8.1 Hz, 2H), 5.78 (brs, 1H),

4.82 (brs, 2H), 3.42 (brs, 2H), 1.47 (s, 9H), 1.44 (s, 9H). Yield: 14 %
NH2
N3
BnO

1

O

O

OBn

H NMR (500 MHz, CDCl3) δ 7.42−7.2 (m, 10H), 4.87−4.70 (m, 3H), 4.68−4.52 (m, 2H),

4.0−3.96 (m, 1H), 3.92−3.77 (m, 2H), 3.69−3.58 (m, 1H), 3.36 (s, 3H), 3.0−2.87 (m, 1H),
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2.78−2.65 (m, 1H);

13

C NMR (125 MHz, CDCl3) δ 128.5, 128.4, 128.1, 128.0, 127.9, 127.8,

127.7, 127.0, 98.6, 78.1, 76.6, 73.8, 73.2, 70.0, 62.0, 55.4, 43.1. Yield: 95 %
N3
NHBoc

1

H NMR (500 MHz, CDCl3) δ 4.86 (brs, 1H), 3.58−3.51 (m, 1H), 3.42−3.34 (m, 1H), 3.0−2.93

(m, 1H), 1.84−1.75 (m, 1H), 1.44 (s, 9H), 1.43−1.38 (m, 1H), 1.32−1.24 (m, 1H), 0.97−0.93 (m,
6H); 13C NMR (125 MHz, CDCl3) δ 155.8, 60.8, 44.7, 40.7, 28.3, 24.9, 22.9, 22.0. Yield: 68 %
NHBoc
NHBoc

1

H NMR (500 MHz, CDCl3) δ 4.88 (brs, 1H), 4.49 (brs, 1H), 3.72 (brs, 1H), 3.27−3.07 (m, 2H),

1.74−1.64 (m, 1H), 1.35−1.18 (m, 2H), 0.97−0.83 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 156.5,
156.18, 79.2, 49.3, 45.4, 42.1, 28.4, 28.3, 24.8, 23.0, 22.2. Yield: 15 %
N3
NHBoc
N
Boc

1

H NMR (500 MHz, CDCl3) δ 5.1 (brs, 1H), 4.2−3.8 (m, 3H), 3.3−3.28 (m, 1H), 3.15−3.05 (m,

1H), 2.43−2.3 (m, 1H), 1.8−1.72 (m, 1H), 1.46 (s, 18 H); 13C NMR (125 MHz, CDCl3) δ 155.3,
154.4, 80.2, 79.7, 55.7, 53.3, 52.7, 48.5, 34.7, 28.4, 28.3, 28.2. Yield: 70 %
BocHN
NHBoc
N
Boc

1

H NMR (500 MHz, CDCl3) δ 5.4 (brs, 1H), 5.2 (brs, 1H), 4.0 (brs, 1H), 3.82−3.68 (m, 2H),

3.4−3.0 (m, 3H), 2.32−2.08 (m, 1H), 1.7−1.57 (m, 1H), 1.38 (s, 27 H);
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13

C NMR (125 MHz,

CDCl3) δ 156.7, 155.6, 154.2, 80.1, 79.5, 56.8, 53.4, 49.4, 43.9, 34.2, 30.9, 28.4, 28.3. Yield: 22
%.
N3

HN
N
Boc

1

NH2

O

H NMR (500 MHz, CDCl3) δ 7.28, (t, J = 8.5 Hz), 6.64 (t, J = 8 Hz), 4.57-4.16 (m, 1H), 3.8-3.3

(m, 3H), 2.59-2.17 (m, 1H), 2.04, 1.87 (m, 1H), 1.4 (d, 9H). Yield (95%).
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Appendix A
Spectral images for Chapters 2, 5 and 6
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